<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001837.pub2" GROUP_ID="TOBACCO" ID="914599071913365018" MERGED_FROM="" MODIFIED="2012-04-17 14:01:16 +0200" MODIFIED_BY="Jamie Hartmann-Boyce" REVIEW_NO="22" REVMAN_SUB_VERSION="5.1.6" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="12.4">
<COVER_SHEET MODIFIED="2012-04-17 14:01:16 +0200" MODIFIED_BY="Jamie Hartmann-Boyce">
<TITLE>Interventions for smoking cessation in hospitalised patients</TITLE>
<CONTACT MODIFIED="2012-04-17 14:01:16 +0200" MODIFIED_BY="Jamie Hartmann-Boyce"><PERSON ID="16603" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Nancy</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Rigotti</LAST_NAME><POSITION>Director of Tobacco Research &amp; Treatment</POSITION><EMAIL_1>nrigotti@partners.org</EMAIL_1><ADDRESS><DEPARTMENT>Tobacco Research and Treatment Center, Department of Medicine</DEPARTMENT><ORGANISATION>Massachusetts General Hospital and Harvard Medical School</ORGANISATION><ADDRESS_1>S50-9</ADDRESS_1><CITY>Boston</CITY><ZIP>02114</ZIP><REGION>Massachusetts</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 617 724-3548</PHONE_1><FAX_1>+1 617 724-6774</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2012-04-17 14:01:16 +0200" MODIFIED_BY="Jamie Hartmann-Boyce"><PERSON ID="16603" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Nancy</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Rigotti</LAST_NAME><POSITION>Director of Tobacco Research &amp; Treatment</POSITION><EMAIL_1>nrigotti@partners.org</EMAIL_1><ADDRESS><DEPARTMENT>Tobacco Research and Treatment Center, Department of Medicine</DEPARTMENT><ORGANISATION>Massachusetts General Hospital and Harvard Medical School</ORGANISATION><ADDRESS_1>S50-9</ADDRESS_1><CITY>Boston</CITY><ZIP>02114</ZIP><REGION>Massachusetts</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 617 724-3548</PHONE_1><FAX_1>+1 617 724-6774</FAX_1></ADDRESS></PERSON><PERSON ID="00175645592969318203110707120830" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Carole</FIRST_NAME><LAST_NAME>Clair</LAST_NAME><EMAIL_1>carole.willi@gmail.com</EMAIL_1><EMAIL_2>CCLAIR@PARTNERS.ORG</EMAIL_2><ADDRESS><DEPARTMENT>Department of Ambulatory Care and Community Medicine</DEPARTMENT><ORGANISATION>University of Lausanne</ORGANISATION><ADDRESS_1>Rue du Bugnon 44</ADDRESS_1><CITY>Lausanne</CITY><ZIP>1011</ZIP><COUNTRY CODE="CH">Switzerland</COUNTRY></ADDRESS></PERSON><PERSON ID="16591" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Marcus</FIRST_NAME><MIDDLE_INITIALS>R</MIDDLE_INITIALS><LAST_NAME>Munafò</LAST_NAME><POSITION>Lecturer</POSITION><EMAIL_1>marcus.munafo@bristol.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Department of Experimental Psychology</DEPARTMENT><ORGANISATION>University of Bristol</ORGANISATION><ADDRESS_1>8 Woodland Road</ADDRESS_1><CITY>Bristol</CITY><ZIP>BS8 1TN</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 117 954 6841</PHONE_1><FAX_1>+44 117 928 8588</FAX_1></ADDRESS></PERSON><PERSON ID="8169" ROLE="AUTHOR"><PREFIX>Mrs</PREFIX><FIRST_NAME>Lindsay</FIRST_NAME><MIDDLE_INITIALS>F</MIDDLE_INITIALS><LAST_NAME>Stead</LAST_NAME><POSITION>Managing Editor</POSITION><EMAIL_1>lindsay.stead@phc.ox.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Department of Primary Care Health Sciences</DEPARTMENT><ORGANISATION>University of Oxford</ORGANISATION><ADDRESS_1>23-38 Hythe Bridge Street</ADDRESS_1><CITY>Oxford</CITY><ZIP>OX1 2ET</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1865 289285</PHONE_1><FAX_1>+44 1865 289287</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2012-04-10 12:03:24 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="8" MONTH="3" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="15" MONTH="12" YEAR="2011"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR=""/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="1999"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2007"/>
</DATES>
<WHATS_NEW MODIFIED="2012-04-10 09:19:42 +0100" MODIFIED_BY="L S">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2012-04-10 09:19:42 +0100" MODIFIED_BY="Lindsay Stead">
<DATE DAY="29" MONTH="3" YEAR="2012"/>
<DESCRIPTION>
<P>Main conclusions unchanged. Small changes to the conclusions about the effects of pharmacotherapies as adjuncts to counselling.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-03-29 12:49:59 +0100" MODIFIED_BY="Lindsay Stead">
<DATE DAY="29" MONTH="3" YEAR="2012"/>
<DESCRIPTION>
<P>Updated with the addition of 17 new included studies. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2012-03-29 12:47:50 +0100" MODIFIED_BY="L S">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-03-29 12:47:50 +0100" MODIFIED_BY="Lindsay Stead">
<DATE DAY="1" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2008-08-07 15:50:25 +0100" MODIFIED_BY="L S">
<DATE DAY="20" MONTH="5" YEAR="2007"/>
<DESCRIPTION>
<P>Updated for issue 3, 2007. Sixteen new trials added to the seventeen trials previously included. Most of the new trials tested intensive counselling interventions. Three of the new trials tested pharmacotherapy (nicotine replacement or bupropion) as an adjunct to behavioral counselling.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2008-08-07 16:12:48 +0100" MODIFIED_BY="L S">
<DATE DAY="26" MONTH="8" YEAR="2002"/>
<DESCRIPTION>
<P>Updated for issue 1, 2003. Two new trials were included, both of a moderately intensive intervention conducted during the hospital stay</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Department of Primary Health Care, Oxford University</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>NHS Research and Development Programme</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>NIH / NHLBI Mid-career Investigator Award in Patient Oriented Research (#K24-044440)</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-04-17 12:59:43 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2012-04-05 14:03:54 +0100" MODIFIED_BY="Kate Cahill">
<TITLE MODIFIED="2012-04-05 14:03:08 +0100" MODIFIED_BY="Kate Cahill">Interventions started during hospitalisation to help people to stop smoking</TITLE>
<SUMMARY_BODY MODIFIED="2012-04-05 14:03:54 +0100" MODIFIED_BY="[Empty name]">
<P>Smoking contributes to many health problems including cancers, cardiovascular disease and lung diseases. Smoking also increases the risk associated with hospitalisation for surgery. People who are in hospital because of a smoking-related illness are likely to be more receptive to help to give up smoking. Our review of fifty trials found that effective programmes to stop smoking are those that begin during a hospital stay and include counselling with follow-up support for at least one month after discharge. Such programmes are effective when administered to all hospitalised smokers, regardless of the reason why they were admitted to hospital, and in the subset of smokers who are admitted to hospital with cardiovascular disease. Adding nicotine replacement therapy to a counselling program increases the success rate of a program for hospitalised smokers.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-04-17 12:59:43 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2012-03-29 13:03:31 +0100" MODIFIED_BY="[Empty name]">
<P>Smoking contributes to reasons for hospitalisation, and the period of hospitalisation may be a good time to provide help with quitting.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To determine the effectiveness of interventions for smoking cessation that are initiated for hospitalised patients.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-04-10 12:10:45 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Tobacco Addiction Group register which includes papers identified from CENTRAL, MEDLINE, EMBASE and PsycINFO in December 2011 for studies of interventions for smoking cessation in hospitalised patients, using terms including (hospital and patient*) or hospitali* or inpatient* or admission* or admitted.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2012-04-05 13:54:55 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized and quasi-randomized trials of behavioural, pharmacological or multicomponent interventions to help patients stop smoking, conducted with hospitalised patients who were current smokers or recent quitters (defined as having quit more than one month before hospital admission). The intervention had to start in the hospital but could continue after hospital discharge. We excluded studies of patients admitted to facilities that primarily treat psychiatric disorders or substance abuse, studies that did not report abstinence rates and studies with follow-up of less than six months. Both acute care hospitals and rehabilitation hospitals were included in this update, with separate analyses done for each type of hospital.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two authors extracted data independently for each paper, with disagreements resolved by consensus.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2012-04-10 09:15:50 +0100" MODIFIED_BY="[Empty name]">
<P>Fifty trials met the inclusion criteria. Intensive counselling interventions that began during the hospital stay and continued with supportive contacts for at least one month after discharge increased smoking cessation rates after discharge (risk ratio (RR) 1.37, 95% confidence interval (CI) 1.27 to 1.48; 25 trials). A specific benefit for post-discharge contact compared with usual care was found in a subset of trials in which all participants received a counselling intervention in the hospital and were randomly assigned to post-discharge contact or usual care. No statistically significant benefit was found for less intensive counselling interventions. Adding nicotine replacement therapy (NRT) to an intensive counselling intervention increased smoking cessation rates compared with intensive counselling alone (RR 1.54, 95% CI 1.34 to 1.79, six trials). Adding varenicline to intensive counselling had a non-significant effect in two trials (RR 1.28, 95% CI 0.95 to 1.74). Adding bupropion did not produce a statistically significant increase in cessation over intensive counselling alone (RR 1.04, 95% CI 0.75 to 1.45, three trials). A similar pattern of results was observed in a subgroup of smokers admitted to hospital because of cardiovascular disease (CVD). In this subgroup, intensive intervention with follow-up support increased the rate of smoking cessation (RR 1.42, 95% CI 1.29 to 1.56), but less intensive interventions did not. One trial of intensive intervention including counselling and pharmacotherapy for smokers admitted with CVD assessed clinical and health care utilization endpoints, and found significant reductions in all-cause mortality and hospital readmission rates over a two-year follow-up period. These trials were all conducted in acute care hospitals. A comparable increase in smoking cessation rates was observed in a separate pooled analysis of intensive counselling interventions in rehabilitation hospitals (RR 1.71, 95% CI 1.37 to 2.14, three trials).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2012-04-17 12:59:43 +0100" MODIFIED_BY="[Empty name]">
<P>High intensity behavioural interventions that begin during a hospital stay and include at least one month of supportive contact after discharge promote smoking cessation among hospitalised patients. The effect of these interventions was independent of the patient's admitting diagnosis and was found in rehabilitation settings as well as acute care hospitals. There was no evidence of effect for interventions of lower intensity or shorter duration. This update found that adding NRT to intensive counselling significantly increases cessation rates over counselling alone. There is insufficient direct evidence to conclude that adding bupropion or varenicline to intensive counselling increases cessation rates over what is achieved by counselling alone.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-04-17 12:58:18 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2012-04-05 14:04:45 +0100" MODIFIED_BY="[Empty name]">
<P>Smoking contributes to many of the health problems leading to hospitalisation, particularly vascular disease, respiratory illness and many cancers. In addition, smoking increases the risk associated with hospitalisations for surgical procedures. Hospitalisation, especially for a tobacco-related illness, may boost receptivity to smoking cessation messages by increasing perceived vulnerability, a so-called 'teachable moment'. Illness also brings smokers to the healthcare setting, where they have contact with health professionals who can provide a smoking cessation message or intervention. In addition, procedures such as coronary arteriography that provide detail of the patient's cardiac status may minimise subsequent denial of cardiac risk by the patient (<LINK REF="REF-Ockene-1992" TYPE="REFERENCE">Ockene 1992</LINK>). Many hospitals restrict or prohibit smoking by patients to protect patients and staff from secondhand smoke exposure. This smoke-free environment may also provide an opportunity for smokers to try out tobacco abstinence away from the usual environmental cues to smoke. For these reasons, providing (or at least initiating) tobacco dependence treatments in hospitals may be an effective preventive health strategy.</P>
<P>A number of studies have evaluated smoking cessation services provided or initiated in hospital. The interventions have included behavioural counselling of different forms and intensity (including post-hospitalisation contacts), pharmacological therapies (such as nicotine replacement therapy [NRT], bupropion and varenicline), and combinations of counselling and pharmacotherapy. The aim of this review is to evaluate the effectiveness of smoking cessation interventions initiated during a hospital stay. In order to inform policy, we aimed to identify the components of effective programmes. In addition, we aimed to explore whether there is a difference in effect according to the reason for hospitalisation or whether the effect holds for patients with a variety of admission diagnoses, and whether the effect of interventions in acute care hospitals is also observed in rehabilitation hospitals.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-04-05 14:05:08 +0100" MODIFIED_BY="[Empty name]">
<P>The primary objective was to determine the efficacy of any type of smoking cessation programme for hospitalised patients. Our hypotheses were that:</P>
<UL>
<LI>Systematic behavioural intervention (brief advice, individual counselling, provision of self-help materials, group therapy) increases quit rates more than usual care, and intensive intervention increases quit rates more than brief intervention.</LI>
</UL>
<UL>
<LI>Interventions that occur both in hospital and after discharge increase quit rates more than interventions limited to the hospital stay, and longer post-discharge follow-up increases quit rates more than short follow-up.</LI>
</UL>
<UL>
<LI>Adding pharmacotherapy (such as NRT, bupropion or varenicline) to a behavioural intervention increases quit rates more than placebo or no medication, and combining pharmacotherapy with a behavioural intervention increases quit rates more than either alone.</LI>
</UL>
<P>
<BR/>A secondary objective was to explore the possibility that the efficacy of interventions differed for patients with different diagnoses. This was done using subgroup analysis of trials that recruited patients from more than one specialty, and by indirect comparison of trials that recruited patients from within one disease category. The primary review focuses on interventions for smokers who are admitted to an acute care hospital. Studies of interventions for smokers in rehabilitation hospitals have now been published. This update includes a new separate review of the efficacy of smoking interventions initiated during a stay in a rehabilitation hospital.<I>
<BR/>
</I>
</P>
</OBJECTIVES>
<METHODS MODIFIED="2012-04-10 13:29:37 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2012-04-05 14:07:54 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES>
<P>Randomized or quasi-randomized controlled trials.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2012-04-05 14:06:03 +0100" MODIFIED_BY="[Empty name]">
<P>Participants were patients who were hospitalised and who were currently smoking (defined as having smoked within one month of hospital admission) or had recently quit (defined as having quit more than one month before hospital admission). We excluded trials of secondary prevention or cardiac rehabilitation that did not recruit on the basis of smoking history, and trials in patients hospitalised in facilities that primarily treated psychiatric disorders or substance abuse (including inpatient tobacco addiction programmes). We included interventions that began in either acute care hospitals or rehabilitation hospitals. We included trials that recruited all hospitalised smokers and those limited to patients who planned to quit smoking after hospital discharge. Trials in which 'recent quitters' were classified as smokers were included, but a sensitivity analysis was performed on these data to determine whether they differed from trials that excluded such individuals.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2012-04-05 14:06:47 +0100" MODIFIED_BY="[Empty name]">
<P>Any intervention that was initiated during hospitalisation and that aimed to increase motivation to quit, to assist a quit attempt, or to help recent quitters avoid relapse was included. Interventions that began in hospital and continued after discharge were included. The intervention could be delivered by physicians, nursing staff, psychologists, smoking cessation counsellors or other hospital staff. The intervention could include advice, more intensive behavioural therapy, or smoking cessation pharmacotherapy, with or without continued contact after hospital discharge. The control intervention could be any less intensive intervention, such as brief advice to quit, or it could be usual care. Studies that provided identical treatment consisting of more than usual or minimal care during the hospital stay and then randomly assigned participants to different post-discharge interventions were analysed separately in a sensitivity analysis. We included studies of smoking interventions that were part of a broader risk reduction or rehabilitation programme only if it was possible to extract data on the outcome effects of the smoking cessation component specifically, and if details of the nature of the intervention and control were explicitly stated. We included studies that reported the use of NRT, bupropion, varenicline, or other pharmacotherapy for smoking cessation.</P>
<P>We categorised behavioural interventions during the hospital stay according to whether they included follow-up after discharge. Within these categories we further defined both the hospital and follow-up interventions by level of intensity. This led to four categories of intervention intensity:</P>
<P>1. Single contact in hospital lasting &lt;= 15 minutes, no follow-up support.<BR/>2. One or more contacts in hospital lasting in total &gt; 15 minutes, no follow-up support.<BR/>3. Any hospital contact plus follow-up &lt;=1 month.<BR/>4. Any hospital contact plus follow-up &gt; 1 month.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2012-04-05 14:07:54 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>The principal outcome measure was abstinence from smoking at least six months after the start of the intervention. We used the most conservative measure of quitting at the longest follow-up, i.e. we preferred a biochemically validated quit rate to self-reported abstinence, and preferred continuous or sustained abstinence to point prevalence abstinence. We used abstinence at 12-month follow-up in preference to abstinence at six-month follow-up. We counted participants lost to follow-up as continuing smokers.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-04-10 12:14:32 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Tobacco Addiction Group trials register in December 2011. This specialised register is regularly updated by electronic searches of databases including CENTRAL (2011 Issue 4), MEDLINE (via OVID to update 20111104.ud), EMBASE (via Ovid to update 20111104.em), PsycINFO (via OVID to 2011 November week 4) and handsearching of conference abstracts. Searches for the register cover smoking cessation, nicotine dependence, nicotine addiction and tobacco use. To identify papers potentially relevant to this reivew we searched for (hospital and patient*) or hospitali* or inpatient* or admission* or admitted in the title or abstract. In addition, we searched CINAHL (EBSCO to March 2012, search strategy in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>). We searched the Centers for Disease Control Smoking and Health database for the original review but since it did not retrieve any additional studies we did not use it for the update. We asked individuals with expertise in the area of smoking cessation for details of conference abstracts and studies in press. We hand-checked bibliographies of studies generated by the search for further studies.<BR/>
</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-04-10 13:29:37 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Identification of studies and data extraction</HEADING>
<P>Three authors checked studies identified by the search strategies for relevance. Two authors extracted data independently. Disagreements were resolved by consensus. We noted reasons for the exclusion of studies. For each study we extracted the following data:</P>
<P>(i) author(s) and year of publication,<BR/>(ii) methods (country of origin, recruitment, randomization and participants),<BR/>(iii) description of intervention(s) and control, including a designation of intensity for behavioural interventions (1-4),<BR/>(iv) outcomes (length of follow-up, definition of abstinence, validation technique).</P>
<P>If necessary we contacted the original authors for clarification of data.</P>
<P>We reported the following information about each trial in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table:<BR/>
</P>
<UL>
<LI>Country</LI>
<LI>Reasons for hospitalisation or specialty of admission</LI>
<LI>Criteria for recruitment (e.g. current smokers only or recent quitters) and whether selected according to willingness to make a quit attempt</LI>
<LI>Method of randomization and adequacy of concealment</LI>
<LI>Smoking behaviour and characteristics of participants</LI>
<LI>Therapist types</LI>
<LI>Description of experimental and control interventions and classification by length of in-hospital contact and post-discharge support</LI>
<LI>Outcome measures (definition of abstinence used in review, use of biochemical validation), number of deaths.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of risk of bias in included studies</HEADING>
<P>We judged risk of bias on the basis descriptions of the randomization and allocation concealment procedure, as this is the main source of bias which has been empirically associated with over-estimation of treatment effects (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>). We also assessed whether the studies reported validation of self-reported smoking cessation, and assessed the studies for attrition bias, including how they handled patients lost to follow-up, since these are possible sources of bias in smoking cessation studies. We also assessed the extent to which study populations consisted of current smokers and recent quitters.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Analysis of the data</HEADING>
<P>We used statistical methods for pooling using a Mantel-Haenszel fixed-effect method, with 95% confidence intervals. This summary statistic replaced the Peto method (<LINK REF="REF-Yusuf-1985" TYPE="REFERENCE">Yusuf 1985</LINK>) used in earlier versions of this review, since the Mantel-Haenszel method is now recommended for Cochrane reviews (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Differences in results using the two methods are small, and most likely to be apparent where numbers are unbalanced between groups, in which case the Peto method may give biased results. Where there was substantial heterogeneity between studies we explored possible reasons using sensitivity analyses or considered the impact of outliers. We express results as a risk ratio (intervention risks/control risks) for achieving abstinence from smoking together with the 95% confidence interval for this estimate. To investigate statistical heterogeneity we used the I² statistic, given by the formula [(Q - df)/Q] x 100%, where Q is the Chi² statistic and df is its degrees of freedom (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). This describes the percentage of the variability in effect estimates that is due to heterogeneity rather than sampling error (chance). A value greater than 50% may be considered to indicate moderate to substantial heterogeneity.</P>
<P>We calculated quit rates based on the numbers of patients randomized to an intervention, excluding any deaths. Those who dropped out or were lost to follow-up were counted as continuing smokers. Most studies verified self-reported smoking status with a biochemical test. In these studies, self-reported nonsmokers who did not pass the verification procedure were counted as smokers. We noted the number of deaths in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<P>We analysed data according to our pre-determined classification of four levels of intensity (see <LINK TAG="CRIT_INTERVENTIONS" TYPE="SECTION">Types of interventions</LINK>, above). Where we included studies that were judged to be more prone to bias, we planned sensitivity analyses to assess whether their inclusion altered our findings. We also planned sensitivity analyses to explore, where possible, the contribution of different components to an overall effect (for example, the role of NRT in a multicomponent intervention) and to determine whether the effects were different when the study population was restricted to those wishing to stop. Another sensitivity analysis explored the efficacy of interventions that differed only after hospital discharge. In these studies participants received an identical intervention in the hospital and were randomly assigned to different post-discharge treatments.</P>
<P>In an exploratory analysis, we evaluated the effects of interventions in patients admitted to hospital because of the following diagnoses: cardiovascular disease, respiratory disease and cancer. We also assessed the effects of interventions that were designed to be delivered to all (or nearly all) of the smokers who were admitted to hospital regardless of the smoker's admitting diagnosis. Where there were insufficient data for meta-analysis, the results were tabulated. In cases where a single study reported data on patients from different categories, we pooled the data only when it was possible to extract data by disease category. Otherwise we included only those studies reporting data from patients in a single disease category. A separate analysis included studies that met inclusion criteria but were conducted in rehabilitation hospitals rather than acute care hospitals. These studies were not included in the main analysis.</P>
<P>We include the Tobacco Addiction Group glossary of tobacco-specific terms (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>).</P>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2012-04-10 12:26:09 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2012-04-10 12:25:35 +0100" MODIFIED_BY="[Empty name]">
<P>Fifty trials conducted in the United States, the United Kingdom, Australia, Belgium, Brazil, Canada, Denmark, Germany, Israel, Japan, the Netherlands, Norway, and Spain between 1990 and 2011 met the inclusion criteria and contributed to the review. The previous version of this review included 33 trials published between 1990 and 2007; this update includes 17 new studies. All but 12 of the 50 studies contributed to the main comparison of a behavioural counselling intervention, classified by intensity, versus control. Eight that did not contribute (<LINK REF="STD-Campbell-1991" TYPE="STUDY">Campbell 1991</LINK>; <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Ortega-2011" TYPE="STUDY">Ortega 2011</LINK>; <LINK REF="STD-Rigotti-2006" TYPE="STUDY">Rigotti 2006</LINK>; <LINK REF="STD-Planer-2011" TYPE="STUDY">Planer 2011</LINK>; <LINK REF="STD-Simon-2009" TYPE="STUDY">Simon 2009</LINK>; <LINK REF="STD-Smith-BJ-2011" TYPE="STUDY">Smith BJ 2011</LINK>; <LINK REF="STD-Steinberg-2011" TYPE="STUDY">Steinberg 2011</LINK>) did not include a control group of usual care or less intensive counselling; the intervention tested in those studies was pharmacotherapy as an adjunct to behavioural support. Three studies that were performed in rehabilitation hospitals (<LINK REF="STD-Floter-2009" TYPE="STUDY">Floter 2009</LINK>; <LINK REF="STD-Haug-2011" TYPE="STUDY">Haug 2011</LINK>; <LINK REF="STD-Metz-2007" TYPE="STUDY">Metz 2007</LINK>) were also analysed separately from the studies conducted in acute care hospitals. Twenty-six studies (<LINK REF="STD-Bolman-2002" TYPE="STUDY">Bolman 2002</LINK>; <LINK REF="STD-Borglykke-2008" TYPE="STUDY">Borglykke 2008</LINK>; <LINK REF="STD-Campbell-1991" TYPE="STUDY">Campbell 1991</LINK>; <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-CASIS-1992" TYPE="STUDY">CASIS 1992</LINK>; <LINK REF="STD-Chouinard-2005" TYPE="STUDY">Chouinard 2005</LINK>; <LINK REF="STD-Cossette-2011" TYPE="STUDY">Cossette 2011</LINK>; <LINK REF="STD-Croghan-2005" TYPE="STUDY">Croghan 2005</LINK>; <LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>; <LINK REF="STD-Dornelas-2000" TYPE="STUDY">Dornelas 2000</LINK>; <LINK REF="STD-Feeney-2001" TYPE="STUDY">Feeney 2001</LINK>; <LINK REF="STD-Froelicher-2004" TYPE="STUDY">Froelicher 2004</LINK>; <LINK REF="STD-Hajek-2002" TYPE="STUDY">Hajek 2002</LINK>; <LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>; <LINK REF="STD-Mohiuddin-2007" TYPE="STUDY">Mohiuddin 2007</LINK>; <LINK REF="STD-Ortigosa-2000" TYPE="STUDY">Ortigosa 2000</LINK>; <LINK REF="STD-Pedersen-2005" TYPE="STUDY">Pedersen 2005</LINK>; <LINK REF="STD-Pederson-1991" TYPE="STUDY">Pederson 1991</LINK>; <LINK REF="STD-Pelletier-1998" TYPE="STUDY">Pelletier 1998</LINK>; <LINK REF="STD-Planer-2011" TYPE="STUDY">Planer 2011</LINK>; <LINK REF="STD-Quist_x002d_Paulsen-2003" TYPE="STUDY">Quist-Paulsen 2003</LINK>; <LINK REF="STD-Reid-2003" TYPE="STUDY">Reid 2003</LINK>; <LINK REF="STD-Reid-2007" TYPE="STUDY">Reid 2007</LINK>; <LINK REF="STD-Rigotti-1994" TYPE="STUDY">Rigotti 1994</LINK>; <LINK REF="STD-Rigotti-2006" TYPE="STUDY">Rigotti 2006</LINK>; <LINK REF="STD-Smith-2009" TYPE="STUDY">Smith 2009</LINK>; <LINK REF="STD-Taylor-1990" TYPE="STUDY">Taylor 1990</LINK>) provided separate data by disease and contributed to the comparison of intervention versus control in different disease categories. We describe each intervention in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. We excluded 66 studies which appeared relevant but did not meet all inclusion criteria (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>). We did not include two studies (<LINK REF="STD-Brunner_x002d_Frandsen-2010" TYPE="STUDY">Brunner-Frandsen 2010</LINK>; <LINK REF="STD-Jimenez-2007" TYPE="STUDY">Jimenez 2007</LINK>) for which there was insufficient data to make a decision, despite our efforts to contact the authors for additional information; these remain in the <LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="3">Counselling interventions</HEADING>
<P>Advice to quit smoking and/or behavioural counselling was provided in all 50 studies. In 48 of them, a nurse or counsellor provided stop-smoking advice and/or behavioural counselling. Twelve studies included physician advice to quit (<LINK REF="STD-Campbell-1991" TYPE="STUDY">Campbell 1991</LINK>; <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Croghan-2005" TYPE="STUDY">Croghan 2005</LINK>; <LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>; <LINK REF="STD-Feeney-2001" TYPE="STUDY">Feeney 2001</LINK>; <LINK REF="STD-Froelicher-2004" TYPE="STUDY">Froelicher 2004</LINK>; <LINK REF="STD-Hennrikus-2005" TYPE="STUDY">Hennrikus 2005</LINK>; <LINK REF="STD-Lacasse-2008" TYPE="STUDY">Lacasse 2008</LINK>; <LINK REF="STD-Lewis-1998" TYPE="STUDY">Lewis 1998</LINK>; <LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>; <LINK REF="STD-Ortigosa-2000" TYPE="STUDY">Ortigosa 2000</LINK>; <LINK REF="STD-Pelletier-1998" TYPE="STUDY">Pelletier 1998</LINK>;), and in one study physician advice was offered prior to admission (<LINK REF="STD-Pederson-1991" TYPE="STUDY">Pederson 1991</LINK>). In three studies, the patient chart was stamped with a prompt to remind the physician to offer smoking cessation advice (<LINK REF="STD-Rigotti-1997" TYPE="STUDY">Rigotti 1997</LINK>; <LINK REF="STD-Smith-2009" TYPE="STUDY">Smith 2009</LINK>; <LINK REF="STD-Smith-PM-2011" TYPE="STUDY">Smith PM 2011</LINK>). Counselling ranged in duration from less than five minutes to two hours. In nine studies, counselling was delivered on more than one occasion during the hospitalisation period (<LINK REF="STD-Borglykke-2008" TYPE="STUDY">Borglykke 2008</LINK>; <LINK REF="STD-CASIS-1992" TYPE="STUDY">CASIS 1992</LINK>; <LINK REF="STD-Cossette-2011" TYPE="STUDY">Cossette 2011</LINK>; <LINK REF="STD-Floter-2009" TYPE="STUDY">Floter 2009</LINK>; <LINK REF="STD-Metz-2007" TYPE="STUDY">Metz 2007</LINK>; <LINK REF="STD-Nagle-2005" TYPE="STUDY">Nagle 2005</LINK>; <LINK REF="STD-Ortega-2011" TYPE="STUDY">Ortega 2011</LINK>; <LINK REF="STD-Pederson-1991" TYPE="STUDY">Pederson 1991</LINK>; <LINK REF="STD-Rigotti-1994" TYPE="STUDY">Rigotti 1994</LINK>). Most studies also included materials such as self-help booklets, relaxation audio tapes and video tapes. In <LINK REF="STD-Haug-2011" TYPE="STUDY">Haug 2011</LINK>, participants were provided with access to an internet-based smoking cessation program and no face-to-face counselling was performed. In <LINK REF="STD-Smith-BJ-2011" TYPE="STUDY">Smith BJ 2011</LINK>, patients were referred to a quitline and were called by a quitline counsellor.</P>
<P>Forty-two of 50 studies (all except <LINK REF="STD-Bolman-2002" TYPE="STUDY">Bolman 2002</LINK>; <LINK REF="STD-Croghan-2005" TYPE="STUDY">Croghan 2005</LINK>; <LINK REF="STD-Hajek-2002" TYPE="STUDY">Hajek 2002</LINK>; <LINK REF="STD-Hennrikus-2005" TYPE="STUDY">Hennrikus 2005</LINK>; <LINK REF="STD-Molyneux-2003" TYPE="STUDY">Molyneux 2003</LINK>; <LINK REF="STD-Nagle-2005" TYPE="STUDY">Nagle 2005</LINK>; <LINK REF="STD-Pederson-1991" TYPE="STUDY">Pederson 1991</LINK>; <LINK REF="STD-Pelletier-1998" TYPE="STUDY">Pelletier 1998</LINK>) offered follow-up support following discharge. Of these, 29 offered support by telephone (<LINK REF="STD-Caruthers-2006" TYPE="STUDY">Caruthers 2006</LINK>; <LINK REF="STD-CASIS-1992" TYPE="STUDY">CASIS 1992</LINK>; <LINK REF="STD-Chouinard-2005" TYPE="STUDY">Chouinard 2005</LINK>; <LINK REF="STD-Cossette-2011" TYPE="STUDY">Cossette 2011</LINK>; <LINK REF="STD-de-Azevedo-2010" TYPE="STUDY">de Azevedo 2010</LINK>; <LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>; <LINK REF="STD-Dornelas-2000" TYPE="STUDY">Dornelas 2000</LINK>; <LINK REF="STD-Floter-2009" TYPE="STUDY">Floter 2009</LINK>; <LINK REF="STD-Froelicher-2004" TYPE="STUDY">Froelicher 2004</LINK>; <LINK REF="STD-Hasuo-2004" TYPE="STUDY">Hasuo 2004</LINK>; <LINK REF="STD-Hennrikus-2005" TYPE="STUDY">Hennrikus 2005</LINK>; <LINK REF="STD-Lacasse-2008" TYPE="STUDY">Lacasse 2008</LINK>; <LINK REF="STD-Lewis-1998" TYPE="STUDY">Lewis 1998</LINK>; <LINK REF="STD-Metz-2007" TYPE="STUDY">Metz 2007</LINK>; <LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>; <LINK REF="STD-Ortigosa-2000" TYPE="STUDY">Ortigosa 2000</LINK>; <LINK REF="STD-Quist_x002d_Paulsen-2003" TYPE="STUDY">Quist-Paulsen 2003</LINK>; <LINK REF="STD-Rigotti-1994" TYPE="STUDY">Rigotti 1994</LINK>; <LINK REF="STD-Rigotti-1997" TYPE="STUDY">Rigotti 1997</LINK>; <LINK REF="STD-Rigotti-2006" TYPE="STUDY">Rigotti 2006</LINK>; <LINK REF="STD-Simon-1997" TYPE="STUDY">Simon 1997</LINK>; <LINK REF="STD-Simon-2003" TYPE="STUDY">Simon 2003</LINK>; <LINK REF="STD-Simon-2009" TYPE="STUDY">Simon 2009</LINK>; <LINK REF="STD-Smith-2009" TYPE="STUDY">Smith 2009</LINK>; <LINK REF="STD-Smith-BJ-2011" TYPE="STUDY">Smith BJ 2011</LINK>; <LINK REF="STD-Smith-PM-2011" TYPE="STUDY">Smith PM 2011</LINK>; <LINK REF="STD-Stevens-1993" TYPE="STUDY">Stevens 1993</LINK>; <LINK REF="STD-Stevens-2000" TYPE="STUDY">Stevens 2000</LINK>; <LINK REF="STD-Taylor-1990" TYPE="STUDY">Taylor 1990</LINK>), nine provided in-person support in various settings (<LINK REF="STD-Borglykke-2008" TYPE="STUDY">Borglykke 2008</LINK>; <LINK REF="STD-Campbell-1991" TYPE="STUDY">Campbell 1991</LINK>; <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Meysman-2010" TYPE="STUDY">Meysman 2010</LINK>; <LINK REF="STD-Mohiuddin-2007" TYPE="STUDY">Mohiuddin 2007</LINK>; <LINK REF="STD-Pedersen-2005" TYPE="STUDY">Pedersen 2005</LINK>; <LINK REF="STD-Reid-2003" TYPE="STUDY">Reid 2003</LINK>; <LINK REF="STD-Steinberg-2011" TYPE="STUDY">Steinberg 2011</LINK>; <LINK REF="STD-Vial-2002" TYPE="STUDY">Vial 2002</LINK>), and two offered support by telephone and/or in-person (<LINK REF="STD-Ortega-2011" TYPE="STUDY">Ortega 2011</LINK>; <LINK REF="STD-Planer-2011" TYPE="STUDY">Planer 2011</LINK>). Two studies used newer technologies to contact patients after discharge: <LINK REF="STD-Haug-2011" TYPE="STUDY">Haug 2011</LINK> provided individual feedback letters, an internet-based smoking cessation program and offered email support and <LINK REF="STD-Reid-2007" TYPE="STUDY">Reid 2007</LINK> used an Interactive Voice Response (IVR) system. The duration of extended support ranged from one week to 12 months from discharge.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Pharmacotherapy</HEADING>
<P>No studies tested the efficacy of pharmacotherapy with nicotine replacement therapy (NRT), bupropion, or varenicline versus placebo in the absence of a counselling intervention. However, six studies tested the marginal value of adding NRT to a counselling intervention (<LINK REF="STD-Campbell-1991" TYPE="STUDY">Campbell 1991</LINK>; <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Lewis-1998" TYPE="STUDY">Lewis 1998</LINK>; <LINK REF="STD-Molyneux-2003" TYPE="STUDY">Molyneux 2003</LINK>; <LINK REF="STD-Ortega-2011" TYPE="STUDY">Ortega 2011</LINK>; <LINK REF="STD-Vial-2002" TYPE="STUDY">Vial 2002</LINK>), three studies tested the marginal value of adding bupropion to a counselling intervention (<LINK REF="STD-Planer-2011" TYPE="STUDY">Planer 2011</LINK>; <LINK REF="STD-Rigotti-2006" TYPE="STUDY">Rigotti 2006</LINK>; <LINK REF="STD-Simon-2009" TYPE="STUDY">Simon 2009</LINK>), and two trials tested the marginal value of adding varenicline to a counselling intervention (<LINK REF="STD-Smith-BJ-2011" TYPE="STUDY">Smith BJ 2011</LINK>; <LINK REF="STD-Steinberg-2011" TYPE="STUDY">Steinberg 2011</LINK>). One trial (<LINK REF="STD-Simon-2003" TYPE="STUDY">Simon 2003</LINK>) tested the marginal value of adding counselling to pharmacotherapy with NRT. In a number of other studies, particularly the newer ones, pharmacotherapy was allowed as part of the intervention or available to participants in the trial but was not specifically offered to all participants in one group and to none in another. Fourteen studies that reported providing NRT to a subgroup of patients did not specify the extent of its use (<LINK REF="STD-Borglykke-2008" TYPE="STUDY">Borglykke 2008</LINK>; <LINK REF="STD-Caruthers-2006" TYPE="STUDY">Caruthers 2006</LINK>; <LINK REF="STD-Chouinard-2005" TYPE="STUDY">Chouinard 2005</LINK>; <LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>; <LINK REF="STD-Froelicher-2004" TYPE="STUDY">Froelicher 2004</LINK>; <LINK REF="STD-Lacasse-2008" TYPE="STUDY">Lacasse 2008</LINK>; <LINK REF="STD-Pedersen-2005" TYPE="STUDY">Pedersen 2005</LINK>; <LINK REF="STD-Quist_x002d_Paulsen-2003" TYPE="STUDY">Quist-Paulsen 2003</LINK>; <LINK REF="STD-Reid-2003" TYPE="STUDY">Reid 2003</LINK>; <LINK REF="STD-Reid-2007" TYPE="STUDY">Reid 2007</LINK>; <LINK REF="STD-Rigotti-1997" TYPE="STUDY">Rigotti 1997</LINK>; <LINK REF="STD-Simon-1997" TYPE="STUDY">Simon 1997</LINK>; <LINK REF="STD-Simon-2003" TYPE="STUDY">Simon 2003</LINK>; <LINK REF="STD-Taylor-1990" TYPE="STUDY">Taylor 1990</LINK>). Two studies included bupropion in a similar fashion (<LINK REF="STD-Chouinard-2005" TYPE="STUDY">Chouinard 2005</LINK>; <LINK REF="STD-Mohiuddin-2007" TYPE="STUDY">Mohiuddin 2007</LINK>) and in one study NRT, bupropion or varenicline were suggested during hospitalisation and follow-up (<LINK REF="STD-Cossette-2011" TYPE="STUDY">Cossette 2011</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Other study characteristics</HEADING>
<P>Three studies compared two durations of post-discharge follow-up with a usual care control (<LINK REF="STD-Chouinard-2005" TYPE="STUDY">Chouinard 2005</LINK>; <LINK REF="STD-Hennrikus-2005" TYPE="STUDY">Hennrikus 2005</LINK>; <LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>). Results from each arm of these studies were included separately in the analysis by intervention intensity. In four other studies that compared two intervention arms to a usual care control, the behavioural support offered in the two arms was comparable and results of the two intervention arms were combined in the analysis by intensity subgroups (<LINK REF="STD-Floter-2009" TYPE="STUDY">Floter 2009</LINK>; <LINK REF="STD-Lewis-1998" TYPE="STUDY">Lewis 1998</LINK>; <LINK REF="STD-Molyneux-2003" TYPE="STUDY">Molyneux 2003</LINK>; <LINK REF="STD-Vial-2002" TYPE="STUDY">Vial 2002</LINK>). In <LINK REF="STD-Lewis-1998" TYPE="STUDY">Lewis 1998</LINK> and <LINK REF="STD-Molyneux-2003" TYPE="STUDY">Molyneux 2003</LINK>, the two intervention arms differed by the presence or absence of nicotine replacement, and these arms were directly compared in the pooled analysis of the effect of NRT. In <LINK REF="STD-Vial-2002" TYPE="STUDY">Vial 2002</LINK>, both intervention arms included the use of NRT, and compared follow-up from either a hospital or community pharmacist. In <LINK REF="STD-Floter-2009" TYPE="STUDY">Floter 2009</LINK>, both intervention arms included group counselling sessions during hospitalisation and follow-up with proactive telephone calls but the post-discharge intervention differed in style. In one study the smoking cessation intervention was part of a multicomponent risk intervention for patients with cardiovascular disease (<LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>); in this case the smoking cessation intervention was well-defined and met our inclusion criteria. Two studies had a third arm consisting of control patients who were not assigned randomly (<LINK REF="STD-de-Azevedo-2010" TYPE="STUDY">de Azevedo 2010</LINK>; <LINK REF="STD-Ortega-2011" TYPE="STUDY">Ortega 2011</LINK>). We excluded the non-randomised patients from analyses of these studies.</P>
<P>Most studies (37 of 50) assessed cigarette abstinence 12 months after hospital discharge. Thirteen studies reported a shorter follow-up period of six months (<LINK REF="STD-Caruthers-2006" TYPE="STUDY">Caruthers 2006</LINK>; <LINK REF="STD-Cossette-2011" TYPE="STUDY">Cossette 2011</LINK>; <LINK REF="STD-Croghan-2005" TYPE="STUDY">Croghan 2005</LINK>; <LINK REF="STD-de-Azevedo-2010" TYPE="STUDY">de Azevedo 2010</LINK>; <LINK REF="STD-Floter-2009" TYPE="STUDY">Floter 2009</LINK>; <LINK REF="STD-Haug-2011" TYPE="STUDY">Haug 2011</LINK>; <LINK REF="STD-Lewis-1998" TYPE="STUDY">Lewis 1998</LINK>; <LINK REF="STD-Meysman-2010" TYPE="STUDY">Meysman 2010</LINK>; <LINK REF="STD-Pedersen-2005" TYPE="STUDY">Pedersen 2005</LINK>; <LINK REF="STD-Pederson-1991" TYPE="STUDY">Pederson 1991</LINK>; <LINK REF="STD-Rigotti-1997" TYPE="STUDY">Rigotti 1997</LINK>; <LINK REF="STD-Simon-2009" TYPE="STUDY">Simon 2009</LINK>; <LINK REF="STD-Steinberg-2011" TYPE="STUDY">Steinberg 2011</LINK>). Fewer than half of the studies (20 of 50) used the preferred outcome measure, sustained abstinence. Twenty-eight studies used point prevalence abstinence as the outcome measure and two studies did not specify how abstinence was defined (<LINK REF="STD-Cossette-2011" TYPE="STUDY">Cossette 2011</LINK>; <LINK REF="STD-Ortega-2011" TYPE="STUDY">Ortega 2011</LINK>). One study reported sustained abstinence rates for overall cessation but point prevalence rates by diagnosis (<LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>).</P>
<P>All but two studies included both males and females; the exceptions (<LINK REF="STD-Floter-2009" TYPE="STUDY">Floter 2009</LINK>; <LINK REF="STD-Froelicher-2004" TYPE="STUDY">Froelicher 2004</LINK>) included only females. All studies included adults who smoked cigarettes currently or recently (e.g., within the past month). Seven studies included recent quitters as well as current smokers (<LINK REF="STD-CASIS-1992" TYPE="STUDY">CASIS 1992</LINK>; <LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>; <LINK REF="STD-Haug-2011" TYPE="STUDY">Haug 2011</LINK>; <LINK REF="STD-Nagle-2005" TYPE="STUDY">Nagle 2005</LINK>; <LINK REF="STD-Rigotti-1994" TYPE="STUDY">Rigotti 1994</LINK>; <LINK REF="STD-Stevens-1993" TYPE="STUDY">Stevens 1993</LINK>; <LINK REF="STD-Stevens-2000" TYPE="STUDY">Stevens 2000</LINK>).</P>
</SUBSECTION>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-04-05 14:49:09 +0100" MODIFIED_BY="[Empty name]">
<P>Fifteen of the fifty studies reported procedures for both random sequence generation and allocation concealment that we judged likely to avoid selection bias (<LINK REF="STD-Cossette-2011" TYPE="STUDY">Cossette 2011</LINK>; <LINK REF="STD-de-Azevedo-2010" TYPE="STUDY">de Azevedo 2010</LINK>; <LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>; <LINK REF="STD-Froelicher-2004" TYPE="STUDY">Froelicher 2004</LINK>; <LINK REF="STD-Hajek-2002" TYPE="STUDY">Hajek 2002</LINK>; <LINK REF="STD-Hasuo-2004" TYPE="STUDY">Hasuo 2004</LINK>; <LINK REF="STD-Lewis-1998" TYPE="STUDY">Lewis 1998</LINK>; <LINK REF="STD-Nagle-2005" TYPE="STUDY">Nagle 2005</LINK>; <LINK REF="STD-Reid-2003" TYPE="STUDY">Reid 2003</LINK>; <LINK REF="STD-Reid-2007" TYPE="STUDY">Reid 2007</LINK>; <LINK REF="STD-Rigotti-2006" TYPE="STUDY">Rigotti 2006</LINK>; <LINK REF="STD-Smith-BJ-2011" TYPE="STUDY">Smith BJ 2011</LINK>; <LINK REF="STD-Steinberg-2011" TYPE="STUDY">Steinberg 2011</LINK>; <LINK REF="STD-Taylor-1990" TYPE="STUDY">Taylor 1990</LINK>; <LINK REF="STD-Vial-2002" TYPE="STUDY">Vial 2002</LINK>). Seventeen studies did not report the method of randomization and concealment in enough detail to judge the risk of selection bias, nine studies had low risk of selection bias for random sequence generation but unclear risk for allocation concealment, and three studies had unclear risk for random sequence generation and low risk for allocation concealment. Six studies did not allocate treatment at the individual patient level (<LINK REF="STD-Borglykke-2008" TYPE="STUDY">Borglykke 2008</LINK>; <LINK REF="STD-Bolman-2002" TYPE="STUDY">Bolman 2002</LINK>; <LINK REF="STD-Haug-2011" TYPE="STUDY">Haug 2011</LINK>; <LINK REF="STD-Pelletier-1998" TYPE="STUDY">Pelletier 1998</LINK>; <LINK REF="STD-Stevens-1993" TYPE="STUDY">Stevens 1993</LINK>; <LINK REF="STD-Stevens-2000" TYPE="STUDY">Stevens 2000</LINK>). Two of them allocated treatment by alternating the intervention condition between hospitals over time (<LINK REF="STD-Stevens-1993" TYPE="STUDY">Stevens 1993</LINK>, <LINK REF="STD-Stevens-2000" TYPE="STUDY">Stevens 2000</LINK>) and one study employed a quasi-experimental design with one intervention and two control hospitals (<LINK REF="STD-Pelletier-1998" TYPE="STUDY">Pelletier 1998</LINK>). One study used a quasi-experimental design and assigned participants to intervention or control group according to bed availability in two wards of the same hospital (<LINK REF="STD-Borglykke-2008" TYPE="STUDY">Borglykke 2008</LINK>) while another used a quasi-randomized design where participants were assigned to control or intervention groups based on the calendar week of admission (<LINK REF="STD-Haug-2011" TYPE="STUDY">Haug 2011</LINK>). One other study (<LINK REF="STD-Bolman-2002" TYPE="STUDY">Bolman 2002</LINK>) was not fully randomized; seven of 11 participating hospitals were randomized to condition, but four others selected their study arm. All six of these studies share the potential problems of recruitment bias and of underestimation of confidence limits due to intracluster correlation. Therefore, we conducted sensitivity analyses on the effect of excluding them.</P>
<P>The majority of studies (33 out of 50) reported numbers lost to follow-up and methods for addressing incomplete outcome data that we judged at low risk of attrition bias. Fourteen studies did not report enough information to be assessed for incomplete outcome data and were hence rated as unclear. Three studies were rated at high risk of attrition bias: <LINK REF="STD-Feeney-2001" TYPE="STUDY">Feeney 2001</LINK> assessed only those participants who attended a follow-up programme and hence had a large and unequal percentage of losses to follow-up; in <LINK REF="STD-Metz-2007" TYPE="STUDY">Metz 2007</LINK>, sensitivity analysis excluding losses to follow-up removes the significance of the study findings due to differential drop-out rates between study arms; and differential drop-out rates in <LINK REF="STD-Taylor-1990" TYPE="STUDY">Taylor 1990</LINK> increased the apparent effect of the intervention when using an intent-to-treat approach.</P>
<P>Most studies (41 of 50) used a method to validate subjects' self-reports of quitting at the follow-up assessment. Biochemical validation of smoking status was done in 32 studies, using expired air carbon monoxide in 15 studies (<LINK REF="STD-Campbell-1991" TYPE="STUDY">Campbell 1991</LINK>; <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Caruthers-2006" TYPE="STUDY">Caruthers 2006</LINK>; <LINK REF="STD-CASIS-1992" TYPE="STUDY">CASIS 1992</LINK>; <LINK REF="STD-Croghan-2005" TYPE="STUDY">Croghan 2005</LINK>; <LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>; <LINK REF="STD-Hajek-2002" TYPE="STUDY">Hajek 2002</LINK>; <LINK REF="STD-Lewis-1998" TYPE="STUDY">Lewis 1998</LINK>; <LINK REF="STD-Mohiuddin-2007" TYPE="STUDY">Mohiuddin 2007</LINK>; <LINK REF="STD-Molyneux-2003" TYPE="STUDY">Molyneux 2003</LINK>; <LINK REF="STD-Ortigosa-2000" TYPE="STUDY">Ortigosa 2000</LINK>; <LINK REF="STD-Reid-2003" TYPE="STUDY">Reid 2003</LINK>; <LINK REF="STD-Steinberg-2011" TYPE="STUDY">Steinberg 2011</LINK>; <LINK REF="STD-Taylor-1990" TYPE="STUDY">Taylor 1990</LINK>; <LINK REF="STD-Vial-2002" TYPE="STUDY">Vial 2002</LINK>), and using plasma, salivary, or urinary cotinine in 17 studies (<LINK REF="STD-Chouinard-2005" TYPE="STUDY">Chouinard 2005</LINK>; <LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>; <LINK REF="STD-Feeney-2001" TYPE="STUDY">Feeney 2001</LINK>; <LINK REF="STD-Froelicher-2004" TYPE="STUDY">Froelicher 2004</LINK>; <LINK REF="STD-Hajek-2002" TYPE="STUDY">Hajek 2002</LINK>; <LINK REF="STD-Hasuo-2004" TYPE="STUDY">Hasuo 2004</LINK>; <LINK REF="STD-Hennrikus-2005" TYPE="STUDY">Hennrikus 2005</LINK>; <LINK REF="STD-Lacasse-2008" TYPE="STUDY">Lacasse 2008</LINK>; <LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>; <LINK REF="STD-Nagle-2005" TYPE="STUDY">Nagle 2005</LINK>; <LINK REF="STD-Quist_x002d_Paulsen-2003" TYPE="STUDY">Quist-Paulsen 2003</LINK>; <LINK REF="STD-Rigotti-1994" TYPE="STUDY">Rigotti 1994</LINK>; <LINK REF="STD-Rigotti-1997" TYPE="STUDY">Rigotti 1997</LINK>; <LINK REF="STD-Rigotti-2006" TYPE="STUDY">Rigotti 2006</LINK>; <LINK REF="STD-Simon-1997" TYPE="STUDY">Simon 1997</LINK>; <LINK REF="STD-Simon-2003" TYPE="STUDY">Simon 2003</LINK>; <LINK REF="STD-Simon-2009" TYPE="STUDY">Simon 2009</LINK>). Two studies used "corroboration by significant other" as the only validation method (<LINK REF="STD-Dornelas-2000" TYPE="STUDY">Dornelas 2000</LINK>; <LINK REF="STD-Smith-2009" TYPE="STUDY">Smith 2009</LINK>), and five other studies used "corroboration by significant other" in cases where a plasma or salivary cotinine measure was not available (<LINK REF="STD-Froelicher-2004" TYPE="STUDY">Froelicher 2004</LINK>; <LINK REF="STD-Lewis-1998" TYPE="STUDY">Lewis 1998</LINK>; <LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>; <LINK REF="STD-Simon-2003" TYPE="STUDY">Simon 2003</LINK>; <LINK REF="STD-Smith-2009" TYPE="STUDY">Smith 2009</LINK>). Thirteen studies (<LINK REF="STD-Bolman-2002" TYPE="STUDY">Bolman 2002</LINK>; <LINK REF="STD-Cossette-2011" TYPE="STUDY">Cossette 2011</LINK>; <LINK REF="STD-de-Azevedo-2010" TYPE="STUDY">de Azevedo 2010</LINK>; <LINK REF="STD-Floter-2009" TYPE="STUDY">Floter 2009</LINK>; <LINK REF="STD-Haug-2011" TYPE="STUDY">Haug 2011</LINK>; <LINK REF="STD-Metz-2007" TYPE="STUDY">Metz 2007</LINK>; <LINK REF="STD-Meysman-2010" TYPE="STUDY">Meysman 2010</LINK>; <LINK REF="STD-Pedersen-2005" TYPE="STUDY">Pedersen 2005</LINK>; <LINK REF="STD-Pelletier-1998" TYPE="STUDY">Pelletier 1998</LINK>; <LINK REF="STD-Planer-2011" TYPE="STUDY">Planer 2011</LINK>; <LINK REF="STD-Reid-2007" TYPE="STUDY">Reid 2007</LINK>; <LINK REF="STD-Stevens-1993" TYPE="STUDY">Stevens 1993</LINK>; <LINK REF="STD-Stevens-2000" TYPE="STUDY">Stevens 2000</LINK>) did not validate self-reported quitting at the follow-up assessment for any participants. Five others (<LINK REF="STD-Borglykke-2008" TYPE="STUDY">Borglykke 2008</LINK>; <LINK REF="STD-Ortega-2011" TYPE="STUDY">Ortega 2011</LINK>; <LINK REF="STD-Pederson-1991" TYPE="STUDY">Pederson 1991;</LINK> <LINK REF="STD-Reid-2003" TYPE="STUDY">Reid 2003</LINK>; <LINK REF="STD-Vial-2002" TYPE="STUDY">Vial 2002</LINK>) did not validate the smoking status of all participants who self-reported abstinence. Four studies used more than one means of validation other than corroboration by significant other (<LINK REF="STD-Chouinard-2005" TYPE="STUDY">Chouinard 2005</LINK>; <LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>; <LINK REF="STD-Rigotti-2006" TYPE="STUDY">Rigotti 2006</LINK>; <LINK REF="STD-Taylor-1990" TYPE="STUDY">Taylor 1990</LINK>). In one study (<LINK REF="STD-Smith-BJ-2011" TYPE="STUDY">Smith BJ 2011</LINK>), validation of smoking abstinence with expired air carbon monoxide was performed only in a subsample but we used self-reported smoking abstinence rates in the analyses.</P>
<P>Most studies recruited participants on the basis of a convenience sample, with randomization being to group (intervention or control) rather than to initial inclusion. Participation rates (i.e., the proportion of those approached who agreed to take part in the trial) were also seldom recorded. Most studies recorded those lost to follow-up as continuing smokers. In one study (<LINK REF="STD-Stevens-2000" TYPE="STUDY">Stevens 2000</LINK>), the intervention was offered inconsistently, with only 68% of those eligible for the intervention actually being approached.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2012-04-10 12:26:09 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Effect of counselling interventions categorised by intensity</HEADING>
<P>
<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>
</P>
<P>Only one included study (<LINK REF="STD-Hennrikus-2005" TYPE="STUDY">Hennrikus 2005</LINK>) reported on the effect of a brief intervention in hospitalised patients with no follow-up after discharge (intensity 1). That study had a large sample size (&gt;650 subjects per study arm). The brief intervention was no more effective than usual care (RR 1.14, 95% CI 0.82 to 1.59) although the confidence limits did not exclude the possibility of a benefit. Nine studies (<LINK REF="STD-Bolman-2002" TYPE="STUDY">Bolman 2002</LINK>; <LINK REF="STD-Chouinard-2005" TYPE="STUDY">Chouinard 2005</LINK>; <LINK REF="STD-Croghan-2005" TYPE="STUDY">Croghan 2005</LINK>; <LINK REF="STD-Hajek-2002" TYPE="STUDY">Hajek 2002</LINK>; <LINK REF="STD-Meysman-2010" TYPE="STUDY">Meysman 2010</LINK>; <LINK REF="STD-Molyneux-2003" TYPE="STUDY">Molyneux 2003</LINK>; <LINK REF="STD-Nagle-2005" TYPE="STUDY">Nagle 2005</LINK>; <LINK REF="STD-Pederson-1991" TYPE="STUDY">Pederson 1991</LINK>; <LINK REF="STD-Pelletier-1998" TYPE="STUDY">Pelletier 1998</LINK>) used a more intensive intervention in hospital but had no follow-up intervention component after discharge (intensity 2). There was no evidence of a significant benefit from pooling these studies and the confidence intervals suggest that any effect is likely to be small (RR 1.10, 95% CI 0.96 to 1.25, I² = 44%). Similar lack of statistically significant benefit was observed in a pooled analysis of the six studies that tested the effect of an intervention that began during hospitalisation and continued for up to 1 month after discharge (intensity 3). The risk ratio and confidence interval for the estimate of the effect of this level of intervention (RR 1.07, 95% CI 0.93 to 1.24, I² = 11%) is almost identical to that produced by the intensity 2 intervention.</P>
<P>In this update, we added eight new included studies that tested the highest intensity intervention (intensity 4), consisting of counselling that began in the hospital and continued for more than one month after discharge. The pooled estimate showed a statistically significant increase in quit rates that was similar to the previous review (RR 1.37, 95% CI 1.27 to 1.48, 25 studies) and heterogeneity remained relatively low (I² = 32%). This estimate excludes one study (<LINK REF="STD-Feeney-2001" TYPE="STUDY">Feeney 2001</LINK>) which was an extreme outlier reporting a very large effect. In this trial amongst 198 patients admitted to a coronary care unit there was a very high drop out rate (79%) and low quit rate (1%) at 12 months in the usual care condition whilst the dropout rate was 55% and the quit rate 34% in the intervention group. The intervention group quit rate was comparable to that of other trials in the intensity 4 subgroup, but control group quit rates in the other trials were typically over 10%. This suggested that the difference in relative effect might have been due to characteristics of the support given to the control group and we decided to exclude this trial from the meta-analysis.</P>
<P>Three of the eight newly identified studies testing the most intensive intervention had a different design from the other trials (<LINK REF="STD-Caruthers-2006" TYPE="STUDY">Caruthers 2006</LINK>; <LINK REF="STD-Cossette-2011" TYPE="STUDY">Cossette 2011</LINK>; <LINK REF="STD-Reid-2007" TYPE="STUDY">Reid 2007</LINK>). In these studies, all participants received the same intervention while in the hospital but were randomly assigned to interventions that differed after hospital discharge. We conducted a subgroup analysis limited to these trials in order to isolate the specific effect of a post-discharge intervention. The pooled estimate was a statistically significant 51% increase in smoking cessation rates (RR 1.51, 95% CI 1.03 to 2.22, I² = 44% <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>) with the addition of a post-discharge counselling intervention.</P>
<P>The studies included in the preceding analyses were all conducted in acute care hospitals. We also identified three trials conducted in rehabilitation hospitals (<LINK REF="STD-Floter-2009" TYPE="STUDY">Floter 2009</LINK>; <LINK REF="STD-Haug-2011" TYPE="STUDY">Haug 2011</LINK>; <LINK REF="STD-Metz-2007" TYPE="STUDY">Metz 2007</LINK>), where patients are less acutely ill and length of stays are longer. Because of these differences, we chose to analyse studies from rehabilitation hospitals separately from studies in acute care hospitals. The interventions provided by studies based in the rehabilitation hospitals were of similar intensity; each provided over one month of follow-up contact after discharge (intensity 4), allowing us to pool the results. The pooled estimate was a statistically significant 71% increase in smoking cessation rates (RR 1.71, 95% CI 1.37 to 2.14, I² = 0% <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Sensitivity analyses</HEADING>
<P>Some studies of behavioural counselling also included the option of pharmacotherapy, principally NRT. A sensitivity analysis excluding eighteen studies that reported the use of NRT within the highest intervention intensity did not suggest that the efficacy of these interventions was due to the use of NRT. The result from pooling only the seven trials that did not include the option of pharmacotherapy (<LINK REF="STD-CASIS-1992" TYPE="STUDY">CASIS 1992</LINK>; <LINK REF="STD-de-Azevedo-2010" TYPE="STUDY">de Azevedo 2010</LINK>; <LINK REF="STD-Dornelas-2000" TYPE="STUDY">Dornelas 2000</LINK>; <LINK REF="STD-Hasuo-2004" TYPE="STUDY">Hasuo 2004</LINK>; <LINK REF="STD-Hennrikus-2005" TYPE="STUDY">Hennrikus 2005</LINK>; <LINK REF="STD-Smith-2009" TYPE="STUDY">Smith 2009</LINK>; <LINK REF="STD-Smith-PM-2011" TYPE="STUDY">Smith PM 2011</LINK>) though smaller, remained statistically significant (RR 1.24, 95% CI 1.09 to 1.41, I² = 0%).</P>
<P>Another sensitivity analysis excluded studies that did not randomly assign subjects to condition. Within studies that did not provide follow-up (intensity 2) we performed a sensitivity analysis excluding data reported by two studies that did not fully randomise patients (<LINK REF="STD-Bolman-2002" TYPE="STUDY">Bolman 2002</LINK>; <LINK REF="STD-Pelletier-1998" TYPE="STUDY">Pelletier 1998</LINK>). The conclusion did not change (RR 1.03, 95% CI 0.87 to 1.22, I² = 44%). Within the group of studies that delivered an intervention with minimal follow-up (intensity 3) a sensitivity analysis excluding the data reported by two studies that did not randomise patients (<LINK REF="STD-Stevens-1993" TYPE="STUDY">Stevens 1993</LINK>, <LINK REF="STD-Stevens-2000" TYPE="STUDY">Stevens 2000</LINK>) slightly modified the point estimate, but did not substantially affect the confidence intervals (RR 1.01, 95% CI 0.83 to 1.21, I² = 0%). Within the group of studies with highest level of intensity of intervention (intensity 4), a sensitivity analysis excluding the data from one study that used a quasi-experimental design (<LINK REF="STD-Borglykke-2008" TYPE="STUDY">Borglykke 2008</LINK>) did not change the effect estimate (RR 1.35, 95% CI 1.25 to 1.46, I²= 28%).</P>
<P>Approximately half of the studies that delivered the highest intervention intensity (intensity 4) excluded smokers who were not willing to attempt cessation after discharge. We performed a sensitivity analysis excluding the data reported by 13 studies in which participants were selected on the basis of their willingness to make a quit attempt (<LINK REF="STD-Caruthers-2006" TYPE="STUDY">Caruthers 2006</LINK>; <LINK REF="STD-Cossette-2011" TYPE="STUDY">Cossette 2011</LINK>; <LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>; <LINK REF="STD-Froelicher-2004" TYPE="STUDY">Froelicher 2004</LINK>; <LINK REF="STD-Hasuo-2004" TYPE="STUDY">Hasuo 2004</LINK>; <LINK REF="STD-Lacasse-2008" TYPE="STUDY">Lacasse 2008</LINK>; <LINK REF="STD-Lewis-1998" TYPE="STUDY">Lewis 1998</LINK>; <LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>; <LINK REF="STD-Reid-2003" TYPE="STUDY">Reid 2003</LINK>; <LINK REF="STD-Simon-1997" TYPE="STUDY">Simon 1997</LINK>; <LINK REF="STD-Smith-PM-2011" TYPE="STUDY">Smith PM 2011</LINK>; <LINK REF="STD-Taylor-1990" TYPE="STUDY">Taylor 1990</LINK>; <LINK REF="STD-Vial-2002" TYPE="STUDY">Vial 2002</LINK>). An intervention effect persisted in the remaining 12 studies (RR 1.44, 95% CI 1.28 to 1.62, I² = 43%).<BR/>
<BR/>We performed a sensitivity analysis excluding studies that enrolled former smokers (defined as having not smoked for more than one month before admission) as well as current smokers (<LINK REF="STD-CASIS-1992" TYPE="STUDY">CASIS 1992</LINK>; <LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>; <LINK REF="STD-Nagle-2005" TYPE="STUDY">Nagle 2005</LINK>; <LINK REF="STD-Rigotti-1994" TYPE="STUDY">Rigotti 1994</LINK>; <LINK REF="STD-Stevens-1993" TYPE="STUDY">Stevens 1993</LINK>; <LINK REF="STD-Stevens-2000" TYPE="STUDY">Stevens 2000</LINK>, <LINK REF="STD-Taylor-1990" TYPE="STUDY">Taylor 1990</LINK>;). For intensity 3 (studies delivering a minimal intensity intervention with short-term follow-up), limiting the analysis to current smokers produced little change in the result (RR 1.01, 95% CI 0.82 to 1.24, I² = 0%). For studies delivering the highest intervention intensity (intensity 4), a statistically significant increase in quitting remained even after the exclusion of studies that included quitters, and the point estimate changed little (RR 1.35, 95% CI 1.24 to 1.48, I² = 35%). In the update, only one new study included both current smokers and recent former smokers who had quit for six months or less (<LINK REF="STD-Haug-2011" TYPE="STUDY">Haug 2011</LINK>), and this study was performed in a rehabilitation setting. Excluding this study from the analysis did not significantly change the estimate but only two studies remained in the analysis for rehabilitation centres (RR 1.56, 95% CI 1.20 to 2.03, I² = 0%).</P>
<P>We performed a sensitivity analysis excluding 15 studies that did not validate self-reported smoking cessation outcomes (<LINK REF="STD-Bolman-2002" TYPE="STUDY">Bolman 2002</LINK>; <LINK REF="STD-Borglykke-2008" TYPE="STUDY">Borglykke 2008</LINK>; <LINK REF="STD-Cossette-2011" TYPE="STUDY">Cossette 2011</LINK>; <LINK REF="STD-de-Azevedo-2010" TYPE="STUDY">de Azevedo 2010</LINK>; <LINK REF="STD-Floter-2009" TYPE="STUDY">Floter 2009</LINK>; <LINK REF="STD-Haug-2011" TYPE="STUDY">Haug 2011</LINK>; <LINK REF="STD-Metz-2007" TYPE="STUDY">Metz 2007</LINK>; <LINK REF="STD-Meysman-2010" TYPE="STUDY">Meysman 2010</LINK>; <LINK REF="STD-Pedersen-2005" TYPE="STUDY">Pedersen 2005</LINK>; <LINK REF="STD-Pelletier-1998" TYPE="STUDY">Pelletier 1998</LINK>; <LINK REF="STD-Planer-2011" TYPE="STUDY">Planer 2011</LINK>; <LINK REF="STD-Reid-2007" TYPE="STUDY">Reid 2007</LINK>; <LINK REF="STD-Smith-BJ-2011" TYPE="STUDY">Smith BJ 2011</LINK>; <LINK REF="STD-Stevens-1993" TYPE="STUDY">Stevens 1993</LINK>; <LINK REF="STD-Stevens-2000" TYPE="STUDY">Stevens 2000</LINK>). This did not alter the results. The point estimates for the lower intensity interventions declined, but confidence intervals remained wide and conclusions did not change (intensity 2 RR 0.96, 95% CI 0.81 to 1.14, I² = 0%; intensity 3 RR 1.01, 95% CI 0.83 to 1.21, I² = 0%). Five studies in the most intensive intervention category (intensity 4) did not validate self-reported smoking cessation (<LINK REF="STD-Borglykke-2008" TYPE="STUDY">Borglykke 2008</LINK>; <LINK REF="STD-Cossette-2011" TYPE="STUDY">Cossette 2011</LINK>; <LINK REF="STD-de-Azevedo-2010" TYPE="STUDY">de Azevedo 2010</LINK>; <LINK REF="STD-Pedersen-2005" TYPE="STUDY">Pedersen 2005</LINK>; <LINK REF="STD-Reid-2007" TYPE="STUDY">Reid 2007</LINK>). Excluding them did not alter the point estimate or statistical significance of the effect (RR 1.38, 95% CI 1.28 to 1.50, I² = 32%).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Effect of pharmacotherapy</HEADING>
<P>The effect of pharmacotherapy compared with placebo as a single intervention in the absence of counselling has not been tested. Several trials have tested the effect of adding pharmacotherapy to a counselling intervention or, conversely, of adding counselling to a pharmacotherapy intervention.</P>
<SUBSECTION>
<HEADING LEVEL="4">NRT</HEADING>
<P>Six trials (<LINK REF="STD-Campbell-1991" TYPE="STUDY">Campbell 1991</LINK>, <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>, <LINK REF="STD-Lewis-1998" TYPE="STUDY">Lewis 1998</LINK>; <LINK REF="STD-Molyneux-2003" TYPE="STUDY">Molyneux 2003</LINK>; <LINK REF="STD-Ortega-2011" TYPE="STUDY">Ortega 2011</LINK>; <LINK REF="STD-Vial-2002" TYPE="STUDY">Vial 2002</LINK>) tested the marginal effect of NRT added to counselling. In these trials, NRT was compared with placebo NRT or no NRT and all subjects received a counselling intervention. Pooled analysis of these studies produced a significant RR of 1.54 (95% CI 1.34 to 1.79, I² = 33%, <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>.1). This result is consistent with the effect of NRT seen in other settings (<LINK REF="REF-Stead-2008b" TYPE="REFERENCE">Stead 2008b</LINK>). One trial compared the effect of adding intensive counselling versus minimal counselling to an NRT intervention (<LINK REF="STD-Simon-2003" TYPE="STUDY">Simon 2003</LINK>). The study had an RR of 1.68 for sustained abstinence, but the confidence limits of that estimate missed statistical significance (95% CI 0.80, 3.53). However, the result was consistent with the impact of intensive counselling observed in the absence of pharmacotherapy.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Bupropion</HEADING>
<P>Three studies systematically compared the use of bupropion with placebo among hospitalised smokers who also received intensive smoking cessation counselling (<LINK REF="STD-Planer-2011" TYPE="STUDY">Planer 2011</LINK>; <LINK REF="STD-Rigotti-2006" TYPE="STUDY">Rigotti 2006</LINK>; <LINK REF="STD-Simon-2009" TYPE="STUDY">Simon 2009</LINK>). The pooled analysis did not detect a statistically significant effect of the drug over intensive counselling alone (RR 1.04, 95% CI 0.75 to 1.45, I² = 29%, <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>.2). While the confidence limits were wide, they do not encompass the confidence limits for the effect of bupropion in other settings (OR 1.94, 95% CI 1.72 to 2.19, <LINK REF="REF-Hughes-2007" TYPE="REFERENCE">Hughes 2007</LINK>), suggesting that bupropion may not be effective, or may be less effective, when started in the hospital.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Varenicline</HEADING>
<P>Two studies of varenicline compared the use of varenicline with placebo (<LINK REF="STD-Steinberg-2011" TYPE="STUDY">Steinberg 2011</LINK>) or counselling alone (<LINK REF="STD-Smith-BJ-2011" TYPE="STUDY">Smith BJ 2011</LINK>). The pooled estimate suggested an effect of the drug over intensive counselling alone (RR 1.29, 95% CI 0.95 to 1.76) but the wide confidence limits reflect the small numbers of participants (580) and the result was not statistically significant. There was also heterogeneity between the two studies (I²= 62%), with <LINK REF="STD-Steinberg-2011" TYPE="STUDY">Steinberg 2011</LINK> reporting lower quit rates in the varenicline group.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Effect of intervention by diagnosis</HEADING>
<P>The included studies were heterogeneous in the types of hospitalised patients who were recruited. Because of this diagnostic heterogeneity, we examined the results of interventions within the following diagnostic groups, keeping the same intensity subgroups where the number of studies justified this approach. Seventeen studies enrolled hospital patients with a wide range of admitting diagnoses. These studies tested smoking intervention programs that were implemented hospital-wide (<LINK REF="STD-Caruthers-2006" TYPE="STUDY">Caruthers 2006</LINK>; <LINK REF="STD-de-Azevedo-2010" TYPE="STUDY">de Azevedo 2010</LINK>; <LINK REF="STD-Hasuo-2004" TYPE="STUDY">Hasuo 2004</LINK>; <LINK REF="STD-Hennrikus-2005" TYPE="STUDY">Hennrikus 2005</LINK>; <LINK REF="STD-Lewis-1998" TYPE="STUDY">Lewis 1998</LINK>; <LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>; <LINK REF="STD-Molyneux-2003" TYPE="STUDY">Molyneux 2003</LINK>; <LINK REF="STD-Nagle-2005" TYPE="STUDY">Nagle 2005</LINK>; <LINK REF="STD-Rigotti-1997" TYPE="STUDY">Rigotti 1997</LINK>; <LINK REF="STD-Simon-2003" TYPE="STUDY">Simon 2003</LINK>; <LINK REF="STD-Simon-2009" TYPE="STUDY">Simon 2009</LINK>; <LINK REF="STD-Smith-BJ-2011" TYPE="STUDY">Smith BJ 2011</LINK>; <LINK REF="STD-Smith-PM-2011" TYPE="STUDY">Smith PM 2011</LINK>; <LINK REF="STD-Steinberg-2011" TYPE="STUDY">Steinberg 2011</LINK>; <LINK REF="STD-Stevens-1993" TYPE="STUDY">Stevens 1993</LINK>; <LINK REF="STD-Stevens-2000" TYPE="STUDY">Stevens 2000</LINK>; <LINK REF="STD-Vial-2002" TYPE="STUDY">Vial 2002</LINK>). Twenty-two studies reported on the effects of interventions in patients hospitalised with a cardiovascular diagnosis (<LINK REF="STD-Bolman-2002" TYPE="STUDY">Bolman 2002</LINK>; <LINK REF="STD-Campbell-1991" TYPE="STUDY">Campbell 1991</LINK>; <LINK REF="STD-CASIS-1992" TYPE="STUDY">CASIS 1992</LINK>; <LINK REF="STD-Chouinard-2005" TYPE="STUDY">Chouinard 2005</LINK>; <LINK REF="STD-Cossette-2011" TYPE="STUDY">Cossette 2011</LINK>; <LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>; <LINK REF="STD-Dornelas-2000" TYPE="STUDY">Dornelas 2000</LINK>; <LINK REF="STD-Froelicher-2004" TYPE="STUDY">Froelicher 2004</LINK>; <LINK REF="STD-Hajek-2002" TYPE="STUDY">Hajek 2002</LINK>; <LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>; <LINK REF="STD-Mohiuddin-2007" TYPE="STUDY">Mohiuddin 2007</LINK>; <LINK REF="STD-Ortigosa-2000" TYPE="STUDY">Ortigosa 2000</LINK>; <LINK REF="STD-Pedersen-2005" TYPE="STUDY">Pedersen 2005</LINK>; <LINK REF="STD-Pelletier-1998" TYPE="STUDY">Pelletier 1998</LINK>; <LINK REF="STD-Planer-2011" TYPE="STUDY">Planer 2011</LINK>; <LINK REF="STD-Quist_x002d_Paulsen-2003" TYPE="STUDY">Quist-Paulsen 2003</LINK>; <LINK REF="STD-Reid-2003" TYPE="STUDY">Reid 2003</LINK>; <LINK REF="STD-Reid-2007" TYPE="STUDY">Reid 2007</LINK>; <LINK REF="STD-Rigotti-1994" TYPE="STUDY">Rigotti 1994</LINK>; <LINK REF="STD-Rigotti-2006" TYPE="STUDY">Rigotti 2006</LINK>; <LINK REF="STD-Simon-2009" TYPE="STUDY">Simon 2009</LINK>; <LINK REF="STD-Taylor-1990" TYPE="STUDY">Taylor 1990</LINK>). Five studies reported on interventions in patients with a respiratory diagnosis (<LINK REF="STD-Borglykke-2008" TYPE="STUDY">Borglykke 2008</LINK>; <LINK REF="STD-Campbell-1991" TYPE="STUDY">Campbell 1991</LINK>;<LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>; <LINK REF="STD-Pederson-1991" TYPE="STUDY">Pederson 1991</LINK>). Only one small pilot study was found that recruited hospitalised patients admitted for a cancer diagnosis (<LINK REF="STD-Croghan-2005" TYPE="STUDY">Croghan 2005</LINK>).</P>
<P>The pattern of effect across intervention intensities was similar for the eighteen studies that enrolled patients with all admitting diagnoses (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>). Interventions categorized as intensity 4 were effective in a pooled analysis of twelve studies in this subgroup (RR 1.26, 95% CI 1.12 to 1.42, I² = 25%). The risk ratio was lower than the effect of the intensity 4 intervention in the overall analysis, but the confidence intervals overlap and we cannot conclude that intensive interventions are less effective in this subgroup. Pooled analysis of less intensive interventions demonstrated no effect and did not differ from the overall analysis (intensity 2: RR 0.90, 95% CI 0.64 to 1.28, I² = 0%, 2 studies; intensity 3, RR 1.10, 95% CI 0.94 to 1.29, I² = 28%, 4 studies).</P>
<P>The estimate of the effect for each level of intervention intensity among patients with a cardiovascular diagnosis was also very similar to that for the entire sample of hospitalised patients (<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>). Pooled analysis of 14 studies reporting on the effect of the most intensive intervention (intensity 4) found a statistically significant effect (RR 1.42, 95% CI 1.29 to 1.56, I² = 32%, <LINK REF="STD-CASIS-1992" TYPE="STUDY">CASIS 1992</LINK>; <LINK REF="STD-Chouinard-2005" TYPE="STUDY">Chouinard 2005</LINK>; <LINK REF="STD-Cossette-2011" TYPE="STUDY">Cossette 2011</LINK>; <LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>; <LINK REF="STD-Dornelas-2000" TYPE="STUDY">Dornelas 2000</LINK>; <LINK REF="STD-Froelicher-2004" TYPE="STUDY">Froelicher 2004</LINK>; <LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>; <LINK REF="STD-Mohiuddin-2007" TYPE="STUDY">Mohiuddin 2007</LINK>; <LINK REF="STD-Pedersen-2005" TYPE="STUDY">Pedersen 2005</LINK>; <LINK REF="STD-Quist_x002d_Paulsen-2003" TYPE="STUDY">Quist-Paulsen 2003</LINK>; <LINK REF="STD-Reid-2003" TYPE="STUDY">Reid 2003</LINK>; <LINK REF="STD-Reid-2007" TYPE="STUDY">Reid 2007</LINK>; <LINK REF="STD-Smith-2009" TYPE="STUDY">Smith 2009</LINK>; <LINK REF="STD-Taylor-1990" TYPE="STUDY">Taylor 1990</LINK>). The point estimate of the effect was similar to that for overall analysis (RR 1.37, 95% CI 1.27 to 1.48), the confidence intervals overlap substantially, and we cannot conclude that interventions in patients hospitalised for cardiovascular disease are more effective than in the general hospital population. No statistically significant effect was found for interventions of lower intensity. Pooled analysis of four studies of in-hospital counselling without follow-up after discharge (intensity 2) found no intervention effect (RR 1.10, 95% CI 0.94 to 1.28, I² = 58%, <LINK REF="STD-Bolman-2002" TYPE="STUDY">Bolman 2002</LINK>; <LINK REF="STD-Chouinard-2005" TYPE="STUDY">Chouinard 2005</LINK>; <LINK REF="STD-Hajek-2002" TYPE="STUDY">Hajek 2002</LINK>; <LINK REF="STD-Pelletier-1998" TYPE="STUDY">Pelletier 1998</LINK>). Pooled analysis of three studies that provided in-hospital counselling and brief follow-up contact after discharge (intensity 3) also found no intervention effect (RR 1.04, 95% CI 0.84 to 1.28, I² = 0%, <LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>; <LINK REF="STD-Ortigosa-2000" TYPE="STUDY">Ortigosa 2000</LINK>; <LINK REF="STD-Rigotti-1994" TYPE="STUDY">Rigotti 1994</LINK>).</P>
<P>One of the trials that tested an intensity 4 smoking intervention in the cardiovascular subgroup (<LINK REF="STD-Mohiuddin-2007" TYPE="STUDY">Mohiuddin 2007</LINK>) also assessed all-cause mortality and hospital readmission rates as endpoints. Over a two-year follow-up, the intervention produced a relative risk reduction of 0.77 (95% CI 0.27 to 0.93, p=.014) in all-cause mortality and a relative risk reduction of 0.44 (95% CI 0.16 to 0.63, p=.007) in hospital readmissions.</P>
<P>Five studies provided interventions to patients hospitalised with a respiratory diagnosis. Two of these studies evaluated NRT (<LINK REF="STD-Campbell-1991" TYPE="STUDY">Campbell 1991</LINK>; <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>) and three other studies of counselling interventions used different intensity interventions (<LINK REF="STD-Borglykke-2008" TYPE="STUDY">Borglykke 2008</LINK>; <LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>; <LINK REF="STD-Pederson-1991" TYPE="STUDY">Pederson 1991</LINK>). We estimated a separate pooled effect for the NRT studies (RR 1.29, 95% CI 0.62 to 2.69, I² = 65%) and for the counselling studies (RR 1.22, 95% CI 0.93 to 1.60, I² = 76%).</P>
<P>One pilot study reported on the effects of a hospital-based intervention for patients with cancer (<LINK REF="STD-Croghan-2005" TYPE="STUDY">Croghan 2005</LINK>). It found no evidence of efficacy but the sample size was very small and the confidence limits were very broad.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2012-04-17 12:54:25 +0100" MODIFIED_BY="[Empty name]">
<P>The results of this review indicate that smoking cessation counselling interventions delivered during a period of hospitalisation and including follow-up support that lasts at least one month after discharge increase smoking cessation rates. The estimated effect of such interventions was to increase the smoking cessation rate by 37% at six to 12 months after hospital discharge. This finding was robust. It remained statistically significant in sensitivity analyses that excluded studies of lower quality (e.g., those that did not validate self-reported smoking cessation at outcome or those that were not randomized). Neither the exclusion of studies that included recent quitters as well as current smokers nor those that included patients selected for motivation significantly affected the relative effect of intervention over control. This review found no evidence to of an effect of less intensive counselling interventions, such as those delivered only during hospitalisation or those which include less than one month of follow-up support after discharge. Therefore, post-discharge follow-up support appears to be an important component of interventions that begin during hospitalisation. We caution that the effect sizes observed in all these studies may be artificially modest because in many cases the "control" condition was more intensive than usual care or simply brief advice.</P>
<P>The counselling intervention in these studies was generally delivered by a research nurse or trained smoking cessation counsellor, not by a nurse responsible for other aspects of the patients' clinical care. Physician advice was a component of the intervention in many trials. There is no specific evidence from this review that brief physician advice to quit is effective by itself in the hospital setting, although evidence from trials in primary care settings support the efficacy of physician advice to quit (<LINK REF="REF-Stead-2008a" TYPE="REFERENCE">Stead 2008a</LINK>). Pharmacotherapy with nicotine replacement therapy (NRT), bupropion, or varenicline was included in some of the counselling studies, especially the more recent ones. In most of these trials, the pharmacotherapy was not systematically provided to all subjects in the intervention arm or excluded from all subjects in the control arm. The efficacy of counselling interventions remained after excluding those studies that reported the use of NRT, suggesting that counselling alone is effective.</P>
<P>This update includes a new finding regarding pharmacotherapy. In hospitalised smokers the effect of pharmacotherapy by itself, compared to placebo or no pharmacotherapy in the absence of counselling, cannot be determined because no such trials have been conducted. However, the marginal effect of NRT, bupropion, or varenicline when added to counselling in the hospital setting has been tested. Pooled analysis of six studies found a statistically significant 54% increase in the smoking cessation rate when NRT was added to counselling alone. This finding is new since the 2007 update, at which time there was a non-significant trend toward finding the addition of NRT to counselling to be efficacious in the hospital setting. The current estimate of the effect of NRT in the hospital setting is within the confidence intervals of the estimated RRs from the Cochrane review of NRT: 1.43 (95% CI 1.33 to 1.53) for nicotine gum and 1.66 (95% CI 1.53 to 1.81) for nicotine patch (<LINK REF="REF-Stead-2008b" TYPE="REFERENCE">Stead 2008b</LINK>). Hence these data support NRT's usefulness in appropriate patients during and following hospitalisation. Starting NRT before discharge was associated with a higher rate of NRT use two weeks after discharge in a non-randomized observational trial in one hospital (<LINK REF="STD-Regan-2011" TYPE="STUDY">Regan 2011</LINK>). The marginal effect of counselling when added to NRT begun in the hospital was tested in only one study (<LINK REF="STD-Simon-2003" TYPE="STUDY">Simon 2003</LINK>). Intensive counselling increased the rate of smoking cessation over that achieved by NRT alone, but the result was not statistically significant (RR 1.68,95% CI 0.80, 3.53). However, the result was consistent with the pooled estimate from this review of the effect of intensive counselling without pharmacotherapy.</P>
<P>Fewer data are available to assess the benefit of bupropion or varenicline as adjuncts to smoking cessation counselling that starts in the hospital setting. This update identified two new trials of bupropion to add to one previous trial (<LINK REF="STD-Rigotti-2006" TYPE="STUDY">Rigotti 2006</LINK>). All three trials tested the marginal efficacy of bupropion over placebo among smokers who all received intensive counselling in the hospital setting. Bupropion was not more effective than placebo in the pooled analysis (RR 1.06, 95% CI 0.68 to 1.63). This finding contrasts with evidence that bupropion is effective for smoking cessation in other populations (<LINK REF="REF-Hughes-2007" TYPE="REFERENCE">Hughes 2007</LINK>). A possible explanation for the lack of efficacy of bupropion in the context of hospitalisation is the long half-life of sustained-release bupropion. Steady-state bupropion blood levels occur only after five to seven days of drug administration. This is generally after hospital discharge. Consequently, hospitalised smokers may be discharged into an environment filled with cues to smoke before they have sufficient levels of bupropion for it to be effective.</P>
<P>This update also identified the first randomized controlled trials that tested the efficacy of initiating varenicline in the hospital setting. Two trials compared the efficacy of adding varenicline (versus placebo or no drug) to counselling in the hospital setting. The pooled result of these studies produced an estimated 28% increase in the rate of smoking cessation with varenicline, but the result was not statistically significant and confidence intervals were wide due to the small sample sizes of the trials (95% CI 0.88 to 2.26). This contrasts with strong evidence of efficacy and a higher estimate of the effect size of varenicline that has been found in a systematic review of varenicline (RR 2.27, 95% CI 2.02 to 2.55, <LINK REF="REF-Cahill-2012" TYPE="REFERENCE">Cahill 2012</LINK>).</P>
<P>The analyses by diagnosis demonstrate that the intensive counselling intervention was independent of the patient's admitting diagnosis . The absolute cessation rates amongst smokers admitted with cardiovascular disease tended to be higher than amongst smokers not selected by diagnosis, but the relative effect of an intensive counselling intervention was not significantly greater in CVD patients. The potential benefit of intensive intervention in smokers with CVD was illustrated in the one study that assessed health care utilization and mortality outcomes (<LINK REF="STD-Mohiuddin-2007" TYPE="STUDY">Mohiuddin 2007</LINK>). That study found a large increase in smoking cessation in the intervention group, and at two-year follow-up, a substantial decline in hospital readmission and all-cause mortality rates. There was a possibility of confounding due to better control of blood pressure and cholesterol and better medication compliance in the intervention group. Among smokers hospitalised for myocardial infarction, intensive counselling begun in the hospital is highly cost effective, even when the cost of a course of pharmacotherapy is included in the calculation (<LINK REF="REF-Ladapo-2011" TYPE="REFERENCE">Ladapo 2011</LINK>). The effectiveness of smoking cessation interventions for patients who are admitted to hospital with a respiratory diagnosis is less clear, in part because of a small number of studies in this subgroup. Overall, there is no strong evidence for a differential effect of the intensive counselling intervention by diagnosis. These data support offering hospital-based interventions to all smokers, regardless of admitting diagnosis.</P>
<P>Determining how to translate these findings effectively and consistently into routine clinical practice is the next challenge for this field. The intervention in most of the trials included in this review was delivered by research staff. The effectiveness of implementing the intervention in routine clinical practice, where interventions will be delivered by clinical staff, needs to be demonstrated. Feasible models that can be readily implemented in hospital settings are needed. Current evidence on this point is limited. Two studies included in this review illustrate this challenge (<LINK REF="STD-Stevens-1993" TYPE="STUDY">Stevens 1993</LINK>; <LINK REF="STD-Stevens-2000" TYPE="STUDY">Stevens 2000</LINK>). Both studies provided a similar counselling intervention in a similar setting, but counselling was delivered by research staff (masters-level psychologists) in the first study and by clinical staff (trained respiratory therapists) in the second study. The intervention efficacy was demonstrated in the first study but did not persist in the second study. The feasibility of maintaining an efficacious intervention after the conclusion of a research trial was investigated for another study included in this systematic review (<LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK>). The counselling intervention was maintained in the same hospitals for three years after the clinical trial ended. During that time approximately half of the smokers accepted the offer of intervention, and those smokers had a cessation rate comparable to that achieved in the randomized trial. These results suggested that programme effectiveness was maintained (<LINK REF="STD-Smith-2002" TYPE="STUDY">Smith 2002</LINK>). More studies are needed to demonstrate the feasibility and effectiveness of hospital-initiated smoking cessation interventions in routine practice.</P>
<P>Finally, this update includes the first studies conducted in rehabilitation hospitals. The results of the pooled analysis finds that smoking interventions in these settings are effective and extend the effect from acute care hospitals to a broader group of settings.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2012-04-17 12:58:18 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2012-04-17 12:58:18 +0100" MODIFIED_BY="[Empty name]">
<P>The results support the use of smoking cessation counselling interventions that begin during the hospitalisation period and include at least one month of follow-up supportive contact after discharge. There is no evidence of an effect of less intensive counselling interventions, particularly those that do not continue after hospital discharge, on smoking cessation. The effect of the counselling intervention does not clearly vary by a smoker's admitting diagnosis, and it is appropriate to offer the intervention to hospitalised smokers regardless of their admitting diagnosis. Adding nicotine replacement therapy to an intensive counselling intervention further increases the effect of hospital-initiated interventions and should be routinely offered. There is insufficient evidence regarding the benefit of adding varenicline or bupropion to counselling, although there was a trend toward statistical significance for varenicline and the results are compatible with data which show the efficacy of varenicline in other settings. Bupropion may not have an effect when added to counselling started in the hospital.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-04-17 12:56:54 +0100" MODIFIED_BY="[Empty name]">
<P>The impact of an intensive counselling intervention that continues after hospital discharge is well-established. The effect of adding NRT to a counselling intervention in hospitalised patients is now also established, with a relative risk estimate that is consistent with the established efficacy of NRT. Further studies testing the efficacy of adding varenicline to counselling are warranted in view of the results of early studies. They might generate sufficient data to produce a statistically significant result in future pooled analyses. The pooled evidence of studies with bupropion does not provide support for further studies of the drug in this context.</P>
<P>Research is needed to identify effective strategies for implementing and disseminating this evidence into routine practice in health care systems.</P>
<P>Additional research is needed to assess the cost-effectiveness of the intensive counselling intervention and to explore the impact of counselling on health and healthcare utilization outcomes.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2012-04-17 12:58:39 +0100" MODIFIED_BY="[Empty name]">
<P>Mike Murphy was an author on the original version of this review (2001, Issue 2), and on the first update (2003, Issue 1). The authors would like to thank Sarah Welch and Sarah Roberts of the ICRF General Practice Research Group for their assistance in extracting data for the original review, Nete Villebro, Hitomi Kobayashi and Roland Fischer for their assistance in translating and extracting data, and Corinne Husten, John Britton and Ian Campbell for helpful comments during peer review. Jamie Hartmann-Boyce completed the expanded Risk of Bias tables for studies included in the review prior to the 2012 update.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2012-04-17 11:43:12 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Dr Rigotti was the co-author of three studies included in the review. Dr. Rigotti's research is funded by the U.S. National Institutes of Health, by private nonprofit foundations, and by the pharmaceutical companies that make investigational or approved smoking cessation products. Her work on this review was funded by a Midcareer Investigator Award in Patient-Oriented Research from the U.S. National Heart Lung and Blood Institute. Marcus Munafò has received grant funding from Pfizer through their Investigator Initiated Research programme.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-04-01 06:44:19 +0100" MODIFIED_BY="[Empty name]">
<P>NR and CC extracted data for the 2012 update, with input from LS. NR and CC wrote the update, with input from MM and LS. All authors except CC were involved in the conception, data extraction and writing of the original review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2012-04-10 09:13:53 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2012-04-10 09:11:23 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2012-04-10 09:08:48 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bolman-2002" MODIFIED="2012-04-10 09:03:44 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" NAME="Bolman 2002" YEAR="2002">
<REFERENCE NOTES="&lt;p&gt;New 2006&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bolman C, De Vries H, van Breukelen G</AU>
<TI>A minimal-contact intervention for cardiac inpatients: long-term effects on smoking cessation</TI>
<SO>Preventive Medicine</SO>
<YR>2002</YR>
<VL>35</VL>
<PG>181-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bolman C, de Vries H, Van Breukelen G</AU>
<TI>Evaluation of a nurse-managed minimal-contact smoking cessation intervention for cardiac inpatients</TI>
<SO>Health Education Research</SO>
<YR>2002</YR>
<VL>17</VL>
<PG>99-116</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-04-10 09:03:44 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Spencer L, Anderson DRE</AU>
<TI>A minimal-contact intervention for cardiac inpatients: Long-term effects on smoking cessation</TI>
<SO>American Journal of Health Promotion</SO>
<YR>2004</YR>
<VL>18</VL>
<PG>399-400</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Borglykke-2008" MODIFIED="2012-04-10 09:04:00 +0100" MODIFIED_BY="[Empty name]" NAME="Borglykke 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-04-10 09:04:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Borglykke A, Pisinger C, Jorgensen T, Ibsen H</AU>
<TI>The effectiveness of smoking cessation groups offered to hospitalised patients with symptoms of exacerbations of chronic obstructive pulmonary disease (COPD)</TI>
<SO>The Clinical Respiratory Journal</SO>
<YR>2008</YR>
<VL>2</VL>
<NO>3</NO>
<PG>158-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Campbell-1991" MODIFIED="2012-04-10 09:04:19 +0100" MODIFIED_BY="[Empty name]" NAME="Campbell 1991" YEAR="1991">
<REFERENCE MODIFIED="2012-04-10 09:04:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Campbell IA, Prescott RJ, Tjeder-Burton SM</AU>
<TI>Smoking cessation in hospital patients given repeated advice plus nicotine or placebo chewing gum</TI>
<SO>Respiratory Medicine</SO>
<YR>1991</YR>
<VL>85</VL>
<PG>155-7</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:53:14 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Campbell-1996" MODIFIED="2012-04-10 09:04:25 +0100" MODIFIED_BY="[Empty name]" NAME="Campbell 1996" YEAR="1996">
<REFERENCE MODIFIED="2012-04-10 09:04:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Campbell IA, Prescott RJ, Tjeder-Burton SM</AU>
<TI>Transdermal nicotine plus support in patients attending hospital with smoking related diseases - a placebo controlled study</TI>
<SO>Respiratory Medicine</SO>
<YR>1996</YR>
<VL>90</VL>
<NO>1</NO>
<PG>47-51</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:53:18 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Caruthers-2006" MODIFIED="2012-02-21 14:07:09 +0000" MODIFIED_BY="[Empty name]" NAME="Caruthers 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-02-21 14:07:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Caruthers D, Perkins K, Sereika S, Albrecht S, Dunbar-Jacob J</AU>
<TI>Enhancing tobacco abstinence following hospitalization (POS1-59)</TI>
<SO>Society for Research on Nicotine and Tobacco 12th Annual Meeting February 15-18, Orlando, Florida</SO>
<YR>2006</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-CASIS-1992" MODIFIED="2011-03-02 14:53:29 +0000" MODIFIED_BY="[Empty name]" NAME="CASIS 1992" YEAR="1992">
<REFERENCE MODIFIED="2011-03-02 14:53:22 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ockene JK, Kristeller J, Goldberg R, Ockene IS, Merriam P, Barrett S et al</AU>
<TI>Smoking cessation and severity of disease: The coronary artery smoking intervention study</TI>
<SO>Health Psychology</SO>
<YR>1992</YR>
<VL>11</VL>
<PG>119-26</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:53:22 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-02 14:53:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rosal MC, Ockene JK, Ma YS, Hebert JR, Ockene IS, Merriam P et al</AU>
<TI>Coronary Artery Smoking Intervention Study (CASIS): 5-year Follow-up</TI>
<SO>Health Psychology</SO>
<YR>1998</YR>
<VL>17</VL>
<NO>5</NO>
<PG>476-8</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:53:29 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chouinard-2005" MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" NAME="Chouinard 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chouinard MC, Robichaud-Ekstrand S</AU>
<TI>Predictive value of the transtheoretical model to smoking cessation in hospitalized patients with cardiovascular disease</TI>
<SO>European Journal of Cardiovascular Prevention &amp; Rehabilitation</SO>
<YR>2007</YR>
<VL>14</VL>
<NO>1</NO>
<PG>51-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;New 2006&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chouinard MC, Robichaud-Ekstrand S</AU>
<TI>The effectiveness of a nursing inpatient smoking cessation program in individuals with cardiovascular disease</TI>
<SO>Nursing Research</SO>
<YR>2005</YR>
<VL>54</VL>
<NO>4</NO>
<PG>243-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cossette-2011" MODIFIED="2012-02-21 14:07:20 +0000" MODIFIED_BY="[Empty name]" NAME="Cossette 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-02-21 14:07:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cossette S, Frasure-Smith N, Robert M, Chouinard MC, Juneau M, Guertin MCal</AU>
<TI>[A pre assessment for nursing intervention to support tobacco cessation in patients hospitalized for cardiac problems: a pilot study (So-Live)]. [French]</TI>
<SO>Recherche En Soins Infirmiers</SO>
<YR>2011</YR>
<NO>105</NO>
<PG>60-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Croghan-2005" NAME="Croghan 2005" YEAR="2005">
<REFERENCE NOTES="&lt;p&gt;New 2006&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Croghan GA, Croghan IT, Frost MH, Sloan JA, Novotny PJ, Nelson MA et al</AU>
<TI>Smoking cessation interventions and post-operative outcomes in esophageal and lung cancer patients [POS3-101]</TI>
<SO>Society for Research on Nicotine and Tobacco 11th Annual Meeting, 20-23 March; Prague, Czech Republic</SO>
<YR>2005</YR>
<PG>139</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Azevedo-2010" MODIFIED="2011-12-20 15:25:11 +0000" MODIFIED_BY="Lindsay Stead" NAME="de Azevedo 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-12-20 15:25:11 +0000" MODIFIED_BY="Lindsay Stead" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Azevedo RCS, Mauro MLF, Lima DD, Gaspar KC, da Silva VF, Botega NJ</AU>
<TI>General hospital admission as an opportunity for smoking-cessation strategies: A clinical trial in Brazil</TI>
<SO>General Hospital Psychiatry</SO>
<YR>2010</YR>
<VL>32</VL>
<NO>6</NO>
<PG>599-606</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-DeBusk-1994" MODIFIED="2012-04-10 09:04:39 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" NAME="DeBusk 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-04-10 09:04:39 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>DeBusk RF, Houston-Miller N, Superko HR, Dennis CA, Thomas RJ, Lew HT et al</AU>
<TI>A case-management system for coronary risk factor modification after acute myocardial infarction</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1994</YR>
<VL>120</VL>
<NO>9</NO>
<PG>721-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dornelas-2000" MODIFIED="2012-04-10 09:04:42 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" NAME="Dornelas 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-04-10 09:04:42 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dornelas EA, Sampson RA, Gray JF, Waters D, Thompson PD</AU>
<TI>A randomized controlled trial of smoking cessation counseling after myocardial infarction</TI>
<SO>Preventive Medicine</SO>
<YR>2000</YR>
<VL>30</VL>
<PG>261-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feeney-2001" NAME="Feeney 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Feeney GF, McPherson A, Connor JP, McAlister A, Young MR, Garrahy P</AU>
<TI>Randomized controlled trial of two cigarette quit programmes in coronary care patients after acute myocardial infarction</TI>
<SO>Internal Medicine Journal</SO>
<YR>2001</YR>
<VL>31</VL>
<NO>8</NO>
<PG>470-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Floter-2009" MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" NAME="Floter 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Floter S, Kroger C</AU>
<TI>[Effectiveness of telephone aftercare following a smoking cessation program for women on inpatient rehabilitation]. [German]</TI>
<SO>Deutsche Medizinische Wochenschrift</SO>
<YR>2009</YR>
<VL>134</VL>
<NO>47</NO>
<PG>2382-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Froelicher-2004" MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" NAME="Froelicher 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Froelicher ES, Christopherson DJ, Miller NH, Martin K</AU>
<TI>Women's initiative for nonsmoking (WINS) IV: description of 277 women smokers hospitalized with cardiovascular disease</TI>
<SO>Heart &amp; Lung</SO>
<YR>2002</YR>
<VL>31</VL>
<PG>3-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Froelicher ES, Christopherson DJ</AU>
<TI>Women's Initiative for Nonsmoking (WINS) I: Design and methods</TI>
<SO>Heart &amp; Lung</SO>
<YR>2000</YR>
<VL>29</VL>
<NO>6</NO>
<PG>429-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Froelicher ES, Li WW, Mahrer-Imhof R, Christopherson D, Stewart AL</AU>
<TI>Women's Initiative for Non-Smoking (WINS) VI: Reliability and validity of health and psychosocial measures in women smokers with cardiovascular disease</TI>
<SO>Heart &amp; Lung</SO>
<YR>2004</YR>
<VL>33</VL>
<NO>3</NO>
<PG>162-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li WW, Froelicher ES</AU>
<TI>Predictors of smoking relapse in women with cardiovascular disease in a 30-month study: Extended analysis</TI>
<SO>Heart and Lung: Journal of Acute and Critical Care</SO>
<YR>2008</YR>
<VL>37</VL>
<NO>6</NO>
<PG>455-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mahrer-Imhof R, Froelicher ES, Li WW, Parker KM, Benowitz N</AU>
<TI>Women's Initiative for Nonsmoking (WINS)V: under-use of nicotine replacement therapy</TI>
<SO>Heart &amp; Lung</SO>
<YR>2002</YR>
<VL>31</VL>
<PG>368-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martin K, Froelicher ES, Miller NH</AU>
<TI>Women's Initiative for Nonsmoking (WINS) II: The intervention</TI>
<SO>Heart &amp; Lung</SO>
<YR>2000</YR>
<VL>29</VL>
<NO>6</NO>
<PG>438-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oka RK, Katapodi MC, Lim JW, Bacchetti P, Froelicher ES</AU>
<TI>Quantifying smoking cessation outcomes: from The Women's Initiative for Nonsmoking Study (X): methodological implications</TI>
<SO>Nursing Research</SO>
<YR>2006</YR>
<VL>55</VL>
<NO>4</NO>
<PG>292-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;New 2006&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sivarajan Froelicher ES, Miller NH, Christopherson DJ, Martin K, Parker KM, Amonetti M et al</AU>
<TI>High rates of sustained smoking cessation in women hospitalized with cardiovascular disease: the Women's Initiative for Nonsmoking (WINS)</TI>
<SO>Circulation</SO>
<YR>2004</YR>
<VL>109</VL>
<NO>5</NO>
<PG>587-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hajek-2002" MODIFIED="2012-04-10 09:04:48 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" NAME="Hajek 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-04-10 09:04:48 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hajek P, Taylor TZ, Mills P</AU>
<TI>Brief intervention during hospital admission to help patients to give up smoking after myocardial infarction and bypass surgery: Randomised controlled trial</TI>
<SO>BMJ</SO>
<YR>2002</YR>
<VL>324</VL>
<PG>87-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hasuo-2004" NAME="Hasuo 2004" YEAR="2004">
<REFERENCE NOTES="&lt;p&gt;New 2006&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hasuo S, Tanaka H, Oshima A</AU>
<TI>[Efficacy of a smoking relapse prevention program by postdischarge telephone contacts: a randomized trial] (Japanese)</TI>
<SO>Nippon Koshu Eisei Zasshi [Japanese Journal of Public Health]</SO>
<YR>2004</YR>
<VL>51</VL>
<NO>6</NO>
<PG>403-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haug-2011" MODIFIED="2012-04-05 14:30:31 +0100" MODIFIED_BY="[Empty name]" NAME="Haug 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-02-21 14:07:50 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haug S, Meyer C, John U</AU>
<TI>Efficacy of an internet program for smoking cessation during and after inpatient rehabilitation treatment: A quasi-randomized controlled trial</TI>
<SO>Addictive Behaviors</SO>
<YR>2011</YR>
<VL>36</VL>
<NO>12</NO>
<PG>1369-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hennrikus-2005" MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" NAME="Hennrikus 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Hennrikus D, Lando HA, McCarty MC, Vessey JT</AU>
<TI>The effectiveness of a systems approach to smoking cessation in hospital inpatients</TI>
<SO>Society for Research on Nicotine and Tobacco 7th Annual Meeting March 23-23 Seattle Washington</SO>
<YR>2001</YR>
<PG>47</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;New 2006&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hennrikus DJ, Lando HA, McCarty MC, Klevan D, Holtan N, Huebsch JA et al</AU>
<TI>The TEAM project: the effectiveness of smoking cessation interventions with hospital patients</TI>
<SO>Preventive Medicine</SO>
<YR>2005</YR>
<VL>40</VL>
<PG>249-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lando H, Hennrikus D, McCarty M, Vessey J</AU>
<TI>Predictors of quitting in hospitalized smokers</TI>
<SO>Nicotine &amp; Tobacco Research</SO>
<YR>2003</YR>
<VL>5</VL>
<NO>2</NO>
<PG>215-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lacasse-2008" MODIFIED="2011-03-03 15:10:00 +0000" MODIFIED_BY="[Empty name]" NAME="Lacasse 2008" YEAR="2006">
<REFERENCE MODIFIED="2011-03-02 15:53:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lacasse Y, Lamontagne R, Martin S, Arsenault M</AU>
<TI>Randomized trial of a smoking cessation intervention in patients hospitalized in a cardio-respiratory institute</TI>
<SO>Chest</SO>
<YR>2005</YR>
<VL>128</VL>
<NO>4 (Suppl)</NO>
<PG>204S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-02 15:53:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lacasse Y, Lamontagne R, Martin S, Simard S, Arsenault M</AU>
<TI>Randomized trial of a smoking cessation intervention in hospitalized patients</TI>
<SO>Nicotine &amp; Tobacco Research</SO>
<YR>2008</YR>
<VL>10</VL>
<NO>7</NO>
<PG>1215-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lewis-1998" MODIFIED="2012-04-10 09:05:02 +0100" MODIFIED_BY="[Empty name]" NAME="Lewis 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-04-10 09:05:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lewis SF, Piasecki TM, Fiore MC, Anderson JE, Baker TB</AU>
<TI>Transdermal nicotine replacement for hospitalized patients: A randomized clinical trial</TI>
<SO>Preventive Medicine</SO>
<YR>1998</YR>
<VL>27</VL>
<NO>2</NO>
<PG>296-303</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:54:52 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Metz-2007" MODIFIED="2011-03-02 15:44:47 +0000" MODIFIED_BY="[Empty name]" NAME="Metz 2007" YEAR="2004">
<REFERENCE MODIFIED="2011-03-02 15:30:55 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Floeter S, Metz K, Kroeger C, Donath C, Piontek D, Gradi S</AU>
<TI>Evaluation of telephone booster sessions after intensive in-patient treatment - a randomized treatment control trial (POS1-78)</TI>
<SO>Society for Research on Nicotine and Tobacco 12th Annual Meeting February 15-18, Orlando, Florida</SO>
<YR>2006</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-02 15:30:55 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kroeger C, Metz K, Buhler A</AU>
<TI>Smoking cessation in patients treated in rehabilitation hospitals</TI>
<SO>Suchtmedizin in Forschung und Praxis</SO>
<YR>2004</YR>
<VL>6</VL>
<NO>1</NO>
<PG>61-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-02 15:44:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Metz K, Floter S, Kroger C, Donath C, Piontek D, Gradl S</AU>
<TI>Telephone booster sessions for optimizing smoking cessation for patients in rehabilitation centers</TI>
<SO>Nicotine &amp; Tobacco Research</SO>
<YR>2007</YR>
<VL>9</VL>
<NO>8</NO>
<PG>853-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meysman-2010" MODIFIED="2011-07-13 14:49:45 +0100" MODIFIED_BY="[Empty name]" NAME="Meysman 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meysman M, Boudrez H, Nackaerts K, Dieriks B, Indemans R, Vermeire P</AU>
<TI>Smoking cessation rates after a nurse-led inpatient smoking cessation intervention</TI>
<SO>Journal of Smoking Cessation</SO>
<YR>2010</YR>
<VL>5</VL>
<NO>1</NO>
<PG>69-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miller-1997" MODIFIED="2011-03-02 14:53:41 +0000" MODIFIED_BY="[Empty name]" NAME="Miller 1997" YEAR="1997">
<REFERENCE MODIFIED="2011-03-02 14:53:41 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Miller NH, Smith PM, DeBusk RF, Sobel DS, Taylor CB</AU>
<TI>Smoking cessation in hospitalized patients - Results of a randomized trial</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1997</YR>
<VL>157</VL>
<PG>409-15</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:53:41 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taylor CB, Miller NH, Herman S, Smith PM, Sobel D, Fisher L et al</AU>
<TI>A nurse-managed smoking cessation program for hospitalized smokers</TI>
<SO>American Journal of Public Health</SO>
<YR>1996</YR>
<VL>86</VL>
<PG>1557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mohiuddin-2007" MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" NAME="Mohiuddin 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kondrack R, Hilleman DE, Maciejewski SR, Grollmes TL, Cloutier DA, Mohiuddin SM</AU>
<TI>Cost analysis of an intensive smoking cessation intervention in cardiac patients</TI>
<SO>Journal of the American College of Cardiology</SO>
<YR>2008</YR>
<VL>51</VL>
<NO>10</NO>
<PG>A257</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE</AU>
<TI>Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease</TI>
<SO>Chest</SO>
<YR>2007</YR>
<VL>131</VL>
<PG>446-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mohjuddin SM, Mooss AN, Hunter CB, Grollmes T, Cloutier DA, Hilleman DE</AU>
<TI>Intensive multicomponent smoking cessation intervention decreases mortality in hospitalized high-risk cardiac smokers</TI>
<SO>Journal of the American College of Cardiology</SO>
<YR>2006</YR>
<VL>47</VL>
<NO>4</NO>
<PG>375A</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Molyneux-2003" NAME="Molyneux 2003" YEAR="2003">
<REFERENCE NOTES="&lt;p&gt;New 2006&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Molyneux A, Lewis S, Leivers U, Anderton A, Antoniak M, Brackenridge A et al</AU>
<TI>Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients</TI>
<SO>Thorax</SO>
<YR>2003</YR>
<VL>58</VL>
<NO>6</NO>
<PG>484-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nagle-2005" NAME="Nagle 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hensley MJ, Nagle AL, Hensley MJ, Schofield MJ, Koschel A</AU>
<TI>Efficacy of a brief nurse provided nicotine management intervention for hospitalised smokers</TI>
<SO>Respirology</SO>
<YR>2002</YR>
<VL>7</VL>
<PG>A12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;New 2006&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Nagle AL, Hensley MJ, Schofield MJ, Koschel AJ</AU>
<TI>A randomised controlled trial to evaluate the efficacy of a nurse-provided intervention for hospitalised smokers</TI>
<SO>Australian and New Zealand Journal of Public Health</SO>
<YR>2005</YR>
<VL>29</VL>
<NO>3</NO>
<PG>285-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ortega-2011" MODIFIED="2011-12-20 15:38:58 +0000" MODIFIED_BY="[Empty name]" NAME="Ortega 2011" YEAR="2011">
<REFERENCE MODIFIED="2011-12-20 15:38:58 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ortega F, Vellisco A, Marquez E, Lopez-Campos JL, Rodriguez A, de los Angeles SM et al</AU>
<TI>Effectiveness of a cognitive orientation program with and without nicotine replacement therapy in stopping smoking in hospitalised patients</TI>
<TO>Efectividad de un programa de orientacion cognitiva con y sin tratamiento sustitutivo con nicotina en la cesacion tabaquica en pacientes hospitalizados</TO>
<SO>Archivos de Bronconeumologia</SO>
<YR>2011</YR>
<VL>47</VL>
<NO>1</NO>
<PG>3-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ortigosa-2000" MODIFIED="2012-04-10 09:05:17 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" NAME="Ortigosa 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-04-10 09:05:17 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ortigosa AM, Gomez FJO, Ramalle-Gomara E, Reta IS, Esteban MVF, Diaz MQ</AU>
<TI>Efficacy of an intervention in smoking cessation in patients with myocardial infarction</TI>
<TO>Eficacia de una intervencion para dejar de fumar en pacientes con infarto de miocardio</TO>
<SO>Medicina Clinica (Barc)</SO>
<YR>2000</YR>
<VL>114</VL>
<PG>209-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pedersen-2005" NAME="Pedersen 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pedersen L, Johansen S, Eksten L</AU>
<TI>[Smoking cessation among patients with acute heart disease. A randomised intervention project] (Danish)</TI>
<SO>Ugeskrift for Laeger</SO>
<YR>2005</YR>
<VL>167</VL>
<NO>33</NO>
<PG>3044-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pederson-1991" MODIFIED="2012-04-10 09:05:11 +0100" MODIFIED_BY="[Empty name]" NAME="Pederson 1991" YEAR="1991">
<REFERENCE MODIFIED="2012-04-10 09:05:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pederson LL, Wanklin JM, Lefcoe NM</AU>
<TI>The effects of counseling on smoking cessation among patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial</TI>
<SO>International Journal of the Addictions</SO>
<YR>1991</YR>
<VL>26</VL>
<NO>1</NO>
<PG>107-19</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:53:51 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pelletier-1998" MODIFIED="2012-04-10 09:05:39 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" NAME="Pelletier 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-04-10 09:05:39 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pelletier JG, Moisan JT</AU>
<TI>Smoking cessation among hospitalized patients: A quasi-experimental study in Quebec</TI>
<SO>Canadian Journal of Public Health</SO>
<YR>1998</YR>
<VL>89</VL>
<PG>264-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Planer-2011" MODIFIED="2012-04-10 09:05:48 +0100" MODIFIED_BY="Lindsay Stead" NAME="Planer 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-04-10 09:05:48 +0100" MODIFIED_BY="Lindsay Stead" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Planer D, Lev I, Elitzur Y, Sharon N, Ouzan E, Pugatsch T et al</AU>
<TI>Bupropion for smoking cessation in patients with acute coronary syndrome</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2011</YR>
<VL>171</VL>
<NO>12</NO>
<PG>1055-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Quist_x002d_Paulsen-2003" NAME="Quist-Paulsen 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brown DW</AU>
<TI>Nurse-led intervention increases smoking cessation among people with coronary heart disease</TI>
<SO>Evidence Based Healthcare</SO>
<YR>2004</YR>
<VL>8</VL>
<PG>128-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quist-Paulsen P, Bakke PS, Gallefoss F</AU>
<TI>Does smoking cessation improve quality of life in patients with coronary heart disease?</TI>
<SO>Scandinavian Cardiovascular Journal</SO>
<YR>2006</YR>
<VL>40</VL>
<NO>1</NO>
<PG>11-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quist-Paulsen P, Bakke PS, Gallefoss F</AU>
<TI>Predictors of smoking cessation in patients admitted for acute coronary heart disease</TI>
<SO>European Journal of Cardiovascular Prevention &amp; Rehabilitation</SO>
<YR>2005</YR>
<VL>12</VL>
<NO>5</NO>
<PG>472-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;New 2006&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Quist-Paulsen P, Gallefoss F</AU>
<TI>Randomised controlled trial of smoking cessation intervention after admission for coronary heart disease</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7426</NO>
<PG>1254-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quist-Paulsen P, Lydersen S, Bakke PS, Gallefoss F</AU>
<TI>Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease</TI>
<SO>European Journal of Cardiovascular Prevention &amp; Rehabilitation</SO>
<YR>2006</YR>
<VL>13</VL>
<NO>2</NO>
<PG>274-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reid-2003" NAME="Reid 2003" YEAR="2003">
<REFERENCE NOTES="&lt;p&gt;New 2006&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reid R, Pipe A, Higginson L, Johnson K, D'Angelo MS, Cooke D et al</AU>
<TI>Stepped care approach to smoking cessation in patients hospitalized for coronary artery disease</TI>
<SO>Journal of Cardiopulmonary Rehabilitation</SO>
<YR>2003</YR>
<VL>23</VL>
<NO>3</NO>
<PG>176-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reid-2007" MODIFIED="2012-03-30 11:31:53 +0100" MODIFIED_BY="[Empty name]" NAME="Reid 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-03-30 11:31:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reid RD, Pipe AL, Quinlan B, Oda J</AU>
<TI>Interactive voice response telephony to promote smoking cessation in patients with heart disease: A pilot study</TI>
<SO>Patient Education &amp; Counseling</SO>
<YR>2007</YR>
<VL>66</VL>
<NO>3</NO>
<PG>319-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rigotti-1994" MODIFIED="2012-04-10 09:07:25 +0100" MODIFIED_BY="[Empty name]" NAME="Rigotti 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-04-10 09:07:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rigotti NA, McKool KM, Shiffman S</AU>
<TI>Predictors of smoking cessation after coronary artery bypass graft surgery. Results of a randomized trial with 5-year follow-up</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1994</YR>
<VL>120</VL>
<NO>4</NO>
<PG>287-93</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:54:03 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rigotti-1997" MODIFIED="2012-04-10 09:07:29 +0100" MODIFIED_BY="[Empty name]" NAME="Rigotti 1997" YEAR="1997">
<REFERENCE MODIFIED="2012-04-10 09:07:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rigotti NA, Arnsten JH, McKool KM, Wood Reid KM, Pasternak RC, Singer DE</AU>
<TI>Efficacy of a smoking cessation program for hospital patients</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1997</YR>
<VL>157</VL>
<NO>22</NO>
<PG>2653-60</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:54:08 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rigotti-2006" MODIFIED="2012-04-10 09:07:45 +0100" MODIFIED_BY="[Empty name]" NAME="Rigotti 2006" YEAR="2006">
<REFERENCE NOTES="&lt;p&gt;New 2006&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rigotti NA, Thorndike AN, Regan S, McKool K, Pasternak RC, Chang Y et al</AU>
<TI>Bupropion for smokers hospitalized with acute cardiovascular disease</TI>
<SO>American Journal of Medicine</SO>
<YR>2006</YR>
<VL>119</VL>
<NO>12</NO>
<PG>1080-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Thorndike A, Rigotti N, Regan S, Pasternak R, McKool K, Emmons K, Singer D</AU>
<TI>Depression and relapse to smoking in patients hospitalized with acute cardiovascular disease [POS3-094]</TI>
<SO>Society for Research on Nicotine and Tobacco 11th Annual Meeting, 20-23 March; Prague, Czech Republic</SO>
<YR>2005</YR>
<PG>137</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-04-10 09:07:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thorndike AN, Regan S, McKool K, Pasternak RC, Swartz S, Torres-Finnerty N et al</AU>
<TI>Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2008</YR>
<VL>168</VL>
<NO>2</NO>
<PG>186-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simon-1997" MODIFIED="2012-04-10 09:07:54 +0100" MODIFIED_BY="[Empty name]" NAME="Simon 1997" YEAR="1997">
<REFERENCE MODIFIED="2012-04-10 09:07:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simon JA, Solkowitz SN, Carmody TP, Browner WS</AU>
<TI>Smoking cessation after surgery - A randomized trial</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1997</YR>
<VL>157</VL>
<PG>1371-6</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:52:43 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simon-2003" NAME="Simon 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simon JA, Carmody TP, Hudes ES, Snyder E, Murray J</AU>
<TI>Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trial</TI>
<SO>American Journal of Medicine</SO>
<YR>2003</YR>
<VL>114</VL>
<NO>7</NO>
<PG>555-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simon-2009" MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" NAME="Simon 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simon JA, Duncan C, Huggins J, Solkowitz S, Carmody TP</AU>
<TI>Sustained-release bupropion for hospital-based smoking cessation: a randomized trial</TI>
<SO>Nicotine &amp; Tobacco Research</SO>
<YR>2009</YR>
<VL>11</VL>
<NO>6</NO>
<PG>663-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-2009" MODIFIED="2012-04-10 09:08:26 +0100" MODIFIED_BY="[Empty name]" NAME="Smith 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-02-21 18:00:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bitton A</AU>
<TI>Intensive smoking cessation programs for hospitalized coronary patients: A proven intervention in need of implementation</TI>
<SO>Journal of Clinical Outcomes Management</SO>
<YR>2009</YR>
<VL>16</VL>
<NO>9</NO>
<PG>398-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-04-10 09:08:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rigotti NA</AU>
<TI>Helping smokers with cardiac disease to abstain from tobacco after a stay in hospital [Comment]</TI>
<SO>CMAJ Canadian Medical Association Journal</SO>
<YR>2009</YR>
<VL>180</VL>
<PG>1283-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-03-30 11:55:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Smith PM, Burgess E</AU>
<TI>Smoking cessation initiated during hospital stay for patients with coronary artery disease: a randomized controlled trial</TI>
<SO>CMAJ Canadian Medical Association Journal</SO>
<YR>2009</YR>
<VL>180</VL>
<NO>13</NO>
<PG>1297-303</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-BJ-2011" MODIFIED="2012-02-28 09:02:10 +0000" MODIFIED_BY="[Empty name]" NAME="Smith BJ 2011" YEAR="2011">
<REFERENCE MODIFIED="2011-12-20 13:57:34 +0000" MODIFIED_BY="Lindsay Stead" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carson KV, Brinn MP, Smith BJ, Garside CG, Goldsworthy SJ, Fitridge RA</AU>
<TI>Varenicline tartrate and counselling versus counselling alone in a randomised controlled trial for inpatient smoking cessation: 3 month interim results [Abstract]</TI>
<SO>Respirology</SO>
<YR>2010</YR>
<VL>15</VL>
<NO>Suppl 1</NO>
<PG>A30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-12-20 13:57:34 +0000" MODIFIED_BY="Lindsay Stead" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith BJ, Peters MJ, Fitridge RA, Esterman AJ, Litt JC, Horowitz JD</AU>
<TI>Varenicline Tartrate And Counselling Versus Counselling Alone In A Randomised Controlled Trial For Inpatient Smoking Cessation: 6 Month Interim Results [Abstract]</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2011</YR>
<VL>183</VL>
<NO>Meeting Abstracts</NO>
<PG>A5445</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-PM-2011" MODIFIED="2012-02-28 09:02:44 +0000" MODIFIED_BY="[Empty name]" NAME="Smith PM 2011" YEAR="2011">
<REFERENCE MODIFIED="2011-07-13 14:42:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith PM, Corso L, Brown KS, Cameron R</AU>
<TI>Nurse case-managed tobacco cessation interventions for general hospital patients: Results of a randomized clinical trial</TI>
<SO>Canadian Journal of Nursing Research</SO>
<YR>2011</YR>
<VL>43</VL>
<PG>98-117</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Steinberg-2011" MODIFIED="2011-12-20 13:38:07 +0000" MODIFIED_BY="Lindsay Stead" NAME="Steinberg 2011" YEAR="2011">
<REFERENCE MODIFIED="2011-12-20 13:38:07 +0000" MODIFIED_BY="Lindsay Stead" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Steinberg MB, Randall J, Greenhaus S, Schmelzer AC, Richardson DL, Carson JL</AU>
<TI>Tobacco dependence treatment for hospitalized smokers: A randomized, controlled, pilot trial using varenicline</TI>
<SO>Addictive Behaviors</SO>
<YR>2011</YR>
<VL>36</VL>
<NO>12</NO>
<PG>1127-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stevens-1993" MODIFIED="2012-04-10 09:08:42 +0100" MODIFIED_BY="[Empty name]" NAME="Stevens 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-04-10 09:08:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stevens VJ, Glasgow RE, Hollis JF, Lichtenstein E, Vogt TM</AU>
<TI>A smoking-cessation intervention for hospital patients</TI>
<SO>Medical Care</SO>
<YR>1993</YR>
<VL>31</VL>
<NO>1</NO>
<PG>65-72</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:52:50 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stevens-2000" NAME="Stevens 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Allaway L, Stevens VJ</AU>
<TI>Respiratory care practitioners can provide effective smoking-cessation counseling to hospitalized smokers</TI>
<SO>Respiratory Care</SO>
<YR>1996</YR>
<VL>41</VL>
<NO>11</NO>
<PG>1026-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Stevens VJ, Glasgow RE, Hollis JF, Mount K</AU>
<TI>Implementation and effectiveness of a brief smoking-cessation intervention for hospital patients</TI>
<SO>Medical Care</SO>
<YR>2000</YR>
<VL>38</VL>
<NO>5</NO>
<PG>451-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taylor-1990" MODIFIED="2012-04-10 09:08:48 +0100" MODIFIED_BY="[Empty name]" NAME="Taylor 1990" YEAR="1990">
<REFERENCE MODIFIED="2012-04-10 09:08:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taylor CB, Houston-Miller NH, Killen JD, DeBusk RF</AU>
<TI>Smoking cessation after acute myocardial infarction: Effects of a nurse-managed intervention</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1990</YR>
<VL>113</VL>
<PG>118-23</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:52:57 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vial-2002" NAME="Vial 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vial RJ, Jones TE, Ruffin RE, Gilbert AL</AU>
<TI>Smoking cessation program using nicotine patches linking hospital to the community</TI>
<SO>Journal of Pharmacy Practice and Research</SO>
<YR>2002</YR>
<VL>32</VL>
<NO>1</NO>
<PG>57-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2012-04-10 09:11:13 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Agewall-2001" NAME="Agewall 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Agewall S, Fagerberg B, Berglund G, Schmidt C, Wendelhag I, Wikstrand J</AU>
<TI>Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima-media thickness and clinical outcome during 6 years of follow-up</TI>
<SO>Journal of Internal Medicine</SO>
<YR>2001</YR>
<VL>249</VL>
<NO>4</NO>
<PG>305-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Allen-1998" MODIFIED="2012-04-10 09:08:56 +0100" MODIFIED_BY="[Empty name]" NAME="Allen 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-04-10 09:08:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Allen B, Pederson LL, Leonard EH</AU>
<TI>Effectiveness of physicians-in-training counseling for smoking cessation in African Americans</TI>
<SO>Journal of the National Medical Association</SO>
<YR>1998</YR>
<VL>90</VL>
<PG>597-604</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:55:03 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Asfar-2005" NAME="Asfar 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Asfar T, Ward KD, Vander Weg MW, Hammal F, Eissenberg T, Maziak W</AU>
<TI>Characteristics of completers and dropouts in Syria's first smoking cessation trial [POS2-132]</TI>
<SO>Society for Research on Nicotine and Tobacco 11th Annual Meeting, 20-23 March 2005; Prague, Czech Republic</SO>
<YR>2005</YR>
<PG>110</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Avanzini-2011" MODIFIED="2011-12-20 13:38:07 +0000" MODIFIED_BY="Lindsay Stead" NAME="Avanzini 2011" YEAR="2011">
<REFERENCE MODIFIED="2011-12-20 13:38:07 +0000" MODIFIED_BY="Lindsay Stead" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Avanzini F, Di GP, Amodeo R, Baldo S, Bergna ML, Busi Gal</AU>
<TI>[Effectiveness of a nurse-led educational intervention for patients admitted for acute coronary syndrome]. [Italian]</TI>
<SO>Assistenza Infermieristica e Ricerca:Air</SO>
<YR>2011</YR>
<VL>30</VL>
<NO>1</NO>
<PG>16-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Becker-2003" NAME="Becker 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Becker BM, Bock BC, Partridge R</AU>
<TI>Smoking cessation interventions in the emergency department for smokers with chest pain</TI>
<SO>Academic Emergency Medicine</SO>
<YR>2003</YR>
<VL>10</VL>
<NO>5</NO>
<PG>507</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bize-2006" NAME="Bize 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bize R, Stoianov R, Ruffieux C, Ghali W, Paccaud F, Cornuz J</AU>
<TI>Effectiveness of a low-intensity smoking cessation intervention for hospitalized patients</TI>
<SO>European Journal of Cancer Prevention</SO>
<YR>2006</YR>
<VL>15</VL>
<NO>5</NO>
<PG>464-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Blom-2005" NAME="Blom 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Blom RA, Mulder M, van Spiegel PI, Christenhusz LCA</AU>
<TI>Determinants of successful quitting in patients with COPD [POS3-088]</TI>
<SO>Society for Research on Nicotine and Tobacco 11th Annual Meeting. 20-23 March; Prague, Czech Republic</SO>
<YR>2005</YR>
<PG>135</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-BTS-1983" NAME="BTS 1983" YEAR="1983">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>British Thoracic Society</AU>
<TI>Comparison of four methods of smoking withdrawal in patients with smoking related diseases</TI>
<SO>British Medical Journal</SO>
<YR>1983</YR>
<VL>286</VL>
<PG>595-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>British Thoracic Society</AU>
<TI>Smoking withdrawal in hospital patients: factors associated with outcome</TI>
<SO>Thorax</SO>
<YR>1984</YR>
<VL>39</VL>
<PG>651-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burt-1974" MODIFIED="2012-04-10 09:09:04 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" NAME="Burt 1974" YEAR="1974">
<REFERENCE MODIFIED="2012-04-10 09:09:04 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burt A, Illingworth D, Shaw T, Thornley P, White P, Turner R</AU>
<TI>Stopping smoking after myocardial infarction</TI>
<SO>Lancet</SO>
<YR>1974</YR>
<VL>1</VL>
<NO>7582</NO>
<PG>304-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chan-2003" NAME="Chan 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Chan SSC, Chan SC, Lam TH, Lau C-P</AU>
<TI>The effectiveness of a stage-matched smoking cessation intervention to cardiac patients: Preliminary results of a randomized controlled trial (POS3-97)</TI>
<SO>Society for Research on Nicotine and Tobacco 9th Annual Meeting February 19-22 New Orleans, Louisiana Rapid Communications Posters</SO>
<YR>2003</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chan-2010" MODIFIED="2012-03-01 10:02:53 +0000" MODIFIED_BY="[Empty name]" NAME="Chan 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-03-01 10:02:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chan SS, Leung DY, Lau C, Wong V, Lam T</AU>
<TI>Cost-effectiveness analysis of a low intensity nurse-led stage-matched smoking cessation intervention to cardiac patients in Hong Kong</TI>
<SO>Circulation</SO>
<YR>2010</YR>
<VL>122</VL>
<NO>2</NO>
<PG>E87</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Choo-2004" NAME="Choo 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Choo YM, Ong KC, Lee WK</AU>
<TI>Effectiveness of a smoking cessation program among hospitalized patients in Singapore</TI>
<SO>Chest</SO>
<YR>2004</YR>
<VL>126</VL>
<NO>4</NO>
<PG>713S</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Colby-1998" MODIFIED="2012-04-10 09:09:10 +0100" MODIFIED_BY="[Empty name]" NAME="Colby 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-04-10 09:09:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Colby SM, Monti PM, Barnett NP, Rohsenow DJ, Weissman K, Spirito A et al</AU>
<TI>Brief motivational interviewing in a hospital setting for adolescent smoking: a preliminary study</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1998</YR>
<VL>66</VL>
<NO>3</NO>
<PG>574-8</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:55:10 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cole-2001" NAME="Cole 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cole TK</AU>
<TI>Smoking cessation in the hospitalized patient using the transtheoretical model of behavior change</TI>
<SO>Heart &amp; Lung</SO>
<YR>2001</YR>
<VL>30</VL>
<NO>2</NO>
<PG>148-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dale-1995" MODIFIED="2012-04-10 09:09:16 +0100" MODIFIED_BY="[Empty name]" NAME="Dale 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-04-10 09:09:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR</AU>
<TI>High-dose nicotine patch therapy - percentage of replacement and smoking cessation</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>274</VL>
<NO>17</NO>
<PG>1353-8</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:55:16 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Davies-2005" NAME="Davies 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Davies SL, Kohler CL, Fish L, Taylor BE, Foster GE, Annang L</AU>
<TI>Evaluation of an intervention for hospitalized African American smokers</TI>
<SO>American Journal of Health Behavior</SO>
<YR>2005</YR>
<VL>29</VL>
<NO>3</NO>
<PG>228-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Elsony-2005" NAME="Elsony 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Elsony A, Salieh M, Elhaj H, Adam K</AU>
<TI>Brief smoking cessation intervention with tuberculosis patients in Sudan [PA2-5]</TI>
<SO>Society for Research on Nicotine and Tobacco 11th Annual Meeting, 20-23 March 2005; Prague, Czech Republic</SO>
<YR>2005</YR>
<PG>22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Emmons-2000" NAME="Emmons 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Emmons KM, Goldstein MG, Roberts M, Cargill B, Sherman CB, Millman R et al</AU>
<TI>The use of nicotine replacement therapy during hospitalization</TI>
<SO>Annals of Behavioral Medicine</SO>
<YR>2000</YR>
<VL>22</VL>
<NO>4</NO>
<PG>325-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Freund-2009" MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" NAME="Freund 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Freund M, Campbell E, Paul C, Sakrouge R, Lecathelinais C, Knight Jet al</AU>
<TI>Increasing hospital-wide delivery of smoking cessation care for nicotine-dependent in-patients: A multi-strategic intervention trial</TI>
<SO>Addiction</SO>
<YR>2009</YR>
<VL>104</VL>
<NO>5</NO>
<PG>839-49</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fung-2005" NAME="Fung 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fung PR, Snape-Jenkinson SL, Godfrey MT, Love KW, Zimmerman PV, Yang IA et al</AU>
<TI>Effectiveness of hospital-based smoking cessation</TI>
<SO>Chest</SO>
<YR>2005</YR>
<VL>128</VL>
<NO>1</NO>
<PG>216-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gadomski-2011" MODIFIED="2011-07-13 14:42:35 +0100" MODIFIED_BY="[Empty name]" NAME="Gadomski 2011" YEAR="2011">
<REFERENCE MODIFIED="2011-07-13 14:42:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gadomski AM, Gavett J, Krupa N, Tallman N, Jenkins P</AU>
<TI>Effectiveness of an inpatient smoking cessation program</TI>
<SO>Journal of Hospital Medicine (Online)</SO>
<YR>2011</YR>
<VL>6</VL>
<NO>1</NO>
<PG>E1-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Galvin-2001" NAME="Galvin 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Galvin K, Webb C, Hillier V</AU>
<TI>Assessing the impact of a nurse-led health education intervention for people with peripheral vascular disease who smoke: the use of physiological markers, nicotine dependence and withdrawal</TI>
<SO>International Journal of Nursing Studies</SO>
<YR>2001</YR>
<VL>38</VL>
<NO>1</NO>
<PG>91-105</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gariti-2002" NAME="Gariti 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gariti P, Alterman A, Mulvaney F, Mechanic K, Dhopesh V, Yu E et al</AU>
<TI>Nicotine intervention during detoxification and treatment for other substance use</TI>
<SO>American Journal of Drug and Alcohol Abuse</SO>
<YR>2002</YR>
<VL>28</VL>
<NO>4</NO>
<PG>673-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gies-2008" MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" NAME="Gies 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gies CE, Buchman D, Robinson J, Smolen D</AU>
<TI>Effect of an inpatient nurse-directed smoking cessation program</TI>
<SO>Western Journal of Nursing Research</SO>
<YR>2008</YR>
<VL>30</VL>
<NO>1</NO>
<PG>6-19</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gritz-1993" MODIFIED="2011-03-02 14:55:23 +0000" MODIFIED_BY="[Empty name]" NAME="Gritz 1993" YEAR="1993">
<REFERENCE MODIFIED="2011-03-02 14:55:23 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gritz ER, Carr CR, Rapkin D, Abemayor E, Chang LJ, Wong WK et al</AU>
<TI>Predictors of long-term smoking cessation in head and neck cancer patients</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>1993</YR>
<VL>2</VL>
<NO>3</NO>
<PG>261-70</PG>
<IDENTIFIERS MODIFIED="2011-03-02 14:55:23 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Gritz ER, Ward PH, Beumer J, Carr CR, Rapkin DA</AU>
<TI>Increasing adherence to a provider-implemented smoking cessation intervention for head and neck cancer patients</TI>
<SO>Advances in Cancer Control: Screening and Prevention</SO>
<YR>1990</YR>
<PG>83-93</PG>
<ED>Association of Community Cancer Centers</ED>
<PB>Wiley-Liss</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hand-2002" NAME="Hand 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hand S, Edwards S, Campbell IA, Cannings R</AU>
<TI>Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support</TI>
<SO>Thorax</SO>
<YR>2002</YR>
<VL>57</VL>
<NO>8</NO>
<PG>715-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hanssen-2007" MODIFIED="2011-12-20 15:23:12 +0000" MODIFIED_BY="Lindsay Stead" NAME="Hanssen 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-12-20 15:23:12 +0000" MODIFIED_BY="Lindsay Stead" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hanssen TA, Nordrehaug JE, Eide GE, Hanestad BR</AU>
<TI>Does a telephone follow-up intervention for patients discharged with acute myocardial infarction have long-term effects on health-related quality of life? A randomised controlled trial</TI>
<SO>Journal of Clinical Nursing</SO>
<YR>2009</YR>
<VL>18</VL>
<NO>9</NO>
<PG>1334-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-12-20 15:23:12 +0000" MODIFIED_BY="Lindsay Stead" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hanssen TA, Nordrehaug JE, Eide GE, Hanestad BR</AU>
<TI>Improving outcomes after myocardial infarction: a randomized controlled trial evaluating effects of a telephone follow-up intervention</TI>
<SO>European Journal of Cardiovascular Prevention &amp; Rehabilitation</SO>
<YR>2007</YR>
<VL>14</VL>
<NO>3</NO>
<PG>429-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hasan-2007" MODIFIED="2011-03-02 15:30:22 +0000" MODIFIED_BY="[Empty name]" NAME="Hasan 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hasan FM, Pischke K, Saiyed S, Macys D, McCleary N</AU>
<TI>Hypnotherapy as an aid to smoking cessation of hospitalized patients: Preliminary results</TI>
<SO>Chest</SO>
<YR>2007</YR>
<VL>132</VL>
<PG>527S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-02 15:30:22 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hasan FM, Saiyed S, Pischke K, Macys D, Bettencourt AM, Beal L</AU>
<TI>Non-pharmacologic therapy for smoking cessation of hospitalized patients: a role for hypnotherapy [Abstract]</TI>
<SO>American Thoracic Society International Conference, May 15-20 2009, San Diego</SO>
<YR>2009</YR>
<PG>A3959</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hilleman-2004" NAME="Hilleman 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hilleman DE, Mohiuddin SM, Packard KA</AU>
<TI>Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery</TI>
<SO>Chest</SO>
<YR>2004</YR>
<VL>125</VL>
<NO>2</NO>
<PG>435-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Holmes_x002d_Rovner-2008" MODIFIED="2011-03-02 15:33:42 +0000" MODIFIED_BY="[Empty name]" NAME="Holmes-Rovner 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-03-02 15:33:42 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Holmes-Rovner M, Stommel M, Corser WD, Olomu A, Holtrop JS, Siddiqi A et al</AU>
<TI>Does outpatient telephone coaching add to hospital quality improvement following hospitalization for acute coronary syndrome?</TI>
<SO>Journal of General Internal Medicine</SO>
<YR>2008</YR>
<VL>23</VL>
<NO>9</NO>
<PG>1464-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-02 15:31:57 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Holtrop JS, Corser W, Jones G, Brooks G, Holmes-Rovner M, Stommel M</AU>
<TI>Health behavior goals of cardiac patients after hospitalization</TI>
<SO>American Journal of Health Behavior</SO>
<YR>2006</YR>
<VL>30</VL>
<NO>4</NO>
<PG>387-99</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-02 15:32:26 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Holtrop JS, Corser W, Stommel M, Holmes-Rovner M</AU>
<TI>Predictors of smoking cessation and relapse after hospitalization for acute coronary syndrome (POS1-111)</TI>
<SO>Society for Research on Nicotine and Tobacco 13th Annual Meeting February 21-24, Austin, Texas</SO>
<YR>2007</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Horn-2008" MODIFIED="2011-12-20 15:28:51 +0000" MODIFIED_BY="Lindsay Stead" NAME="Horn 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-12-20 15:28:51 +0000" MODIFIED_BY="Lindsay Stead" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Horn K, Dino G, Hamilton C, Noerachmanto N, Zhang J</AU>
<TI>Feasibility of a smoking cessation intervention for teens in the emergency department: reach, implementation fidelity, and acceptability</TI>
<SO>American Journal of Critical Care</SO>
<YR>2008</YR>
<VL>17</VL>
<NO>3</NO>
<PG>205-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jeong-2002" NAME="Jeong 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jeong HS, Chae JS, Moon JS, Yoo YS</AU>
<TI>An individualized teaching program for atherosclerotic risk factor reduction in patients with myocardial infarction</TI>
<SO>Yonsei Medical Journal</SO>
<YR>2002</YR>
<VL>43</VL>
<NO>1</NO>
<PG>93-100</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Johnson-1999" MODIFIED="2012-04-10 09:10:09 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" NAME="Johnson 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-04-10 09:10:09 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnson JL, Budz B, Mackay M, Miller C</AU>
<TI>Evaluation of a nurse-delivered smoking cessation intervention for hospitalized patients with cardiac disease</TI>
<SO>Heart &amp; Lung</SO>
<YR>1999</YR>
<VL>28</VL>
<NO>1</NO>
<PG>55-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jones-2001" NAME="Jones 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jones C, Griffiths RD, Skirrow P, Humphris G</AU>
<TI>Smoking cessation through comprehensive critical care</TI>
<SO>Intensive Care Medicine</SO>
<YR>2001</YR>
<VL>27</VL>
<NO>9</NO>
<PG>1547-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Joseph-2004" NAME="Joseph 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Joseph A, Lexau B, Willenbring M, Nugent S, Nelson D</AU>
<TI>Factors associated with readiness to stop smoking among patients in treatment for alcohol use disorder</TI>
<SO>American Journal on Addictions</SO>
<YR>2004</YR>
<VL>13</VL>
<NO>4</NO>
<PG>405-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Joseph-2005" NAME="Joseph 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Joseph A, Hecht S, Murphy S, Gross M, Lando H, Bliss R et al</AU>
<TI>A randomized controlled trial of smoking reduction in heart disease patients [PA2-4]</TI>
<SO>Society for Research on Nicotine and Tobacco 11th Annual Meeting, 20-23 March 2005; Prague, Czech Republic</SO>
<YR>2005</YR>
<PG>22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Joseph A, Hecht S, Murphy S, Gross M, Lando H, Bliss R et al</AU>
<TI>A randomized controlled trial of smoking reduction in heart disease patients</TI>
<SO>Nicotine &amp; Tobacco Research</SO>
<YR>2005</YR>
<VL>7</VL>
<NO>4</NO>
<PG>687</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kalman-2001" NAME="Kalman 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kalman D, Hayes K, Colby SM, Eaton CA, Rohsenow DJ, Monti PM</AU>
<TI>Concurrent versus delayed smoking cessation treatment for persons in early alcohol recovery - A pilot study</TI>
<SO>Journal of Substance Abuse Treatment</SO>
<YR>2001</YR>
<VL>20</VL>
<NO>3</NO>
<PG>233-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lewis-2009" MODIFIED="2012-02-21 14:09:03 +0000" MODIFIED_BY="[Empty name]" NAME="Lewis 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-02-21 14:09:03 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lewis KE, Dixon H, Edwards VM, Whitehead C, Durgan L, Sykes R</AU>
<TI>Can smokers pass seamlessly from a hospital based to a community based smoking cessation service? A randomised controlled trial [Abstract]</TI>
<SO>Thorax</SO>
<YR>2006</YR>
<VL>61</VL>
<NO>Suppl 2</NO>
<PG>ii22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-02-21 14:09:03 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lewis KE, Durgan L, Edwards VM, Dixon H, Whitehead C, Sykes RN</AU>
<TI>Can smokers switch from a hospital-based to a community-based stop smoking service? An open-label, randomized trial comparing three referral schemes</TI>
<SO>Nicotine &amp; Tobacco Research</SO>
<YR>2009</YR>
<VL>11</VL>
<NO>6</NO>
<PG>756-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lisspers-1999" NAME="Lisspers 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lisspers J, Sundin O, HofmanBang C, Nordlander R, Nygren A, Ryden L et al</AU>
<TI>Behavioral effects of a comprehensive, multifactorial program for lifestyle change after percutaneous transluminal coronary angioplasty: a prospective, randomized, controlled study</TI>
<SO>Journal of Psychosomatic Research</SO>
<YR>1999</YR>
<VL>46</VL>
<PG>143-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McHugh-2001" NAME="McHugh 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McHugh F, Lindsay GM, Hanlon P, Hutton I, Brown MR, Morrison C et al</AU>
<TI>Nurse-led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial</TI>
<SO>Heart</SO>
<YR>2001</YR>
<VL>86</VL>
<PG>317-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meenan-1998" NAME="Meenan 1998" YEAR="1998">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Meenan RT, Stevens VJ, Hornbrook MC, La Chance PA, Glasgow RE, Hollis JF et al</AU>
<TI>Cost-effectiveness of a hospital-based smoking cessation intervention</TI>
<SO>Medical Care</SO>
<YR>1998</YR>
<VL>36</VL>
<NO>5</NO>
<PG>670-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1998255497"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moller-2002" NAME="Moller 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moller AM, Villebro N, Pedersen T, Tonnesen H</AU>
<TI>Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial</TI>
<SO>Lancet</SO>
<YR>2002</YR>
<VL>359</VL>
<NO>9301</NO>
<PG>114-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mosca-2010" MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" NAME="Mosca 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mosca L, Christian AH, Mochari-Greenberger H, Kligfield P, Smith SCJ</AU>
<TI>A randomized clinical trial of secondary prevention among women hospitalized with coronary heart disease</TI>
<SO>Journal of Women's Health</SO>
<YR>2010</YR>
<VL>19</VL>
<NO>2</NO>
<PG>195-202</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nackaerts-2009" MODIFIED="2012-04-10 09:10:23 +0100" MODIFIED_BY="[Empty name]" NAME="Nackaerts 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-04-10 09:10:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nackaerts K, Salhi B, Devolder A, Meysman M, Boudrez H, Van-Dyck L</AU>
<TI>A randomised, double-blind, placebo-controlled phase 3 study investigating the effficacy of nicotine substitution (NS) on nicotine withdrawal symptoms (NWS) in hospitalised smokers (HS) [Abstract]</TI>
<SO>European Respiratory Society Annual Congress, Vienna, Austria, September 12-16</SO>
<YR>2009</YR>
<PG>4632</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nasell-2010" MODIFIED="2011-12-20 12:29:56 +0000" MODIFIED_BY="[Empty name]" NAME="Nasell 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-03-02 18:19:10 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nasell H, Adami J, Samnegard E, Tonnesen H, Ponzer S</AU>
<TI>Effect of smoking cessation intervention on results of acute fracture surgery: a randomized controlled trial</TI>
<SO>Journal of Bone &amp; Joint Surgery - American Volume</SO>
<YR>2010</YR>
<VL>92</VL>
<PG>1335-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ong-2005" NAME="Ong 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ong KC, Cheong GN, Prabhakaran GL, Earnest A</AU>
<TI>Predictors of success in smoking cessation among hospitalized patients</TI>
<SO>Respirology</SO>
<YR>2005</YR>
<VL>10</VL>
<NO>1</NO>
<PG>63-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Ranote-2003" NAME="Ranote 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Ranote P, Smith M, Smith S, Ballance K, Miles J</AU>
<TI>Effects of an immediate smoking cessation programme on long-term quit rates in patients admitted to acute medical wards of a UK general hospital [abstract]</TI>
<SO>American Thoracic Society 99th International Conference</SO>
<YR>2003</YR>
<PG>A027</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ratner-2004" MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" NAME="Ratner 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bottorff JL, Johnson JL, Moffat B, Fofonoff D, Budz B, Groening M</AU>
<TI>Synchronizing clinician engagement and client motivation in telephone counseling</TI>
<SO>Qualitative Health Research</SO>
<YR>2004</YR>
<VL>14</VL>
<NO>4</NO>
<PG>462-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ratner PA, Johnson JL, Richardson CG, Bottorff JL, Moffat B, Mackay M et al</AU>
<TI>Efficacy of a smoking-cessation intervention for elective-surgical patients</TI>
<SO>Research in Nursing and Health</SO>
<YR>2004</YR>
<VL>27</VL>
<NO>3</NO>
<PG>148-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Regan-2011" MODIFIED="2012-02-21 14:09:58 +0000" MODIFIED_BY="[Empty name]" NAME="Regan 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-02-21 14:09:58 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Regan S, Reyen M, Lockhart AC, Richards AE, Rigotti NA</AU>
<TI>An interactive voice response system to continue a hospital-based smoking cessation intervention after discharge</TI>
<SO>Nicotine &amp; Tobacco Research</SO>
<YR>2011</YR>
<VL>13</VL>
<NO>4</NO>
<PG>255-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reid-2006" NAME="Reid 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reid RD, Pipe AL, Quinlan B.</AU>
<TI>Promoting smoking cessation during hospitalization for coronary artery disease</TI>
<SO>Canadian Journal of Cardiology</SO>
<YR>2006</YR>
<VL>22</VL>
<PG>775-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Richman-2000" NAME="Richman 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Richman PB, Dinowitz S, Nashed AH, Eskin B, Sylvan E, Allegra C et al</AU>
<TI>The emergency department as a potential site for smoking cessation intervention: A randomized, controlled trial</TI>
<SO>Academic Emergency Medicine</SO>
<YR>2000</YR>
<VL>7</VL>
<NO>4</NO>
<PG>348-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rissel-2000" NAME="Rissel 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rissel C, Salmon A, Hughes AM</AU>
<TI>Evaluation of a (pilot) stage-tailored brief smoking cessation intervention among hospital patients presenting to a hospital pre-admission clinic</TI>
<SO>Australian Health Review</SO>
<YR>2000</YR>
<VL>23</VL>
<NO>3</NO>
<PG>83-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmitz-1999" MODIFIED="2012-04-10 09:10:37 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" NAME="Schmitz 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-04-10 09:10:37 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmitz JM, Spiga R, Rhoades HM, Fuentes F, Grabowski J</AU>
<TI>Smoking cessation in women with cardiac risk: a comparative study of two theoretically based therapies</TI>
<SO>Nicotine &amp; Tobacco Research</SO>
<YR>1999</YR>
<VL>1</VL>
<PG>87-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-2002" NAME="Smith 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith PM, Reilly KR, Houston-Miller N, DeBusk RF, Taylor CB</AU>
<TI>Application of a nurse-managed inpatient smoking cessation program</TI>
<SO>Nicotine &amp; Tobacco Research</SO>
<YR>2002</YR>
<VL>4</VL>
<NO>2</NO>
<PG>211-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Strecher-1985" MODIFIED="2012-04-10 09:10:43 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" NAME="Strecher 1985" YEAR="1985">
<REFERENCE MODIFIED="2012-04-10 09:10:43 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Strecher VJ, Becker MH, Kirscht JP, Eraker SA, Graham-Tomasi RP</AU>
<TI>Evaluation of a minimal-contact smoking cessation program in a health care setting</TI>
<SO>Patient Education and Counselling</SO>
<YR>1985</YR>
<VL>7</VL>
<PG>395-407</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sundblad-2008" MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" NAME="Sundblad 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sundblad BM, Larsson K, Nathell L</AU>
<TI>High rate of smoking abstinence in COPD patients: Smoking cessation by hospitalization</TI>
<SO>Nicotine &amp; Tobacco Research</SO>
<YR>2008</YR>
<VL>10</VL>
<NO>5</NO>
<PG>883-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Takahashi-2006" NAME="Takahashi 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Takahashi K, Sako H, Sasa H, Sako H, Iwata M, Hashimoto I et al</AU>
<TI>A pilot study on inducement of smoking cessation by a simple 5A (asking, advice, assess, assist, and arrange) approach at outpatient clinics</TI>
<SO>Asian Pacific Journal of Cancer Prevention</SO>
<YR>2006</YR>
<VL>7</VL>
<NO>1</NO>
<PG>131-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Targhetta-2011" MODIFIED="2011-12-20 13:38:07 +0000" MODIFIED_BY="Lindsay Stead" NAME="Targhetta 2011" YEAR="2011">
<REFERENCE MODIFIED="2011-12-20 13:38:07 +0000" MODIFIED_BY="Lindsay Stead" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Targhetta R, Bernhard L, Sorokaty JM, Balmes JL, Nalpas B, Perney P</AU>
<TI>Intervention study to improve smoking cessation during hospitalization</TI>
<SO>Public Health</SO>
<YR>2011</YR>
<VL>125</VL>
<NO>7</NO>
<PG>457-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taylor-2005" NAME="Taylor 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taylor CB, Miller NH, Cameron RP, Fagans EW, Das S</AU>
<TI>Dissemination of an effective inpatient tobacco use cessation program</TI>
<SO>Nicotine &amp; Tobacco Research</SO>
<YR>2005</YR>
<VL>7</VL>
<PG>129-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thomsen-2010" MODIFIED="2012-04-10 09:10:58 +0100" MODIFIED_BY="[Empty name]" NAME="Thomsen 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-04-10 09:10:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thomsen T, Tonnesen H, Okholm M, Kroman N, Maibom A, Sauerberg ML et al</AU>
<TI>Brief smoking cessation intervention in relation to breast cancer surgery: a randomized controlled trial</TI>
<SO>Nicotine &amp; Tobacco Research</SO>
<YR>2010</YR>
<VL>12</VL>
<NO>11</NO>
<PG>1118-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wakefield-2004" NAME="Wakefield 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wakefield M, Olver I, Whitford H, Rosenfeld E</AU>
<TI>Motivational interviewing as a smoking cessation intervention for patients with cancer: randomized controlled trial</TI>
<SO>Nursing Research</SO>
<YR>2004</YR>
<VL>53</VL>
<NO>6</NO>
<PG>396-405</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Warner-2005" NAME="Warner 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Warner DO, Patten CA, Ames SC, Offord KP, Schroeder DR</AU>
<TI>Effect of nicotine replacement therapy on stress and smoking behavior in surgical patients</TI>
<SO>Anesthesiology</SO>
<YR>2005</YR>
<VL>102</VL>
<NO>6</NO>
<PG>1138-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wewers-1994" MODIFIED="2012-04-10 09:11:06 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" NAME="Wewers 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-04-10 09:11:06 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wewers ME, Bowen JM, Stanislaw AE, Desimone VB</AU>
<TI>A nurse-delivered smoking cessation intervention among hospitalized postoperative patients--influence of a smoking- related diagnosis: a pilot study</TI>
<SO>Heart &amp; Lung</SO>
<YR>1994</YR>
<VL>23</VL>
<PG>151-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="94266626"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Winickoff-2010" MODIFIED="2012-04-10 09:11:13 +0100" MODIFIED_BY="[Empty name]" NAME="Winickoff 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-04-10 09:11:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Winickoff JP, Healey EA, Regan S, Park ER, Cole C, Friebely J et al</AU>
<TI>Using the postpartum hospital stay to address mothers' and fathers' smoking: the NEWS study</TI>
<SO>Pediatrics</SO>
<YR>2010</YR>
<VL>125</VL>
<NO>3</NO>
<PG>518-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wolfenden-2005" NAME="Wolfenden 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wolfenden L, Wiggers J, Knight J, Campbell E, Rissel C, Kerridge R et al</AU>
<TI>A programme for reducing smoking in pre-operative surgical patients: randomised controlled trial</TI>
<SO>Anaesthesia</SO>
<YR>2005</YR>
<VL>60</VL>
<NO>2</NO>
<PG>172-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wolfenden-2008" MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" NAME="Wolfenden 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-03-02 15:29:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wolfenden L, Wiggers J, Campbell E, Knight J</AU>
<TI>Pilot of a preoperative smoking cessation intervention incorporating post-discharge support from a Quitline</TI>
<SO>Health Promotion Journal of Australia</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>2</NO>
<PG>158-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2012-04-10 09:11:23 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Brunner_x002d_Frandsen-2010" MODIFIED="2012-03-28 18:07:57 +0100" MODIFIED_BY="Lindsay Stead" NAME="Brunner-Frandsen 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-03-28 18:07:57 +0100" MODIFIED_BY="Lindsay Stead" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brunner-Frandsen NS, Bak S</AU>
<TI>Smoking cessation intervention after stroke or transient ischemic attack. A randomised controlled trial</TI>
<SO>Cerebrovascular Diseases</SO>
<YR>2010</YR>
<VL>29</VL>
<NO>323</NO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jimenez-2007" MODIFIED="2012-04-10 09:11:23 +0100" MODIFIED_BY="[Empty name]" NAME="Jimenez 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-04-10 09:11:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jimenez G, Lopez J, Martinez M, Romero A, Gil B, de Dios LJ et al</AU>
<TI>Effectiveness of a specialised intervention for smoking cessation in hospitalised patients [Abstract]</TI>
<SO>European Respiratory Journal</SO>
<YR>2007</YR>
<VL>30</VL>
<NO>Suppl 51</NO>
<PG>502s</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2012-03-28 18:07:57 +0100" MODIFIED_BY="[Empty name]"/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2012-04-10 09:13:53 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2012-04-05 14:19:03 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Cahill-2012" MODIFIED="2012-03-07 13:45:34 +0000" MODIFIED_BY="Jamie Hartmann-Boyce" NAME="Cahill 2012" NOTES="&lt;p&gt;JHB input before pub - verify DOI and issue no once update published&lt;/p&gt;" NOTES_MODIFIED="2012-03-07 13:45:34 +0000" NOTES_MODIFIED_BY="Jamie Hartmann-Boyce" TYPE="COCHRANE_REVIEW">
<AU>Cahill K, Stead LF, Lancaster T</AU>
<TI>Nicotine receptor partial agonists for smoking cessation</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<IDENTIFIERS MODIFIED="2012-03-07 13:44:44 +0000" MODIFIED_BY="Jamie Hartmann-Boyce">
<IDENTIFIER MODIFIED="2012-03-07 13:44:44 +0000" MODIFIED_BY="Jamie Hartmann-Boyce" TYPE="DOI" VALUE="10.1002/14651858.CD006103.pub6"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" NAME="Higgins 2003" NOTES="&lt;p&gt;Higgins 2003&lt;br&gt;Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;7414:557-60.&lt;br&gt;Higgins 2003&lt;br&gt;Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;7414:557-60.&lt;/p&gt;&lt;p&gt;&lt;br&gt;&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>7414</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-04-05 14:19:03 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" NAME="Higgins 2011" NOTES="&lt;p&gt;Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. http://www.cochrane.org/resources/handbook/hbook.htm (accessed 6th October 2006).&lt;/p&gt;" NOTES_MODIFIED="2012-04-05 14:19:03 +0100" NOTES_MODIFIED_BY="Jamie Hartmann-Boyce" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</TI>
<SO>The Cochrane Collaboration,</SO>
<YR>2011</YR>
<PG>available from www.cochrane-handbook.org</PG>
<IDENTIFIERS MODIFIED="2012-03-06 15:09:05 +0000" MODIFIED_BY="Jamie Hartmann-Boyce"/>
</REFERENCE>
<REFERENCE ID="REF-Hughes-2007" MODIFIED="2008-08-07 16:21:41 +0100" MODIFIED_BY="L S" NAME="Hughes 2007" TYPE="COCHRANE_REVIEW">
<AU>Hughes JR, Stead LF, Lancaster T</AU>
<TI>Antidepressants for smoking cessation</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2008-08-07 16:21:41 +0100" MODIFIED_BY="L S">
<IDENTIFIER MODIFIED="2008-08-07 16:21:41 +0100" MODIFIED_BY="L S" TYPE="DOI" VALUE="10.1002/14651858.CD000031"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ladapo-2011" MODIFIED="2011-07-13 14:42:35 +0100" MODIFIED_BY="[Empty name]" NAME="Ladapo 2011" TYPE="JOURNAL_ARTICLE">
<AU>Ladapo JA, Jaffer FA, Weinstein MC, Froelicher ES</AU>
<TI>Projected cost-effectiveness of smoking cessation interventions in patients hospitalized with myocardial infarction</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2011</YR>
<VL>171</VL>
<NO>1</NO>
<PG>39-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Liu-2010" MODIFIED="2011-07-13 14:42:35 +0100" MODIFIED_BY="[Empty name]" NAME="Liu 2010" TYPE="JOURNAL_ARTICLE">
<AU>Liu SK, Prior E, Warren C, Brown T, Snide J, Butterly JR</AU>
<TI>Improving the quality of care for the hospitalized tobacco user--one institution's transformational journey</TI>
<SO>Journal of Cancer Education</SO>
<YR>2010</YR>
<VL>25</VL>
<NO>3</NO>
<PG>297-301</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ockene-1992" NAME="Ockene 1992" TYPE="JOURNAL_ARTICLE">
<AU>Ockene JK, Kristeller J, Goldberg R, Ockene IS, Merriam P, Barrett S et al</AU>
<TI>Smoking cessation and severity of disease: The coronary artery smoking intervention study</TI>
<SO>Health Psychology</SO>
<YR>1992</YR>
<VL>11</VL>
<PG>119-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayes RJ, Altman DG</AU>
<TI>Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stead-2008a" MODIFIED="2012-03-06 15:14:28 +0000" MODIFIED_BY="L S" NAME="Stead 2008a" TYPE="COCHRANE_REVIEW">
<AU>Stead LF, Bergson G, Lancaster T</AU>
<TI>Physician advice for smoking cessation</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2012-03-06 15:12:46 +0000" MODIFIED_BY="L S">
<IDENTIFIER MODIFIED="2012-03-06 15:12:46 +0000" MODIFIED_BY="L S" TYPE="DOI" VALUE="10.1002/14651858.CD000165.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stead-2008b" MODIFIED="2012-03-06 15:15:03 +0000" MODIFIED_BY="L S" NAME="Stead 2008b" TYPE="COCHRANE_REVIEW">
<AU>Stead LF, Perera R, Bullen C, Mant D, Lancaster T</AU>
<TI>Nicotine replacement therapy for smoking cessation</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2012-03-06 15:15:03 +0000" MODIFIED_BY="L S">
<IDENTIFIER MODIFIED="2012-03-06 15:15:03 +0000" MODIFIED_BY="L S" TYPE="DOI" VALUE="10.1002/14651858.CD000146.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Yusuf-1985" NAME="Yusuf 1985" TYPE="JOURNAL_ARTICLE">
<AU>Yusuf S, Peto R, Lewis J, Collins R, Sleight P</AU>
<TI>Beta blockade during and after myocardial infarction: An overview of the randomized trials</TI>
<SO>Progress in Cardiovascular Diseases</SO>
<YR>1985</YR>
<VL>27</VL>
<NO>5</NO>
<PG>335-71</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2012-04-10 09:13:53 +0100" MODIFIED_BY="L S">
<REFERENCE ID="REF-Munafo-2001" NAME="Munafo 2001" TYPE="JOURNAL_ARTICLE">
<AU>Munafo M, Rigotti N, Lancaster T, Stead L, Murphy M</AU>
<TI>Interventions for smoking cessation in hospitalised patients: a systematic review</TI>
<SO>Thorax</SO>
<YR>2001</YR>
<VL>56</VL>
<PG>656-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rigotti-2001" MODIFIED="2008-08-07 16:17:38 +0100" MODIFIED_BY="L S" NAME="Rigotti 2001" TYPE="COCHRANE_REVIEW">
<AU>Rigotti NA, Munafo MR, Murphy MF, Stead LF</AU>
<TI>Interventions for smoking cessation in hospitalised patients</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2008-08-07 16:17:38 +0100" MODIFIED_BY="L S">
<IDENTIFIER MODIFIED="2008-08-07 16:17:38 +0100" MODIFIED_BY="L S" TYPE="DOI" VALUE="10.1002/14651858.CD001837"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rigotti-2003" MODIFIED="2008-08-07 16:14:59 +0100" MODIFIED_BY="L S" NAME="Rigotti 2003" TYPE="COCHRANE_REVIEW">
<AU>Rigotti NA, Munafo MR, Murphy MF, Stead LF</AU>
<TI>Interventions for smoking cessation in hospitalised patients</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2008-08-07 16:14:59 +0100" MODIFIED_BY="L S">
<IDENTIFIER MODIFIED="2008-08-07 16:14:59 +0100" MODIFIED_BY="L S" TYPE="DOI" VALUE="10.1002/14651858.CD001837"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rigotti-2007" MODIFIED="2012-04-10 09:13:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" NAME="Rigotti 2007" TYPE="COCHRANE_REVIEW">
<AU>Rigotti N, Munafò MR, Stead LF</AU>
<TI>Interventions for smoking cessation in hospitalised patients</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2012-04-10 09:13:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<IDENTIFIER MODIFIED="2012-04-10 09:13:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" TYPE="DOI" VALUE="10.1002/14651858.CD001837.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2012-04-05 13:51:37 +0100" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2012-04-10 13:27:00 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2012-04-10 13:26:49 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-04-05 16:40:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bolman-2002">
<CHAR_METHODS MODIFIED="2011-07-21 14:18:48 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Netherlands<BR/>Recruitment: Cardiac ward patients in 11 hospitals<BR/>Selection: All eligible patients asked to participate by ward nurses</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:40:25 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 789 smokers who had smoked in previous week<BR/>Number smoked: not stated<BR/>Age: 56 yrs average<BR/>Therapists: Physician, nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 16:40:32 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention (5 hospitals): Cardiologist advice, 15-30 min counselling from ward nurse. follow-up: Cardiologist prompted to advise at 4-6 wk clinic but no counselling provided by team. Self-help materials. No pharmacotherapy. [Intensity 2]<BR/>2. Control: Usual care<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:40:33 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Sustained at 12m<BR/>Validation: None<BR/>Died: 25 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-21 14:17:57 +0100" MODIFIED_BY="[Empty name]">
<P>Included in CVD subcategory<BR/>Numbers in meta-analysis adjusted to approximate the OR reported from a logistic regression analysis on continuous abstinence (OR 1.17, 90% CI 0.85 to 1.61)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 13:25:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Borglykke-2008">
<CHAR_METHODS MODIFIED="2012-04-05 16:40:49 +0100" MODIFIED_BY="[Empty name]">
<P>Country:Denmark</P>
<P>Recruitment: patients admitted with symptoms of acute exacerbation of COPD in 1 university hospital</P>
<P>Selection: all eligible patients asked to participate</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:40:53 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 223 current smokers</P>
<P>Diagnosis: COPD</P>
<P>Age: 65.9 yrs av.</P>
<P>Gender: 35% male</P>
<P>Willingness to quit: not reported</P>
<P>Therapists: nurses</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 16:41:14 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention: smoking cessation groups: standard information on the benefits of smoking cessation, weekly sessions of 2 hours during 5 weeks. follow-up session at 3 month. [Intensity 4]</P>
<P>2. Control: usual care (not described)</P>
<P>Pharmacotherapy: complimentary NRT when needed in intervention group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:42:51 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence: self-reported PP at 12m</P>
<P>Validation: CO (in 84% of patients)</P>
<P>Died: none reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 16:42:58 +0100" MODIFIED_BY="[Empty name]">
<P>Category: pulmonary patients</P>
<P>Only 48/105 intervention patients received intervention</P>
<P>OR adjusted for sex, age and duration of COPD: 2.83 (1.40-5.74)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 16:43:39 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Campbell-1991">
<CHAR_METHODS MODIFIED="2012-04-05 16:43:18 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: UK<BR/>Recruitment: Inpatients with smoking-related diseases<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:43:25 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 212 current smokers<BR/>Number smoked: not stated<BR/>Most had heart or lung disease<BR/>Therapists: Physician and non-specialist counsellor</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 16:43:31 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Physician advice, inpatient counselling (1x, total not stated, type not stated). NRT (gum, dose 2-4 mg, for 3m). follow-up (5x at 2, 3, 5 wks, 3m, 6m in clinic by counsellor)<BR/>2. Control: Other (as above, placebo NRT gum) [Intensity 4 for both arms]<BR/>NRT: Yes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:43:39 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Sustained abstinence at 6 and 12m<BR/>Validation: Expired air CO<BR/>Died: None reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Not included in analysis by counselling intensity because arms differed only by use of NRT<BR/>Heart disease, lung disease and other given separately in analysis by diagnosis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 16:43:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Campbell-1996">
<CHAR_METHODS MODIFIED="2011-07-21 14:21:34 +0100" MODIFIED_BY="[Empty name]">
<P>Country: UK<BR/>Recruitment: Inpatients with respiratory or cardiovascular disease<BR/>Selected: Prepared to make quit attempt<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:43:54 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 62 current smokers<BR/>Age: not stated<BR/>Approx. 75% had respiratory disease<BR/>Therapists: Physician and non-specialist counsellor</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 13:55:15 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Physician advice. Counselling (1x, total 30-60 mins, type information). NRT (patch, dose 17.5-35 mg, for 12 wks). follow-up (4x at 2, 4, 8, 12 wks in clinic by counsellor)<BR/>2. Control: Other (as above, placebo NRT patch) [Intensity 4 for both arms]<BR/>NRT: Yes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:43:59 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Sustained abstinence at 3, 6, 12m<BR/>Validation: Expired air CO<BR/>Died: None reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Only data on inpatients extracted from study. Included in respiratory disease subcategory.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 16:47:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Caruthers-2006">
<CHAR_METHODS MODIFIED="2012-04-05 16:44:06 +0100" MODIFIED_BY="[Empty name]">
<P>Country:USA</P>
<P>Recruitment: smokers admitted to a medical/surgical unit</P>
<P>Selection: A convenience sample of 80 participants of 106 individuals screened for participation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:44:09 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 80 smokers (smoking at least one cigarette within 30 days of their hospital admission)</P>
<P>Diagnosis: med and surgical</P>
<P>Age: 51 yrs av.</P>
<P>Gender: 40% male</P>
<P>Willingness to quit: 79/80 indicated a desire to quit</P>
<P>Therapists: nurses</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 16:46:30 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention: In-hospital counselling and study specific intervention booklet + post discharge phone calls (8 individualized telephone calls in 12 weeks after discharge). [Intensity 4]</P>
<P>2. Control: enhanced usual care during hospitalisation</P>
<P>Pharmacotherapy: Smoking cessation pharmacotherapy was not provided as part of the intervention; however, several patients were prescribed such medication during their hospital admission.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:47:41 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence: self-reported 7-day PP at 12 and 24 wks (6m) post-discharge</P>
<P>Validation: CO confirmed</P>
<P>Died: 3 (2 in intervention, 1 in control group)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 16:47:46 +0100" MODIFIED_BY="[Empty name]">
<P>Additional information provided by 1<SUP>st</SUP> author 2/2012</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 16:48:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-CASIS-1992">
<CHAR_METHODS MODIFIED="2012-04-05 16:48:00 +0100" MODIFIED_BY="[Empty name]">
<P>Country: USA<BR/>Recruitment: Inpatients with coronary artery stenosis confirmed by catheterization.<BR/>Selected: Invited to participate.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:48:41 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 267 current smokers or recent quitters (50%, defined as at least 5 cpd at any time in previous 2m)<BR/>Number smoked: 25 cpd<BR/>Age: 53 yrs av.<BR/>78 had acute MI, 21 recent MI, 152 other symptoms<BR/>Therapists: Masters level health educators</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 16:48:45 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Counselling (2x, total 40 mins, type not stated). Self-help materials, relaxation tapes. Follow-up (4x at 1, 3 wks and 3m if quit or 2,4m if did not quit, by telephone) [Intensity 4]<BR/>2. Control: Advice only<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Abstinence: Sustained abstinence at 6m, 12m<BR/>Validation: Expired air CO.<BR/>Died: None reported.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Patients admitted with MI more likely to be quitters at 6m (74%). Evidence of interaction between intervention and illness.<BR/>Included in CVD subcategory</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 16:49:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chouinard-2005">
<CHAR_METHODS MODIFIED="2011-07-21 14:22:45 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Canada<BR/>Recruitment: Inpatients with cardiovascular disease (MI, angina, CHF) or PVD<BR/>Selected: Not by motivation<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:49:01 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 168 past-month smokers<BR/>Number smoked: not stated<BR/>Age: 56 yrs av<BR/>Therapist: nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 13:55:18 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention 1: Counselling by research nurse (1x, 10-60 mins, av. 40 min, tailored to stage of change), 23% used pharmacotherapy. [Intensity 2]<BR/>2. Intervention 2: As 1 plus telephone follow-up, 6 calls over 2m post-discharge [Intensity 4]<BR/>3. Control: cessation advice<BR/>NRT: Yes (partial)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:49:07 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Sustained abstinence at 2 &amp; 6m<BR/>Validation: Urine cotinine or expired air CO<BR/>Died: 3 in 1. 1 in 2. 0 in 3.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Two interventions compared separately to control in intensity subgroups<BR/>Included in CVD subcategory</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 09:16:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cossette-2011">
<CHAR_METHODS MODIFIED="2012-04-10 09:16:44 +0100" MODIFIED_BY="[Empty name]">
<P>Country:Canada</P>
<P>Recruitment: smokers admitted to 1 specialized cardiac hospital</P>
<P>Selection: all smokers who were hospitalised were asked to participate by the study nurse</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:49:23 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 40 current daily smokers</P>
<P>Diagnosis: cardiovascular diseases</P>
<P>Age: 57.1 yrs av.</P>
<P>Gender: 60% male</P>
<P>Willingness to quit: yes (most in preparation stage, 1 in contemplation stage in control group)</P>
<P>Therapists: nurse specialized in smoking cessation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 16:50:11 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention:usual care during hospitalisation consisting of 1 or more sessions with the study nurse. Follow-up: 6 phone calls by study nurse at wk 1, 2, 3, 4, 8, 12 and then if needed additional phone calls could be arranged between 3 and 6m post discharge. At wk 3 appointment with the study nurse if asked by patient. [Intensity 4]</P>
<P>2. Control: usual care during hospitalisation consisting of 1 and more sessions with the study nurse. Follow-up: referral to a national quitline or a community centre for smoking cessation</P>
<P>Pharmacotherapy: NRT, bupropion or varenicline were suggested during hospitalisation and follow-up</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:50:22 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence: self-reported abstinence at 6m</P>
<P>Validation: only for one participant</P>
<P>Died: 0</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-03-29 12:29:45 +0100" MODIFIED_BY="[Empty name]">
<P>Included in post-discharge intervention category (randomization after discharge)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 16:50:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Croghan-2005">
<CHAR_METHODS MODIFIED="2011-07-21 14:23:47 +0100" MODIFIED_BY="[Empty name]">
<P>Country: USA<BR/>Recruitment: Inpatients having surgical resection of lung or oesophageal cancers<BR/>Selected: unclear<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:50:37 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 30 smokers admitted for surgery for newly diagnosed lung or oesophageal cancer<BR/>Age: not stated<BR/>Therapist: doctor, nurse and trained smoking counsellor</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. Intervention: Physician advice from thoracic surgeons and study nurses. Counselling (1x 45 min. Stage of change assessed, individualized pharmacotherapy) [Intensity 2]<BR/>2. Control: Physician advice only<BR/>NRT: Yes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Abstinence: 7-day PP at 6m<BR/>Validation: expired air CO or saliva tobacco alkaloid<BR/>Died: 1 in 6m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 13:25:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-de-Azevedo-2010">
<CHAR_METHODS MODIFIED="2012-04-05 16:51:01 +0100" MODIFIED_BY="[Empty name]">
<P>Country:Brazil</P>
<P>Recruitment: patients admitted to 1 public university hospital</P>
<P>Selection: research team approached all patients admitted to the hospital wards (except for ICU and psychiatric unit)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:50:56 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 273 current smokers (smoked &#8805; 1 cpd in month prior to admission)</P>
<P>Diagnosis: all (exclude ICU and psychiatric units)</P>
<P>Age: not reported</P>
<P>Gender: 63.7% male</P>
<P>Willingness to quit: any</P>
<P>Therapists: trained smoking cessation counsellor (psychologists, nurses, occupational therapist)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 16:51:25 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention: 30 minutes session of individual counselling with motivational interview + 7 follow-up telephone calls over 4 months at wk 1, 2, 3 and month 1, 2, 3, 4. [Intensity 4]</P>
<P>2. Control: 15 minute session of individual counselling</P>
<P>Pharmacotherapy: none provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:51:30 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence:self-reported 7-day PP at 6m</P>
<P>Validation: none</P>
<P>Died: 28</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 16:51:45 +0100" MODIFIED_BY="[Empty name]">
<P>In the article, analyses excluded lost to follow-up and death.</P>
<P>Extra control arm not randomized and not included in data extraction.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 16:52:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-DeBusk-1994">
<CHAR_METHODS MODIFIED="2012-04-05 16:51:53 +0100" MODIFIED_BY="[Empty name]">
<P>Country: USA<BR/>Recruitment: Inpatients with acute MI<BR/>Selected: Invited to participate if prepared to make a quit attempt<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:52:00 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 252 current smokers or recent quitters (proportion not stated, defined as any tobacco use in previous 6m).<BR/>Number smoked: not stated<BR/>Age: 57 yrs av.<BR/>First year after MI<BR/>Therapists: Physician and nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 13:55:19 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Physician advice; Counselling (1x, total not stated, type not stated); NRT ('reserved for highly-addicted patients'); Other (self-help materials, relaxation tapes); follow-up (8x at 48 hr, 1 wk, and every month for 6m by telephone) [Intensity 4]<BR/>2. Control: Advice only<BR/>NRT: Yes (partial)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:52:10 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Sustained abstinence at 6 and 12m<BR/>Validation: Expired air CO and plasma cotinine<BR/>Died: None reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Included in CVD subcategory</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 16:52:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dornelas-2000">
<CHAR_METHODS MODIFIED="2012-04-05 16:52:27 +0100" MODIFIED_BY="[Empty name]">
<P>Country: USA<BR/>Recruitment: Inpatients with acute MI<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:52:33 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 100 current smokers.<BR/>Number smoked: 29 cpd<BR/>Age: 54 yrs av.<BR/>Therapists: Psychologist</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 13:55:20 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Counselling (1x, total 20 mins, type behavioural); follow-up (7x at &lt;1, 4, 8, 12, 16, 20, 26 wk by telephone) [Intensity 4]<BR/>2. Control: Advice only<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:52:39 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: PP at 12m<BR/>Validation: Significant other<BR/>Died: 5 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Validation by significant other only in 70% of cases.<BR/>Included in CVD subcategory</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 16:53:55 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Feeney-2001">
<CHAR_METHODS MODIFIED="2012-04-05 16:52:50 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: Australia<BR/>Recruitment: Inpatients admitted for acute MI to coronary care unit of 1 hospital<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:53:00 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 198 current smokers (smoked in past week)<BR/>Age: 54 yrs av.<BR/>Therapists: Physician and nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 16:53:18 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Physician advice to quit, nurse counselling (time not specified, type cognitive/ behavioural); follow-up (8x at 1, 2, 3, 4 wks and 2, 3, 6,12m by telephone) [Intensity 4]<BR/>2. Control: In hospital: same as intervention (physician advice to quit, nurse counselling); follow-up counselling available but no proactive contact [Intensity 2]<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:53:34 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Sustained abstinence at 1, 3, 12m.<BR/>Validation: Urinary cotinine (limit not stated)<BR/>Died: 9 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 16:53:55 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Very large treatment effect (31/92 vs 1/97) but risk of attrition bias. Excluded from meta-analyses because of heterogeneity.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 13:26:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Floter-2009">
<CHAR_METHODS MODIFIED="2012-04-05 16:54:30 +0100" MODIFIED_BY="[Empty name]">
<P>Country:Germany</P>
<P>Recruitment: women admitted in 21 prevention or rehabilitation clinics</P>
<P>Selection: all women who smoked were offered a smoking cessation course</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-10 09:16:56 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 527 smokers &#8805; 1 cigarette during the 30 days preceding hospitalisation</P>
<P>Diagnosis: women hospitalised with their children for medical, psycho physiologic or psychiatric reasons</P>
<P>Age: 35.9</P>
<P>Gender: 100% female</P>
<P>Willingness to quit: all stages</P>
<P>Therapists: social workers, psychologists, physicians or nurses and counsellors</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 16:55:21 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention: we pooled the 2 interventions</P>
<P>-  Intervention 1: 3 sessions (60 min each) in groups during hospitalisation featuring cognitive behavioral therapy and motivational interviewing + 3 proactive telephone calls (10 min duration) post discharge in a structured and directive style</P>
<P>-   Intervention 2: 3 sessions (60 min each) in groups during hospitalisation featuring cognitive behavioral therapy and motivational interviewing + 3 proactive telephone calls (10 min duration) post discharge in a non directive style</P>
<P>[Interventions 1 and 2: intensity 4]</P>
<P>2. Control: 3 sessions (60 min each) in groups during clinic hospitalisation and no follow-up</P>
<P>Pharmacotherapy: not reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:55:29 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence: self-reported abstinence during the past 30 days at 6m</P>
<P>Validation: none</P>
<P>Died: none reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-10 09:17:00 +0100" MODIFIED_BY="[Empty name]">
<P>Category: post discharge intervention and rehabilitation centre</P>
<P>OR adjusted for age, single mother (yes/no), education, weight concern, smoking dependence, self efficacy, depression, perceived social support:</P>
<P>- 2.0 (95% CI 1.1-3.8) for intervention 1</P>
<P>- 1.3 (95% CI 0.7-2.5) for intervention 2</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 16:56:06 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Froelicher-2004">
<CHAR_METHODS MODIFIED="2012-04-05 16:55:40 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: USA<BR/>Recruitment: Inpatients with CVD or PVD admitted to 10 hospitals<BR/>Selected: Willing to make quit attempt<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:55:51 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 277 current smokers or recent quitters (smoked in past month), willing to make serious quit attempt at discharge<BR/>Gender: All females<BR/>Number smoked: 20 cpd<BR/>Age: 61 yrs av.<BR/>Therapists: Physician and nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 16:55:59 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Physician advice to quit, nurse counselling (30-45 mins, type cognitive/behavioural and relapse prevention); follow-up (5x at 2, 7, 21, 28, 90 days by telephone (5-10 min/call) [Intensity 4]<BR/>2. Control: modified usual care (physician advice + booklet)<BR/>NRT: Patch or gum offered to selected women after discharge who had relapsed and wanted to try to quit (pharmacotherapy used by 20% of intervention and 23% of control group).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:56:06 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: 7-day PP at 12m<BR/>Validation: Saliva cotinine &lt; 14 ng/ml OR family/friend verification<BR/>Died: 11 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Included in CVD subcategory</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 16:56:29 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Hajek-2002">
<CHAR_METHODS MODIFIED="2012-04-05 16:56:20 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: UK<BR/>Recruitment: Inpatients with acute MI<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:56:25 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 540 current smokers.<BR/>Number smoked: 23 cpd<BR/>Age: 56 yrs av.<BR/>Therapists: cardiac rehab nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1. Intervention: Nurse advice. Counselling (1x, total 20-30 min). Self-help materials. [Intensity 2]<BR/>2. Control: Brief advice and booklet<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:56:29 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: PP at 12m, with visit to self-reported non-smoker<BR/>Validation: Expired air CO and salivary cotinine<BR/>Died: 35 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Included in CVD subcategory</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 16:57:18 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Hasuo-2004">
<CHAR_METHODS MODIFIED="2012-04-05 16:56:38 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: Japan<BR/>Recruitment: Inpatients (all diagnoses) to 1 hospital<BR/>Selected: Intending to be quit on day of discharge<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:56:47 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 120 current smokers or recent quitters (smoked in past month)<BR/>Diagnoses include cancer (n=37), cardiac (n=57)<BR/>Age: not stated<BR/>Therapists: Nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 16:56:51 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: nurse counselling (3 x 20 min sessions). follow-up (3x at 7, 21, 42 days by telephone) (5 min/call) [Intensity 4]<BR/>2. Control: In hospital: same as intervention (nurse sessions, 3 x 20 min each) but no follow-up contact [Intensity 2]<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:57:15 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Abstinence at 12m (type not stated)<BR/>Validation: urinary cotinine at 12m<BR/>Died: 6 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 16:57:18 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Not clear whether results are self-report or cotinine-validated.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 09:17:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haug-2011">
<CHAR_METHODS MODIFIED="2012-04-10 09:17:07 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Germany</P>
<P>Recruitment: patients admitted in 3 German inpatient rehabilitation centres</P>
<P>Selection: all consecutively admitted patients were assessed by a medical doctor or a nursing staff for inclusion criteria</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:57:59 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 477 current smokers (at least 1 cpd) and recent former smokers (quit for &lt;= 6 months and used to smoke at least 1 cpd)</P>
<P>Diagnosis: various acute or chronic disorders (stroke, CHD, cancer, diabetes, asthma,&#8230;)</P>
<P>Age: 46.5 yrs av.</P>
<P>Gender: 48% male</P>
<P>Willingness to quit: all stages of change</P>
<P>Therapists: computer expert system</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 16:58:20 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention: access to an internet-based smoking cessation program with 3 complementary modules during 6m: up to 7 individual counselling sessions by a computer expert system, information websites and message board (individual feedback letters) [Intensity 4]</P>
<P>2. Control: usual care (assessment only)</P>
<P>Pharmacotherapy: not reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:58:29 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence:self-reported 7-day point prevalence smoking abstinence at 6m</P>
<P>Validation: no</P>
<P>Died: 1 (in control group)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 16:58:35 +0100" MODIFIED_BY="[Empty name]">
<P>Category: rehabilitation centres</P>
<P>Not clear if intervention began during hospitalisation but probably</P>
<P>OR (Intention to treat analyses) adjusted for rehabilitation centre, baseline stage of change and baseline self-efficacy: 2.0 (95% CI 1.1-3.7)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 16:59:33 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Hennrikus-2005">
<CHAR_METHODS MODIFIED="2012-04-05 16:59:01 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: USA<BR/>Recruitment: Inpatients (all diagnoses) admitted to 4 hospitals<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 16:59:07 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 2095 current smokers (smoked in past week and considered self to be regular smoker in month before admission)<BR/>Age: 47 yrs av.<BR/>Therapists: Physician and nurse.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 16:59:24 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Physician advice to quit (60 seconds) + smoking cessation booklet + additional mailed booklet after discharge. [Intensity 1]<BR/>2. Intervention: Physician advice to quit (60 seconds) + nurse counselling (motivational interviewing and relapse prevention) for 20 min. av. (note: 43% of counselling sessions conducted after discharge by telephone rather than at bedside). Follow-up: 3-6 phone calls over 6m (10 min/call median). [Intensity 4]<BR/>3. Control: modified usual care: smoking cessation booklet in hospital<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 16:59:33 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: 7-day PP at 12m<BR/>Validation: Saliva cotinine (&lt;15 ng/ml)<BR/>Died: 78 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>High and differential levels of refusal to provide validation/mis-reporting</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 13:26:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lacasse-2008">
<CHAR_METHODS MODIFIED="2012-04-10 09:17:12 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Canada</P>
<P>Recruitment: patients with expected LOS &gt;=36 hours in 1 tertiary cardiopulmonary centre</P>
<P>Selection: Eligible patients who accepted to participate were immediately assigned to one group</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-10 09:17:17 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 196 current smokers</P>
<P>Diagnosis: Mainly cardiology (63%) and pneumology (27%)</P>
<P>Age: 52 yrs av.</P>
<P>Gender: 64-68% male</P>
<P>Willingness to quit: yes, patients in the precontemplation stage of change were excluded</P>
<P>Therapists: counsellors (no further definition)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-10 09:17:19 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention: strong quit smoking message from the treating physician, self-help material, brief cessation counselling with counsellor, pharmacology adjuncts. Follow-up: 4 telephone calls within 6 wks post discharge. [Intensity 4]</P>
<P>2. Control:usual care, no specific instructions on how to quit smoking</P>
<P>Pharmacotherapy: NRT offered to all patients in the intervention group (18 patients used)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:00:25 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence:7-day PP at 6 and 12 months</P>
<P>Validation: urinary cotinine (&lt;200 ng/ml) but non validated quit rates used in the meta-analysis</P>
<P>Died: 1 in intervention group</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 17:00:32 +0100" MODIFIED_BY="[Empty name]">
<P>Study stopped early because of lack of efficacy.</P>
<P>Non validated quit rates used in this meta-analysis instead of cotinine validated because only half of participants had validation.</P>
<P>Mainly cardiac and pulmonary patients but can't separate results.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:01:18 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Lewis-1998">
<CHAR_METHODS MODIFIED="2012-04-05 17:00:52 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: USA<BR/>Recruitment: Inpatients excluding certain cardiac conditions<BR/>Selected: Prepared to make quit attempt<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:01:01 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 185 current smokers.<BR/>Number smoked: 24 cpd<BR/>Age: 43 yrs av.<BR/>12 ICD-9 diagnostic categories<BR/>Therapists: Physician and nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:01:10 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Physician advice. Counselling (1x, total 2-3 mins, type information). NRT (patch, dose 22mg, for 3 wks + 11 mg, for 3 wks). Self-help materials. follow-up (4x at 1, 3, 6 wks, 6m by telephone). [Intensity 4]<BR/>2. Intervention: Physician advice. Counselling (1x, total 2-3 mins, type information). Placebo patch. Self-help materials. follow-up (4x at 1, 3, 6 wks, 6m by telephone). [Intensity 4]<BR/>3. Control: Advice only<BR/>NRT: Yes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:01:18 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: PP at 6m<BR/>Validation: Expired air CO<BR/>Died: None reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>1 vs 2 for effect of NRT. 1+2 vs 3 for behavioural counselling intervention analysis. Highest quit rates found in patients with respiratory disease.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 13:26:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Metz-2007">
<CHAR_METHODS MODIFIED="2012-04-05 17:01:29 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Germany</P>
<P>Recruitment: patients with length of stay of at least 3 weeks in 13 rehabilitation hospitals treating respiratory diseases, CVD, cancer or DM</P>
<P>Selection: not reported</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:01:39 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 307 smokers &#8805;1 cigarette during the past month</P>
<P>Diagnosis: Diverse disease (stroke, CHD, cancer, pulmonary disease diabetes, etc)</P>
<P>Age: not reported</P>
<P>Gender: 58.6% male</P>
<P>Willingness to quit: all stages (12.5% precontemplation, 54.6% contemplation, 17.9% preparation, 15% action)</P>
<P>Therapists: therapeutic staff with 3-day training performed the in-hospital interventions and 2 specially trained psychologists performed the telephone sessions</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:02:13 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention: 7 sessions lasting 60 min of either cognitive-behavioral or a motivational treatment during hospitalisation + 5 proactive telephone booster sessions after discharge (2 during first week after discharge, third during 3<SUP>rd</SUP> wk, fourth during 5<SUP>th</SUP> wk and 5<SUP>th</SUP> between 6<SUP>th</SUP> and 10<SUP>th</SUP> wk). [Intensity 4]</P>
<P>2. Control: 7 sessions lasting 60 min of either cognitive-behavioral or a motivational treatment during hospitalisation</P>
<P>Pharmacotherapy: not reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:02:22 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence:self-reported 7-day PP at 3, 6 and 12m</P>
<P>Validation: none</P>
<P>Died: none reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-10 09:17:24 +0100" MODIFIED_BY="[Empty name]">
<P>Category: Rehabilitation centres and postdischarge intervention</P>
<P>OR (not ITT): 2.18 (95% CI 1.21-3.93)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 13:26:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meysman-2010">
<CHAR_METHODS MODIFIED="2012-04-05 17:02:34 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Belgium</P>
<P>Recruitment: patients admitted on surgical wards in 4 university hospitals</P>
<P>Selection: inpatients admitted on surgical wards, recruited within 24 hours of admission</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-10 09:17:28 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 358 current smokers of &gt; 10 cpd</P>
<P>Diagnosis: surgical patients (orthopaedics, traumatology, ENT, head and neck surgery and neurosurgery)</P>
<P>Age: 43.2 year av.</P>
<P>Gender: 63% male</P>
<P>Willingness to quit: all stages of change (precontemplation 25%, contemplation 56%, preparation and action 19%)</P>
<P>Therapists: nurse and counsellor</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-10 09:17:29 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention: brief nurse-delivered intervention (5 A&#8217;s) and referral to smoking cessation counsellor for smokers in the preparation/action stage [Intensity 2]</P>
<P>2. Control: booklet with information on smoking cessation</P>
<P>Pharmacotherapy: not reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:03:02 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence:self-reported continuous abstinence at 6m</P>
<P>Validation: none</P>
<P>Died: none reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-21 16:43:27 +0000" MODIFIED_BY="[Empty name]">
<P>category: surgical patients</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 09:17:35 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Miller-1997">
<CHAR_METHODS MODIFIED="2012-04-05 17:03:13 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: USA<BR/>Recruitment: Inpatients excluding obstetric and psychiatric patients<BR/>Selected: Prepared to make quit attempt, those wishing to do so alone excluded<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:03:21 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 1942 current smokers.<BR/>Number smoked: 20 cpd<BR/>Age: 51 yrs av.<BR/>32% with cardiovascular, 12% pulmonary diagnosis<BR/>Therapists: Physician and nurse counsellor</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 13:55:29 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Physician advice. Counselling (1x, total 30 mins, type behavioural). Self-help materials, relaxation tapes, video. follow-up (4x at 48hr, 1, 3 wks, 3m by telephone) [Intensity 4]<BR/>2. Intervention: Physician advice. Counselling (1x, total 30 mins, type behavioural). Self-help materials, relaxation tapes, video. follow-up (1x at 48 hr by telephone) [Intensity 3]<BR/>3. Control: Advice only<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-10 09:17:35 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Sustained abstinence at 3, 6 &amp; 12m<BR/>Validation: Plasma cotinine or family member corroboration<BR/>Died: 82 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>1 vs 3 in intensive comparison, 2 vs 3 in minimal comparison<BR/>12 months abstinence (PP) 1+2 vs 3 separately for cardiovascular, pulmonary and other diagnosis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:04:01 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Mohiuddin-2007">
<CHAR_METHODS MODIFIED="2012-04-05 17:03:45 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: USA<BR/>Recruitment: Inpatients with diagnosis of acute coronary syndrome (including MI) or decompensated CHF, admitted to CCU of 1 hospital<BR/>Selected: Invited to participate.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:03:51 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 209 current smokers who had smoked for 5+ yrs, FTND&gt;7<BR/>Number smoked: 24 cpd<BR/>Age: 55 yrs av.<BR/>Therapists: Physician and trained tobacco counsellor or nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:03:54 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Counselling (30 mins, type not specified). Self-help booklet. Free NRT and/or bupropion. follow-up: weekly group meetings (60 min session for up to 3m) with trained tobacco counsellor (content: behavioural counselling, social support, relaxation training, risk factor management). [Intensity 4]<BR/>2. Control: same inpatient component as intervention group: counselling (30 mins, type not specified). Self-help booklet. Free NRT and/or bupropion. No follow-up offered. [Intensity 2]<BR/>NRT: NRT or bupropion offered on individualized basis to both groups</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:04:01 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Sustained abstinence at 3, 6, 12m. (note: sustained abstinence to 24m reported but not used in pooling)<BR/>Validation: CO<BR/>Died: 15 at 12m (12 control, 3 intervention)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>1 vs 2 in intensity 4 subgroup. Same in-hospital intervention; differed in follow-up component only.<BR/>Included in CVD subcategory</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:04:36 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Molyneux-2003">
<CHAR_METHODS MODIFIED="2012-04-05 17:04:07 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: UK<BR/>Recruitment: Medical and surgical inpatients admitted to 1 hospital<BR/>Selected: Invited to participate.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:04:13 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 274 current smokers (smoked in past month)<BR/>Number smoked: 17 cpd<BR/>Age: 50 yrs av.<BR/>Therapists: Physician or nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 13:55:34 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: brief counselling + booklet, no NRT. No follow-up. [Intensity 2]<BR/>2. Intervention: brief counselling (20 mins) + booklet + offer of open label NRT x 6 wks (choice of gum, patch, inhalator, lozenge, nasal spray); 96% used some NRT. No follow-up. [Intensity 2]<BR/>3. Control: usual care<BR/>NRT: Yes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:04:27 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Sustained abstinence at 3, 12m<BR/>Validation: CO &lt;10 ppm at 12m<BR/>Died: not stated</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 17:04:36 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1+2 vs 3 for intensity 2 comparison, 2 vs 1v for NRT comparison.</P>
<P>Deaths not stated so not excluded from main analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:05:18 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Nagle-2005">
<CHAR_METHODS MODIFIED="2012-04-05 17:05:03 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: Australia<BR/>Recruitment: Inpatients (all diagnoses) admitted to 1 teaching hospital (excluded intensive care units)<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:05:10 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 1422 current smokers or quitters (smoked in past 12m)<BR/>Age: not stated<BR/>Therapists: nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 13:55:35 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Nurse counselling (2 x 10 min sessions, type: withdrawal symptom management, coping skills) + booklet + offer of NRT in hospital and for 5 days post-discharge (3% received in hospital). follow-up: none. [Intensity 2]<BR/>2. Control: modified usual care (Physician advice + booklet)<BR/>NRT: Yes (partial)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:05:18 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: 7-day PP at 12m (Continuous self-reported abstinence also given)<BR/>Validation: Saliva cotinine &lt;=15 ng/ml<BR/>Died: 28 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Study includes recent quitters (smoked in past year but not in past month); results not stratified by baseline smoking status.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 09:17:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ortega-2011">
<CHAR_METHODS MODIFIED="2012-04-10 09:17:38 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Spain</P>
<P>Recruitment: patients admitted in 1 hospital</P>
<P>Selection: all hospitalised smokers were asked to enter in the smoking cessation protocol</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-10 09:17:44 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 1843 current smokers (smoked &gt; 100 cigarettes lifetime)</P>
<P>Diagnosis: medicine and surgery patients</P>
<P>Age: 61-66</P>
<P>Gender: 83-88% males</P>
<P>Willingness to quit: all stages</P>
<P>Therapists: nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:06:51 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention: cognitive behavioral intervention (30-45 min sessions every 3 days during hospitalisation) + NRT (patches or chewing gum) free during hospital for 12 wks + post discharge follow-up: Smoking cessation outpatient clinic or telephone calls (patient could chose) at 1, 2 wks, 1, 2, 3, 6, and 12m </P>
<P>2. Control: cognitive behavioral intervention (30-45 min sessions every 3 days during hospitalisation)+ post discharge follow-up: Smoking cessation outpatient clinic or telephone calls (patient could chose) at 1, 2 wks, 1, 2, 3, 6, and 12 month</P>
<P>[Both arms: intensity 4]</P>
<P>Pharmacotherapy: NRT (patches or chewing gums) in intervention group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:07:29 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence: smoking abstinent at 1 year (not more specified)</P>
<P>Validation: CO in subgroup only</P>
<P>Died: none reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 17:07:22 +0100" MODIFIED_BY="[Empty name]">
<P>Category: pharmacotherapy</P>
<P>1 extra arm = control who refuse to enter study but not eligible for this meta-analysis</P>
<P>No blinding, no placebo.</P>
<P>Used in NRT comparison only as both arms offered same counselling.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:07:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Ortigosa-2000">
<CHAR_METHODS MODIFIED="2012-04-05 17:07:39 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: Spain<BR/>Recruitment: Inpatients with acute MI<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:07:42 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 90 current smokers<BR/>Number smoked: 25 cpd<BR/>Age: 57 yrs av<BR/>Therapists: Physician</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:07:48 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Physician advice. follow-up (3x at 2, 3, 4 wks by telephone). [Intensity 3]<BR/>2. Control: Usual care<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Abstinence: PP at 12m.<BR/>Validation: Expired air CO.<BR/>Died: 3 at 12m.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 17:07:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Intervention not delivered by specialist counsellor.<BR/>Included in CVD subcategory.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:08:17 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Pedersen-2005">
<CHAR_METHODS MODIFIED="2012-04-05 17:08:01 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: Denmark<BR/>Recruitment: Inpatients with cardiac disease<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:08:08 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 105 current smokers (not defined)<BR/>Age: not stated<BR/>Therapists: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:08:13 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: usual hospital protocol: advice to quit + information about NRT + NRT available. follow-up: visits 5 times after discharge (30 min/meeting) [Intensity 4]<BR/>2. Control: usual care: advice to quit + information about NRT + NRT available.<BR/>NRT: Yes (partial)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:08:17 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Abstinence (probably PP) at 12m<BR/>Validation: none<BR/>Died: not stated</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Included in CVD subcategory</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:08:38 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Pederson-1991">
<CHAR_METHODS MODIFIED="2012-04-05 17:08:29 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: USA<BR/>Recruitment: Inpatients with COPD.<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:08:34 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 74 current smokers<BR/>Number smoked: 25 cpd<BR/>Age: 53 yrs av.<BR/>43% chronic bronchitis, 57% emphysema<BR/>Therapists: Non-specialist trained in counselling</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 13:55:38 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Physician advice (prior to admission). Counselling (3-9x, total 45-160 mins, type information). Self-help materials. No follow-up. [Intensity 2]<BR/>2. Control: Advice only<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:08:38 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: PP at 6m<BR/>Validation: Serum COHb (in sample)<BR/>Died: 8 at 6m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-03-30 10:29:02 +0100" MODIFIED_BY="Jamie Hartmann-Boyce"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:09:32 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Pelletier-1998">
<CHAR_METHODS MODIFIED="2012-04-05 17:09:08 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: Canada<BR/>Recruitment: Inpatients with acute MI<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:09:19 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 504 current smokers<BR/>Age: not stated<BR/>Therapists: Nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:09:30 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Physician advice. Self-help materials [Intensity 2]<BR/>2. Control: Usual care<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:09:32 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: self-reported PP at 12m<BR/>Validation: None<BR/>Died: Not stated</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Included in CVD subcategory</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 09:17:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Planer-2011">
<CHAR_METHODS MODIFIED="2012-04-05 17:09:46 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Israel</P>
<P>Recruitment: patients hospitalised for ACS in 2 separate campuses in Jerusalem</P>
<P>Selection: all smokers hospitalised for acute coronary syndrome were approached on their 2<SUP>nd</SUP> day of hospitalisation by the study nurse</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:10:01 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 151 smokers of &gt; 10 cpd</P>
<P>Diagnosis: acute coronary syndrome</P>
<P>Age: 51.9 yrs av.</P>
<P>Gender: 79.9% male</P>
<P>Willingness to quit: yes, patients required to exhibit intention to quit smoking</P>
<P>Therapists: study physician and research nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:11:03 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention: counselling (at least 15 min of motivational support) during hospitalisation and continued after discharge (at least 2 visits with physician and nurse at 1 and 2m and weekly telephone call by nurse during first and second month, then monthly telephone calls during rest of the year) + Bupropion for 2m</P>
<P>2. Control: counselling as per 1 + Placebo for 2m</P>
<P>[Both arms: intensity 4]</P>
<P>Pharmacotherapy: Bupropion during 2m in the intervention group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:11:07 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence: self-reported continuous abstinence at 12m</P>
<P>Validation: none</P>
<P>Died: none reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-10 09:17:50 +0100" MODIFIED_BY="[Empty name]">
<P>Category: pharmacotherapy and cardiac patients</P>
<P>Study stopped early after interim analysis indicated no benefit</P>
<P>OR adjusted for age, sex, invasive procedure, risk factors, Fagerstrome score, cpd: 0.90 (95% CI 0.39-2.09)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:11:41 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Quist_x002d_Paulsen-2003">
<CHAR_METHODS MODIFIED="2012-04-05 17:11:17 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: Norway<BR/>Recruitment: Inpatients admitted to cardiac ward of 1 general hospital (Diagnoses: MI, unstable angina, post-CABG care)<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:11:21 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 240 current smokers (smoked daily before symptoms began).<BR/>Number smoked: 15 cpd<BR/>Age: 57 yrs av.<BR/>Therapists: Nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:11:36 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Nurse counselling (1-2 times, time not specified, type: fear arousal, advice on using NRT); follow-up (5x at 2, 7, 21 days, 3m, 5m) by telephone, clinic visit to cardiac nurse at 6 wks); NRT: Gum or patch encouraged for subjects with strong urges to smoke in hospital. [Intensity 4]<BR/>2. Control: usual care (advice to quit + booklet)<BR/>NRT: Yes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:11:41 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: PP at 12m<BR/>Validation: Urine cotinine &lt;2.0 mmol/mol creatinine<BR/>Died: 5 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Included in CVD subcategory</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:12:05 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Reid-2003">
<CHAR_METHODS MODIFIED="2012-04-05 17:11:48 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: Canada<BR/>Recruitment: Inpatients with MI, CABG, coronary angioplasty, coronary angiography admitted to 1 cardiac hospital<BR/>Selected: Motivated to quit<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:11:52 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 254 current smokers (smoked in month before admission)<BR/>Number smoked: not stated<BR/>Age: 54 yrs av.<BR/>Therapists: Nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:11:56 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Brief nurse counselling at bedside (5-10 mins) + booklet. follow-up: nurse call at 4 wks; if smoking, offered 3 x 20 min in-person counselling sessions (wks 4,8,12) and NRT patch recommended for 8 wks. [Intensity 4]<BR/>2. Control: Brief nurse counselling (5-10 mins) + self-help booklet (same in hospital as intervention group)<BR/>NRT: Yes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:12:05 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: 7-day PP at 12m<BR/>Validation: Random sample of 25 self-reported non-smokers asked for CO validation; 91% validated, similar in both arms. Results not adjusted for this.<BR/>Died: 2 at 12m.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Included in CVD subcategory</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 13:26:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Reid-2007">
<CHAR_METHODS MODIFIED="2012-04-05 17:12:52 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Canada</P>
<P>Recruitment: patients admitted in 1 tertiary care cardiac facility</P>
<P>Selection: current smokers who met eligibility criteria were recruited within 24 hours of admission. Patients living &gt; 1 hour away were excluded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:12:58 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 99 current smokers &#8805; 5 cpd</P>
<P>Diagnosis: ACS, elective PCI or diagnostic catheterization related to CHD</P>
<P>Age: 54</P>
<P>Gender: 61-75% male</P>
<P>Willingness to quit: not assessed</P>
<P>Therapists: nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-10 09:17:56 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention: standard in-hospital treatment for smokers (personalized advice to quit smoking, access to NRT, brief bedside counselling and self-help guide) + interactive voice response system (IVR) follow-up on days 3, 14 and 30 post-discharge [Intensity 3]</P>
<P>2. Control: standard in-hospital treatment for smokers (personalized advice to quit smoking, access to NRT, brief bedside counselling and self-help guide)</P>
<P>Pharmacotherapy: access to NRT during hospitalisation for both arms</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:13:14 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence: 7-day PP at 12m</P>
<P>Validation: none</P>
<P>Died: 1 in control group</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-21 17:48:15 +0000" MODIFIED_BY="[Empty name]">
<P>Category: post discharge intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 09:18:09 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Rigotti-1994">
<CHAR_METHODS MODIFIED="2012-04-05 17:13:22 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: USA<BR/>Recruitment: Inpatients scheduled for CABS<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-10 09:18:09 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 87 current smokers or recent quitters (38%, defined as at least 1 pack/cigarettes in previous 6m)<BR/>Number smoked: 33 cpd<BR/>Age: 58 yrs av.<BR/>82% of all CABG surgery<BR/>Therapists: Nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 13:55:41 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Counselling (3x, total 60 mins, type behavioural). Self-help materials, video. follow-up (1x at 1 wk by telephone). [Intensity 3]<BR/>2. Control: Advice only<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:13:34 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Sustained abstinence at 4, 8, 12m.<BR/>Validation: Salivary cotinine<BR/>Died: 7 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 17:13:37 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence rates include smokers who had quit prior to surgery.<BR/>Included in CVD subcategory.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 09:18:15 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Rigotti-1997">
<CHAR_METHODS MODIFIED="2012-04-05 17:13:48 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: USA<BR/>Recruitment: Inpatients in medical or surgical services.<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-10 09:18:15 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 615 current smokers or recent quitters (proportion not stated, defined as at least 1 cigarette in previous month)<BR/>Number smoked: 24 cpd<BR/>Age: 48 yrs av.<BR/>23% had cardiac or pulmonary diagnosis<BR/>Therapists: Research assistant and nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:13:58 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Physician advice (prompt on chart). Counselling (1x, total 15 mins, type behavioural). Self-help materials. Follow-up (1-3x at 1-3 wks by telephone); [Intensity 3]<BR/>2. Control: Usual care<BR/>NRT: 'some' (around 4%).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:13:59 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: PP at 6m.<BR/>Validation: Salivary cotinine<BR/>Died: 35 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 17:14:14 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>50% of patients could recall being given physician advice.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:14:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Rigotti-2006">
<CHAR_METHODS MODIFIED="2012-04-05 17:14:25 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: USA<BR/>Recruitment: Inpatients with cardiovascular disease (MI, unstable angina, CHF) or PVD admitted to 5 hospitals<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:14:31 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 254 current smokers (smoked in past month) and willing to consider smoking cessation at discharge (no commitment required)<BR/>Number smoked: 23/21 cpd<BR/>Age: 56 yrs av.<BR/>Therapists: Nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:14:41 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Bupropion SR 300 mg/day x 12 wks, started in hospital. Nurse counselling (30-45 min, type cognitive/behavioural and relapse prevention) in hospital + booklet + follow-up telephone calls (10 min/call) 5x at 2, 7, 21 days, 2m, 3m. Total counselling time: 85-90 mins.<BR/>2. Control: As above, but placebo pill<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:14:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Continuous abstinence at 2, 4, 12, 52 wks.<BR/>Validation: Saliva cotinine at 12 and 52 wks, CO at 2 and 4 wks<BR/>Died: 2 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Used for bupropion comparison and CV diagnosis, not for comparison of counselling intensity because both groups had same counselling.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:15:11 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Simon-1997">
<CHAR_METHODS MODIFIED="2012-04-05 17:15:02 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: USA<BR/>Recruitment: Inpatients undergoing non-cardiac surgery<BR/>Selected: Prepared to make quit attempt</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:15:07 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 299 current smokers<BR/>Number smoked: 20 cpd<BR/>Age: 54 yrs av.<BR/>Most cardiovascular or respiratory disease<BR/>Therapists: Public health educator</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 13:55:43 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Inpatient counselling (1x, total 30-60 mins, type behavioural). Self-help materials, video. NRT if no contraindications (gum, dose not stated, for 3m). follow-up (5x at 1-3 wks, 2m, 3m by telephone). [Intensity 4]<BR/>2. Control: Advice only<BR/>NRT: Yes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:15:11 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: PP at 12m<BR/>Validation: Serum or salivary cotinine or corroboration by significant other<BR/>Died: 25 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Approx 65% intervention and 17% control used NRT. Not associated with quitting in either group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:15:42 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Simon-2003">
<CHAR_METHODS MODIFIED="2012-04-05 17:15:25 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: USA<BR/>Recruitment: Inpatients (all diagnoses) admitted to 1 hospital for military veterans<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:15:29 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 223 current smokers (smoked &gt;=20 cigarettes in wk before admission), contemplation or action stage of change, able to use NRT.<BR/>Number smoked: 23 cpd<BR/>Age: 55 yrs av.<BR/>Therapists: Nurse or health educator</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:15:36 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Nurse or health educator counselling (30-60 mins; type cognitive/behavioural) + booklet + NRT patches x 8 wks. follow-up: 5x at 1,3 wks and 1m, 2m, 3m (&lt;30 min/call) [Intensity 4]<BR/>2. Control: brief counselling (10 mins) + booklet + NRT patches x 8 wks. No follow-up contact.<BR/>NRT: Yes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:15:39 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: 7-day PP at 12m<BR/>Validation: Saliva cotinine &lt;15 ng/ml OR spousal corroboration<BR/>Died: 14 at 12m.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 17:15:42 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Study tests marginal efficacy of counselling in setting of NRT.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 13:26:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Simon-2009">
<CHAR_METHODS MODIFIED="2012-04-10 09:18:19 +0100" MODIFIED_BY="[Empty name]">
<P>Country: United States</P>
<P>Recruitment: patients admitted in 1 VA hospital</P>
<P>Selection: all smokers hospitalised &#8805; 24h screened for eligibility (exclusion criteria: CI to Bupropion, admitted for ACS, terminally ill, serious unstable psychiatric illness, family history of seizure, women pregnant or lactating, history of drug abuse consumption of &gt;= 3 alcoholic beverages/d)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:15:59 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 85 smokers &#8805; 5cpd during previous year and smoking the week prior admission</P>
<P>Diagnosis: not specified</P>
<P>Age: 56 yrs av.</P>
<P>Gender: 96% male</P>
<P>Willingness to quit: not assessed</P>
<P>Therapists: public health educator</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-10 09:18:25 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention: Bupropion during 7wks + counselling (1 cognitive behavioral intervention of 30-60 minutes during hospitalisation) + telephone counselling after discharge at wk 1, 3, month 1, 2, 3</P>
<P>2. Control: Placebo + counselling as above</P>
<P>[Both arms: intensity 4]</P>
<P>Pharmacotherapy: Bupropion in intervention group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:16:54 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence: 7-day PP at 6m</P>
<P>Validation: salivary cotinine</P>
<P>Died: 2 (1 in each group)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 17:17:21 +0100" MODIFIED_BY="[Empty name]">
<P>Category: pharmacotherapy</P>
<P>Not used in primary meta-analysis by counselling intensity as both arms received same counselling.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:18:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smith-2009">
<CHAR_METHODS MODIFIED="2012-04-05 17:17:30 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Canada</P>
<P>Recruitment: patients admitted in 4 cardiac units in a large urban hospital</P>
<P>Selection: sequential patients admitted for acute MI or CABG who met inclusion criteria were included</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:17:41 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 276 patients who used tobacco in the month before admission</P>
<P>Diagnosis: acute MI or CABG</P>
<P>Age: 54 yrs av.</P>
<P>Gender: 82-83% male</P>
<P>Willingness to quit: ranged from 3-7, mean 6.8 (on a 1-7 scale, with 7 = full intention)</P>
<P>Therapists: nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:18:00 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention:minimal intervention + 45-60 minutes of bedside education and counselling, take-home material and 7 telephone counselling sessions at 2, 7, 14, 21, 30, 45, and 60 days after discharge. [Intensity 4]</P>
<P>2. Control: : minimal intervention: research nurse advice smoker to quit, review 2 pamphlets and asked the attending physician to give a scripted nonsmoking message.</P>
<P>Pharmacotherapy: not part of the study but available through hospital if requested</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:18:18 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence: 7-day PP and continuous abstinence at 12m</P>
<P>Validation: proxy corroboration at 12m only for 7-day PP only</P>
<P>Died: 4 (2 in each group)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 16:41:47 +0100" MODIFIED_BY="[Empty name]">
<P>Category: cardiac patients</P>
<P>For the meta-analysis we used validated 7-day PP</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 13:26:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smith-BJ-2011">
<CHAR_METHODS MODIFIED="2012-04-05 17:18:33 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Australia</P>
<P>Recruitment: patients with smoking-related diseases admitted on pulmonary, cardiology, neurology, vascular or general medicine wards in 3 hospitals</P>
<P>Selection: patients who agree to make a serious smoking cessation attempt, plan to return home were included</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-10 09:18:30 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 392 current smoker (<U>&gt;</U> 10 cpd on average in past year)  </P>
<P>Diagnosis: smoking related in respiratory, cardiology, neurology, or vascular medicine</P>
<P>Age: 18-75</P>
<P>Gender: both</P>
<P>Willingness to quit: yes (only patients willing to make a serious smoking cessation attempt were included)</P>
<P>Therapists: Quitline counsellors at Quit SA  (South Australia quitline)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:20:18 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention: initial contact with quitline made in hospital at bedside; also got booklet + Varenicline (standard titration to 1 mg bid x 12 wk) + follow-up: Quitline (Quit SA)  - 8 scheduled calls over 12 wks, 5-10 min each call </P>
<P>2. Control: counselling as above</P>
<P>[Both arms: intensity 4]</P>
<P>Pharmacotherapy: Varenicline in intervention group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-10 09:18:38 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence: continuous abstinence (2-52 weeks) defined as &lt;=5 cigarettes during 12 months  </P>
<P>Validation: a random subsample was CO validated, but we use self report   </P>
<P>Died: 13 (7 in control and 6 in intervention group)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-05 17:20:04 +0100" MODIFIED_BY="[Empty name]">
<P>Category: pharmacotherapy.</P>
<P>Data from abstract and unpublished manuscript only.</P>
<P>Open label (varenicline vs. no varenicline).</P>
<P>Not included in primary meta-analysis  as both arms received same counselling.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 13:26:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smith-PM-2011">
<CHAR_METHODS MODIFIED="2012-04-05 17:20:34 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Canada</P>
<P>Recruitment: patients admitted in 3 community hospitals</P>
<P>Selection: study nurses approached eligible patients</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:20:50 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 643 current smokers (tobacco use in the last 30 days)  </P>
<P>Diagnosis: diverse (CVD, pulmonary, other internal medicine, cancer, orthopaedic, gynaecology, non cardiac surgery)</P>
<P>Age: 49 yrs av.</P>
<P>Gender: 49.3% male</P>
<P>Willingness to quit: yes</P>
<P>Therapists: nurses</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:21:07 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention:brief intervention + in hospital education, take home materials, counselling and post-discharge telephone counselling: post-discharge telephone counselling (5-10 min/call) for the intervention group at 2, 7, 14, 21, 30, 45 and 60 days. [Intensity 4]</P>
<P>2. Control: brief intervention (5 minutes): cessation advice personalized to patient&#8217;s medical conditions and 2 pamphlets + note in patient&#8217;s chart for the attending physician to provide a message personalized to patient&#8217;s medical condition.</P>
<P>Pharmacotherapy: not provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:21:15 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence: self-reported 7 day point-prevalence abstinence at 12m</P>
<P>Validation: with saliva cotinine (&lt; 15 ng/mL) or proxy confirmation at 1 year only</P>
<P>Died: 27 (19 in control and 8 in intervention group)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-03-05 09:30:47 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-10 13:26:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Steinberg-2011">
<CHAR_METHODS MODIFIED="2012-04-05 17:21:25 +0100" MODIFIED_BY="[Empty name]">
<P>Country: USA</P>
<P>Recruitment: patients admitted in 1 university-based hospital</P>
<P>Selection:patients approached within 24-48h after admission, hospital computer system identified all patients</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-10 09:18:52 +0100" MODIFIED_BY="[Empty name]">
<P>Participants: 79 smokers (smoking &#8805; 10 cpd within the past month)</P>
<P>Diagnosis: various diagnoses (CVD, orthopedic, pulmonary, other)</P>
<P>Age: 51 yrs av.</P>
<P>Gender: 59 % male</P>
<P>Willingness to quit: not specified</P>
<P>Therapists: tobacco treatment specialist</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:22:13 +0100" MODIFIED_BY="[Empty name]">
<P>1. Intervention: Varenicline (12 wks) + during hospitalisation: personalized strong quit message, printed information on behavioral change, outpatient quit resources (Quitline, Quitnet, local tobacco dependence program) + brief behavioral treatment after discharge at a local Tobacco Dependence Treatment (weekly follow-up sessions for 6 wks after discharge followed by monthly follow-up sessions x 4 or 5 to get them out to 6m after discharge. </P>
<P>2. Control: Placebo (12 weeks) + same as intervention group</P>
<P>[Both arms: intensity 4]</P>
<P>Pharmacotherapy: Varenicline in intervention group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:22:24 +0100" MODIFIED_BY="[Empty name]">
<P>Abstinence: sustained abstinence at 6 months (abstinent at 4w, 12w &amp; 6m visits)</P>
<P>Validation: expired CO (&lt;8ppm)</P>
<P>Died: 0</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-03-05 09:44:34 +0000" MODIFIED_BY="[Empty name]">
<P>OR adjusted for age, race, education and level of dependence 0.34 (95% CI 0.10-1.23)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:22:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Stevens-1993">
<CHAR_METHODS MODIFIED="2012-04-05 17:22:36 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: USA<BR/>Recruitment: Inpatients with stay &gt;36 hrs excluding postpartum and psychiatric patients.<BR/>Selected: Invited to participate</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:22:43 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 1119 current smokers or recent quitters (5%, defined as smoking regularly at any time in previous 3m)<BR/>Number smoked: 20 cpd<BR/>Age: 44 yrs av.<BR/>17% cardiovascular or respiratory diagnosis<BR/>Therapists: Masters level cessation counsellors</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 13:55:47 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Counselling (1x, total 20 mins, type behavioural). Self-help materials, video. follow-up (1-2x at 1-3 wks by telephone); [Intensity 3]<BR/>2. Control: Usual care<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:22:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Sustained abstinence at 3 and 12m<BR/>Validation: None (low success in obtaining cotinine returns)<BR/>Died: None reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No significant baseline differences between patient characteristics in intervention and control.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:23:33 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Stevens-2000">
<CHAR_METHODS MODIFIED="2012-04-05 17:23:15 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: USA<BR/>Recruitment: Inpatients with stay &gt;36 hours excluding postpartum and psychiatric patients<BR/>Selected: Invited to participate<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:23:23 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 1173 current smokers or recent quitters (proportion not stated, defined as smoking regularly at any time in previous 3m)<BR/>Numbers smoked: 19 cpd<BR/>Age: 47 yrs av.<BR/>Therapists: Respiratory therapist</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:23:26 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Counselling (1x, total 20 mins, type behavioural). Self-help materials, video. follow-up (1x at 1 wk by telephone) [Intensity 3]<BR/>2. Control: Usual care<BR/>NRT: No</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:23:33 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Sustained abstinence at 6 and 12m<BR/>Validation: None<BR/>Died: None reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Only 68% of intervention group actually offered intervention.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:23:57 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Taylor-1990">
<CHAR_METHODS MODIFIED="2012-04-05 17:23:39 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: USA<BR/>Recruitment: Inpatients with acute MI.<BR/>Selected: Invited to participate if prepared to make a quit attempt<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:23:48 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 173 current smokers (within last 6m)<BR/>Number smoked: 25 cpd<BR/>Age: 58 yrs av.<BR/>10% previous MI<BR/>Therapists: Nurse</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 13:55:49 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Counselling (1x, total not stated, type behavioural), Self-help materials, relaxation tapes. NRT (gum 'available', dose not stated, period not stated). follow-up (6-7x at 1-3 wks, every month for 4m by telephone); [Intensity 4]<BR/>2. Control: Usual care.<BR/>NRT: Yes (partial)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:23:57 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Sustained abstinence at 3 and 12m.<BR/>Validation: Serum thiocyanate, expired air CO<BR/>Died: 7 at 12m</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-03-30 13:45:21 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>NRT gum prescribed to 5 patients.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-04-05 17:24:40 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Vial-2002">
<CHAR_METHODS MODIFIED="2012-04-05 17:24:04 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Country: Australia<BR/>Recruitment: Inpatients (medical and surgical wards) of 1 teaching hospital<BR/>Selected: Willing to stop smoking<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-05 17:24:13 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Participants: 102 current smokers (&gt;= 10 cpd)<BR/>Number smoked: not stated<BR/>Age: not stated<BR/>Therapists: Pharmacist</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-05 17:24:30 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>1. Intervention: Pharmacist consultation about NRT use (30-45 mins)+ booklet + up to 16 wks patches at half-price. Follow-up: weekly visits x &lt;=16 to obtain patches from hospital pharmacist.<BR/>2. Intervention as above, but follow-up patches supplied by community-based pharmacist</P>
<P>[Arms 1 and 2: intensity 4]<BR/>3. Control: usual care: advice to quit + booklet<BR/>NRT: Yes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-05 17:24:40 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Abstinence: Sustained abstinence at 3, 6, 12m.<BR/>Validation: CO test 'whenever possible' - frequency not stated<BR/>Died: not stated</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Smoking cessation counselling not clearly done (pharmacist consultation about NRT) ; deletion of study does not change results.<BR/>1&amp;2 compared to 3 in both the intensity analysis and the NRT efficacy analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>
<B>Intensity of intervention:</B> 1. Single contact in hospital lasting &lt;= 15 mins, no follow-up support. 2. One or more contacts in hospital lasting in total &gt; 15 mins, no follow-up support. 3. Any hospital contact plus follow-up &lt;=1 month. 4. Any hospital contact plus follow-up &gt; 1 month.<BR/>
<B>Abbreviations: </B>ACS: acute coronary syndrome; av: average; CABG/S: coronary artery bypass graft/surgery; CCU: coronary care unit; CHD: coronary heart disease; CHF: congestive heart failure; CI: confidence interval; CO: carbon monoxide; COPD: Chronic Obstructive Pulmonary Disease; cpd: cigarettes per day; CVD: cardiovascular disease; FTND: Fagerstrom Test for Nicotine Dependence; m: month(s); MI: myocardial infarction; NRT: nicotine replacement therapy; OR: odds ratio; PCI: percutaneous coronary intervention; PP: point prevalence; PVD: peripheral vascular disease; yrs: years</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2012-04-10 13:27:00 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Agewall-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Multifactorial intervention. No smoking cessation outcomes reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Allen-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention not delivered in inpatient setting.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Asfar-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention not delivered in inpatient setting.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:02:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Avanzini-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:02:31 +0100" MODIFIED_BY="[Empty name]">
<P>Case control study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Becker-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants admitted to observation unit for less than 24 hour hospital stay. Insufficient data.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bize-2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized (uses historical controls).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Blom-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention not delivered in inpatient setting.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-BTS-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>Included both inpatient and outpatient data (results for inpatients alone not available).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Burt-1974">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Chan-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention not delivered in inpatient setting.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:01:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chan-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:01:44 +0100" MODIFIED_BY="[Empty name]">
<P>Coronary heart disease patients recruited in outpatient clinics.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-05 13:55:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Choo-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-05 13:55:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Short follow-up (1m).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-05 13:55:52 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Colby-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-05 13:55:52 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Short follow-up (3m). Enrolled only adolescents.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cole-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Review article (no new data).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dale-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention not delivered in inpatient setting (some participants admitted to inpatient unit for smoking intervention).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Davies-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Insufficient data on cessation outcome.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Elsony-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention not delivered in inpatient setting.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Emmons-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Baseline and pharmacy data from a trial. Main outcomes not reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:01:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Freund-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:01:34 +0100" MODIFIED_BY="[Empty name]">
<P>Smoking behavior is not measured as outcome.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fung-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:02:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gadomski-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:02:51 +0100" MODIFIED_BY="[Empty name]">
<P>Not randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Galvin-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention not delivered in inpatient setting.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gariti-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants were inpatients in a substance abuse treatment unit.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:00:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gies-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:00:39 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up too short (3 months).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gritz-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention not delivered in inpatient setting (only recruitment carried out in hospital setting).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hand-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Included both inpatient and outpatient data (results for inpatients alone not available).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:00:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hanssen-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:00:02 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention after hospital discharge, intervention was secondary prevention (general cardiac rehab intervention), not limited to smokers.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-03-29 12:30:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hasan-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-03-29 12:30:23 +0100" MODIFIED_BY="[Empty name]">
<P>Not randomized (patients could chose their treatment), tested hypnotherapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hilleman-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:00:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Holmes_x002d_Rovner-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:00:46 +0100" MODIFIED_BY="[Empty name]">
<P>Recruitment after hospital discharge, intervention was secondary prevention, not limited to smokers, and insufficient data in article to calculate quit rates.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 13:27:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Horn-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:00:24 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention in emergency department, not inpatients, teens. No smoking cessation outcome.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jeong-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Multifactorial intervention with little smoking cessation content.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Johnson-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jones-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention delivered after discharge from ITU.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Joseph-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants inpatients for substance abuse treatment.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Joseph-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention goal smoking reduction, not cessation (enrolled only smokers who do not plan to quit).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kalman-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Participants inpatients for alcohol dependence treatment.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:00:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lewis-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:00:55 +0100" MODIFIED_BY="[Empty name]">
<P>Enrolled outpatients and inpatients; inpatients not analysed separately in article.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 08:57:35 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Lisspers-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 08:57:35 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Intervention delivered after discharge following PTCA.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-McHugh-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Multicomponent intervention delivered prior to hospitalisation for CABG.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Meenan-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Moller-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention delivered prior to hospital admission.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:02:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mosca-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:02:06 +0100" MODIFIED_BY="[Empty name]">
<P>Does not only recruit smokers; insufficient data to calculate quit rates. Assesses the impact of a systematic hospital-based educational intervention among women hospitalised with CHD.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:01:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nackaerts-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:01:07 +0100" MODIFIED_BY="[Empty name]">
<P>No data for 6m quit rates</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:02:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nasell-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:02:10 +0100" MODIFIED_BY="[Empty name]">
<P>Outcome is postoperative complications and not smoking cessation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ong-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ranote-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not an RCT (quasi-experimental design). Abstract only. Insufficient data.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ratner-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention delivered prior to hospital admission.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:02:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Regan-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:02:42 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up too short (12 wks).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Reid-2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not an RCT (uncontrolled cohort study).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-05 13:55:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Richman-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-05 13:55:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Patients not admitted to hospital, follow-up 3m.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rissel-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention delivered to outpatients. Not randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schmitz-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control / usual care group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 08:59:19 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Smith-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 08:59:19 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Not an RCT (evaluates real world effect of intervention used in <LINK REF="STD-DeBusk-1994" TYPE="STUDY">DeBusk 1994</LINK>, <LINK REF="STD-Miller-1997" TYPE="STUDY">Miller 1997</LINK> and <LINK REF="STD-Taylor-1990" TYPE="STUDY">Taylor 1990</LINK>).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Strecher-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:00:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sundblad-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:00:09 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention starts before hospital stay; this is a residential smoking cessation program.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 08:59:50 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Takahashi-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 08:59:50 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Intervention not delivered in inpatient setting.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 08:59:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Targhetta-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 08:59:56 +0100" MODIFIED_BY="[Empty name]">
<P>No follow-up assessment after discharge.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Taylor-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not an RCT (observational study only).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:02:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Thomsen-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:02:24 +0100" MODIFIED_BY="[Empty name]">
<P>Does not start in hospital but before hospitalisation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 08:59:34 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Wakefield-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 08:59:34 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Intervention not delivered in inpatient setting.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Warner-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention not delivered in inpatient setting (prior to hospital admission).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-05 13:55:51 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" STUDY_ID="STD-Wewers-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-05 13:55:51 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Short follow-up (5 wks).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:02:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Winickoff-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:02:18 +0100" MODIFIED_BY="[Empty name]">
<P>Subjects are not hospital patients but the parents of hospitalised children.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wolfenden-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention not delivered in inpatient setting (begun pre-operatively).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-10 09:00:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wolfenden-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-10 09:00:16 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT, starts before hospital admission.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>CABG: coronary artery bypass graft; ITU: Intensive Therapy Unit; m: month(s); PTCA: percutaneous transluminal coronary angioplasty; wk(s): week(s)</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2012-03-28 18:07:57 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2012-03-28 18:07:57 +0100" MODIFIED_BY="Lindsay Stead" NOTES="&lt;p&gt;&lt;span modified=&quot;2012-03-01 11:11:00 +0100&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;More info needed in order to make a decision. &lt;/span&gt;&lt;span modified=&quot;2012-03-01 11:12:00 +0100&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Authors contacted but no response sofar.&lt;/span&gt;&lt;/p&gt;" NOTES_MODIFIED="2012-03-28 18:07:57 +0100" NOTES_MODIFIED_BY="Lindsay Stead" STUDY_ID="STD-Brunner_x002d_Frandsen-2010">
<CHAR_METHODS MODIFIED="2012-03-28 18:07:57 +0100" MODIFIED_BY="Lindsay Stead"/>
<CHAR_PARTICIPANTS MODIFIED="2012-03-28 18:07:57 +0100" MODIFIED_BY="Lindsay Stead"/>
<CHAR_INTERVENTIONS MODIFIED="2012-03-28 18:07:57 +0100" MODIFIED_BY="Lindsay Stead"/>
<CHAR_OUTCOMES MODIFIED="2012-03-28 18:07:57 +0100" MODIFIED_BY="Lindsay Stead"/>
<CHAR_NOTES MODIFIED="2012-03-28 18:07:57 +0100" MODIFIED_BY="Lindsay Stead"/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2012-03-01 10:11:37 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;&lt;span modified=&quot;2012-03-01 11:11:00 +0100&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;More info needed in order to make a decision. 2 attempts made to contact authors but no answer so far.&lt;/span&gt;&lt;/p&gt;" NOTES_MODIFIED="2012-03-01 10:11:37 +0000" NOTES_MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jimenez-2007">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2012-03-28 18:07:57 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-04-10 09:18:47 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2012-04-05 17:20:23 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-21 14:17:41 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bolman-2002">
<DESCRIPTION>
<P>Cluster randomized by hospital, 4/11 self-selected intervention condition, although exclusion of these did not change results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 08:51:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Borglykke-2008">
<DESCRIPTION>
<P>Not randomized. Participants assigned to intervention ward or control ward based on vacancy.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-21 14:22:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-CASIS-1992">
<DESCRIPTION>
<P>Randomized, method not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:14:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Campbell-1991">
<DESCRIPTION>
<P>"those who had agreed were given packages of identical appearance randomly containing either nicotine (2mg) or placebo gum"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:19:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Campbell-1996">
<DESCRIPTION>
<P>"randomized," method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 16:47:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caruthers-2006">
<DESCRIPTION>
<P>Adaptive randomization by minimization was computer generated via a program which provided stratification by gender, ethnicity, and whether the participant was admitted with or without tobacco related disorder(s)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 09:06:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chouinard-2005">
<DESCRIPTION>
<P>"Cluster randomization was used... by first randomly assigning individuals to predetermined clusters of three to six subjects. The group assignment was then randomly assigned to each of these clusters."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:20:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cossette-2011">
<DESCRIPTION>
<P>Not specified, but generated by a centre for randomized controlled trials</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-21 14:24:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Croghan-2005">
<DESCRIPTION>
<P>Randomized, method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:26:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-DeBusk-1994">
<DESCRIPTION>
<P>"Patients were randomly assigned using a computer program that achieved a balanced allocation to the two management conditions within each hospital."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:27:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dornelas-2000">
<DESCRIPTION>
<P>Method of sequence generation not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 09:22:22 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Feeney-2001">
<DESCRIPTION>
<P>"A random list of odd and even numbers was generated and a sequence of 200 sealed envelopes created."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-21 14:01:59 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Floter-2009">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 09:23:34 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Froelicher-2004">
<DESCRIPTION>
<P>"Randomization was by random permuted blocks, stratified by hospital, with an equal chance of assignment to the usual-care group or the intervention group."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:31:39 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Hajek-2002">
<DESCRIPTION>
<P>"Participants...were randomised to the intervention or control group on a 1:1 ratio by nurses opening a serially numbered.... envelope."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 09:25:06 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Hasuo-2004">
<DESCRIPTION>
<P>Computerized randomization stratified by smoking status, FTND, and self-efficacy</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 16:58:49 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Haug-2011">
<DESCRIPTION>
<P>Quasi randomized study. Randomly assigned to intervention or control group based on the calendar week of admission.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 16:59:37 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Hennrikus-2005">
<DESCRIPTION>
<P>Method of sequence generation not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 09:36:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lacasse-2008">
<DESCRIPTION>
<P>"table of random numbers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 09:44:33 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Lewis-1998">
<DESCRIPTION>
<P>"using a predetermined computer-generated randomization code"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 09:49:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Metz-2007">
<DESCRIPTION>
<P>Randomized, 1:2 ratio, method not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:35:01 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Meysman-2010">
<DESCRIPTION>
<P>Participants stratified by stage of change. Method of randomization not specified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 09:54:55 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Miller-1997">
<DESCRIPTION>
<P>Method of sequence generation not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:35:44 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Mohiuddin-2007">
<DESCRIPTION>
<P>"Consenting patients were then randomly assigned using simple randomization without block assignment." </P>
<P>Comment: method not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 10:08:51 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Molyneux-2003">
<DESCRIPTION>
<P>"Patients were randomised ... using a list generated for each centre,<BR/>allocating equally in random permuted blocks of nine".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 17:05:23 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Nagle-2005">
<DESCRIPTION>
<P>Computerised. "Randomization was based on blocks of 20 patients... Stratification into recent smoker and recent quitter categories occurred prior to randomization."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 10:14:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ortega-2011">
<DESCRIPTION>
<P>Participants were randomized using a "computerized algorithm."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 10:18:44 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Ortigosa-2000">
<DESCRIPTION>
<P>Stratified randomization, method of sequence generation not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 17:08:24 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Pedersen-2005">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:38:23 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Pederson-1991">
<DESCRIPTION>
<P>Details not provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 10:37:59 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="NO" STUDY_ID="STD-Pelletier-1998">
<DESCRIPTION>
<P>Quasi experimental design. 2 control hospitals, 1 experimental hospital.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 11:07:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Planer-2011">
<DESCRIPTION>
<P>"Randomized," method not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:39:24 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Quist_x002d_Paulsen-2003">
<DESCRIPTION>
<P>"Randomization was in blocks of varying sizes." Method not specified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 17:12:25 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Reid-2003">
<DESCRIPTION>
<P>"random numbers table," stratified by diagnosis on admission and degree of nicotine dependence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:40:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reid-2007">
<DESCRIPTION>
<P>"mediated through the Clinical Epidemiology Unit&#8217;s data centre, using a computer generated randomization list" </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:40:29 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Rigotti-1994">
<DESCRIPTION>
<P>"Patients were randomly assigned to control or intervention groups after surgery." Method not specified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:41:05 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Rigotti-1997">
<DESCRIPTION>
<P>Each day's list of eligible smokers put in random order and patients recruited consecutively in this order. Randomized by research assistant.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 11:38:40 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Rigotti-2006">
<DESCRIPTION>
<P>"Using a computer program, the study statistician generated a sequence of randomly-permuted blocks of 4 within strata formed by study site and daily cigarette consumption (10 vs 10)."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 11:41:21 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Simon-1997">
<DESCRIPTION>
<P>"Random list of assignments"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 11:42:23 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Simon-2003">
<DESCRIPTION>
<P>"Randomly assigned using computerized algorithm"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 11:46:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Simon-2009">
<DESCRIPTION>
<P>"computer algorithm to generate a random list of treatment assignments."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 11:57:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smith-2009">
<DESCRIPTION>
<P>"... randomization code using a computer random-number generator to select random permuted blocks of 10... stratified by acute MI and CABG."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 17:20:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smith-BJ-2011">
<DESCRIPTION>
<P>A pre-defined, central, computer-generated randomisation sequence was used to assign subjects in a 1:1 ratio to either intervention or control</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-05 09:36:53 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smith-PM-2011">
<DESCRIPTION>
<P>computerized random number generator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:43:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Steinberg-2011">
<DESCRIPTION>
<P>"randomized in a 1:1 ratio through centralized telephone randomization process by the study statistician and hospital research pharmacist"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:44:08 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="NO" STUDY_ID="STD-Stevens-1993">
<DESCRIPTION>
<P>Not random, intervention alternated between hospitals on a monthly basis in order to avoid contamination</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:03:45 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="NO" STUDY_ID="STD-Stevens-2000">
<DESCRIPTION>
<P>"Eligible smokers in each hospital were assigned to treatment or usual care by a random digit in their HMO member number."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:07:00 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Taylor-1990">
<DESCRIPTION>
<P>"A random list of odd and even numbers was generated"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:10:31 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Vial-2002">
<DESCRIPTION>
<P>"consenting patients were randomized in blocks of ten using computer-generated random numbers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:25:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-de-Azevedo-2010">
<DESCRIPTION>
<P>"An allocation sequence based on a random-number table was used to randomly assign all enrolled subjects"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2012-04-10 09:16:52 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:14:12 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bolman-2002">
<DESCRIPTION>
<P>Participants identified by ward nurses. Possibility of selection bias although control group nurses said to be blind to condition.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 16:43:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borglykke-2008">
<DESCRIPTION>
<P>"On hospital admission, the patients were met by the medical officer in charge of the distribution of patients...who had no knowledge of the study being conducted. The medical officer randomly assigned the patients to one of the hospital wards by ... vacancy."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-21 14:22:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-CASIS-1992">
<DESCRIPTION>
<P>No details reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-21 14:21:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Campbell-1991">
<DESCRIPTION>
<P>No details reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:16:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Campbell-1996">
<DESCRIPTION>
<P>No details reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-21 14:12:00 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Caruthers-2006">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:20:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chouinard-2005">
<DESCRIPTION>
<P>"Individuals not familiar with the study were in charge of the randomization procedure, which included inserting the information into envelopes that were sealed and would be opened by the investigator only at the time of treatment."</P>
<P>Comment: no other information on envelopes provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 09:08:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cossette-2011">
<DESCRIPTION>
<P>opaque sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-21 14:24:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Croghan-2005">
<DESCRIPTION>
<P>No details reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-10 09:16:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-DeBusk-1994">
<DESCRIPTION>
<P>"Randomization was done centrally; nurses were notified of the assignments by telephone calls from the coordinating centre staff."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:26:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dornelas-2000">
<DESCRIPTION>
<P>"drawing random numbers from an envelope"</P>
<P>Comment: no further details provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:27:28 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Feeney-2001">
<DESCRIPTION>
<P>"With patient consent an envelope was opened and they were assigned to either programme."</P>
<P>Comment: no other detail on envelopes provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-21 14:02:03 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Floter-2009">
<DESCRIPTION>
<P>not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 16:56:10 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Froelicher-2004">
<DESCRIPTION>
<P>Centralized randomization</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 09:24:23 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Hajek-2002">
<DESCRIPTION>
<P>Nurses opened a "serially numbered, opaque, sealed envelope designating the patient's allocation."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 16:57:22 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Hasuo-2004">
<DESCRIPTION>
<P>Computerized programme randomly assigned individual participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 16:58:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Haug-2011">
<DESCRIPTION>
<P>See above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:32:38 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Hennrikus-2005">
<DESCRIPTION>
<P>"Research assistants... randomized [participants] to one of three treatment conditions by looking up the next available group assignment on a list on which the three conditions were randomly ordered within blocks of 30 assignments."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 17:00:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lacasse-2008">
<DESCRIPTION>
<P>"Those who were eligible and who accepted to participate were immediately assigned to either the intervention or the control group by one of the hospital pharmacists."</P>
<P>Comment: Method not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 17:01:22 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Lewis-1998">
<DESCRIPTION>
<P>Central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:34:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Metz-2007">
<DESCRIPTION>
<P>Allocation method not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 09:52:45 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Meysman-2010">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:35:12 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Miller-1997">
<DESCRIPTION>
<P>"Nurses opened sealed envelopes in front of patients to determine patients' assignments."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 09:58:25 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Mohiuddin-2007">
<DESCRIPTION>
<P>Method not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 17:04:41 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Molyneux-2003">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:37:22 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Nagle-2005">
<DESCRIPTION>
<P>"Patients who reported smoking within the last 12 months were entered by the research assistant at the patient's bedside into the LAPSMOKE program on a laptop computer, which gave an immediate random allocation to either control or intervention that could not be changed."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:37:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ortega-2011">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 10:19:41 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Ortigosa-2000">
<DESCRIPTION>
<P>Method not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:38:13 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Pedersen-2005">
<DESCRIPTION>
<P>After enrolling, patients drew an envelope containing an allocation. No further details about the envelope provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:38:41 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Pederson-1991">
<DESCRIPTION>
<P>Details not provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 10:39:58 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="NO" STUDY_ID="STD-Pelletier-1998">
<DESCRIPTION>
<P>See above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-21 17:39:40 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Planer-2011">
<DESCRIPTION>
<P>not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 11:09:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Quist_x002d_Paulsen-2003">
<DESCRIPTION>
<P>"The nurses were given a serially numbered sealed envelope from a secretary who was otherwise uninvolved in the study."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 11:21:01 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Reid-2003">
<DESCRIPTION>
<P>"Assignment numbers were concealed until after baseline assessment and brief individual counselling."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 11:33:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reid-2007">
<DESCRIPTION>
<P>"Research staff were unaware of the treatment allocation prior to randomization"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 11:34:37 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Rigotti-1994">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 17:14:08 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Rigotti-1997">
<DESCRIPTION>
<P>See above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:41:16 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Rigotti-2006">
<DESCRIPTION>
<P>"The study pharmacist used this sequence, concealed from enrolment staff, to assign participants to study arm. Subjects and study personnel, except the statistician and pharmacist, were blind to treatment assignment."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 11:41:30 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Simon-1997">
<DESCRIPTION>
<P>"Sealed opaque envelopes opened on formal enrolment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 11:42:09 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Simon-2003">
<DESCRIPTION>
<P>No details provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-05 17:17:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Simon-2009">
<DESCRIPTION>
<P>"All study personnel engaged in providing interventions to participants were blinded to treatment assignment."</P>
<P>Comment: not explicit that this included enrolment staff.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 11:58:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smith-2009">
<DESCRIPTION>
<P>The nurse "opened the randomization envelope and informed the patients of intervention assignment (intensive or minimal)."</P>
<P>Comment: no details of envelope</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:43:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smith-BJ-2011">
<DESCRIPTION>
<P>Allocation concealment was achieved using opaque, sealed envelopes with consecutive numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-05 09:36:59 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Smith-PM-2011">
<DESCRIPTION>
<P>not specified, randomization envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 12:54:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Steinberg-2011">
<DESCRIPTION>
<P>See above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 12:56:24 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="NO" STUDY_ID="STD-Stevens-1993">
<DESCRIPTION>
<P>Intervention or control status of hospital known when patients recruited</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:03:49 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="NO" STUDY_ID="STD-Stevens-2000">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:07:10 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Taylor-1990">
<DESCRIPTION>
<P>"a sequence of numbers sealed in envelopes was created...the nurse<BR/>assessing the intervention called the nurse coordinator who opened the<BR/>next envelope to determine the condition to which the patient would be<BR/>assigned"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-30 13:10:46 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Vial-2002">
<DESCRIPTION>
<P>Centralized, see above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-10 09:16:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-de-Azevedo-2010">
<DESCRIPTION>
<P>"The allocation was maintained in a serially numbered, opaque envelope, which was opened at the Phase 2 interview to prevent counsellor bias."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2012-04-10 09:18:47 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-07-21 14:20:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bolman-2002">
<DESCRIPTION>
<P>25 deaths, 38 refusals, 64 missing baseline data excluded from analysis denominator.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:14:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borglykke-2008">
<DESCRIPTION>
<P>No loss to follow-up at 1 year.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:19:56 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-CASIS-1992">
<DESCRIPTION>
<P>No mention of losses to follow-up. All survivors included in denominators.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:15:00 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Campbell-1991">
<DESCRIPTION>
<P>"Non-attenders were classified as failures"; rate of drop-outs not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:19:33 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Campbell-1996">
<DESCRIPTION>
<P>ITT analysis, but number lost to follow-up in inpatient-only group not specified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 13:56:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caruthers-2006">
<DESCRIPTION>
<P>10 lost to follow-up in control group and 2 in intervention but ITT analyses conducted</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:20:34 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Chouinard-2005">
<DESCRIPTION>
<P>4 deaths and 3 not meeting follow-up criteria excluded from meta-analysis; all other dropouts and those lost to follow-up counted as smokers; similar numbers in all arms.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:21:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cossette-2011">
<DESCRIPTION>
<P>missing data similar in both groups and analyses are ITT, participants lost to follow-up considered smokers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:22:42 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Croghan-2005">
<DESCRIPTION>
<P>2 lost to follow-up in control group considered smokers. 1 death in intervention group excluded from MA.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:26:29 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-DeBusk-1994">
<DESCRIPTION>
<P>Unclear what percentage of smokers were lost to follow-up. "Among participants who did not relapse before death or dropout, censoring occurred at the last point at which they reported not smoking."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 13:55:21 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Dornelas-2000">
<DESCRIPTION>
<P>20 (20%) lost to follow-up included in ITT analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 09:22:47 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="NO" STUDY_ID="STD-Feeney-2001">
<DESCRIPTION>
<P>Only participants who attended basic ADAU follow-up programme assessed, so large number of drop-outs. More drop-outs in group 2 (79%) than group 1 (51%), so treating drop-outs as smokers may overestimate treatment effect. 9 deaths (4/5) excluded from denominator in analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 13:56:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Floter-2009">
<DESCRIPTION>
<P>According to the text there are 80 lost to follow-up and according to table 2 there are 53 lost to follow-up. Not specified in which group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:31:31 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Froelicher-2004">
<DESCRIPTION>
<P>20 participants (13 intervention; 7 control) lost to follow-up included in meta-analysis as smokers.11 deaths excluded from meta-analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 09:24:40 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Hajek-2002">
<DESCRIPTION>
<P>No significant differences in numbers lost to follow-up or patients who had died or moved away. Those who had died or moved away excluded from outcome data; those lost to follow-up counted as smokers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 09:25:37 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Hasuo-2004">
<DESCRIPTION>
<P>More control participants missing outcome data at 12m than intervention group (9 versus 5). MA denominators exclude 6 deaths, but include 8 who were still smoking on day of discharge. This gives marginally larger relative effect.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 16:58:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haug-2011">
<DESCRIPTION>
<P>Similar in both groups and ITT analyses</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:33:21 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Hennrikus-2005">
<DESCRIPTION>
<P>78 deaths and ineligible (too ill) for follow-up excluded from denominators; all other participants missing data at final follow-up counted as smokers. Similar numbers lost to follow-up in all groups. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:33:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lacasse-2008">
<DESCRIPTION>
<P>Similar numbers lost in both groups (14/99 intervention, 13/97 usual care), "analyses were run according to the intention-to-treat principle."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 17:01:23 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Lewis-1998">
<DESCRIPTION>
<P>Drop-out rates not reported, but analyses conducted as ITT</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:34:48 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Metz-2007">
<DESCRIPTION>
<P>17/316 randomized to I excluded, no contact post discharge. Differential drop-out from remainder, 17% Int, 40% Cont. No detected differences in characteristics of drop-outs. Sensitivity analyses excluding losses to follow-up removes significance.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:35:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meysman-2010">
<DESCRIPTION>
<P>Patients lost to follow-up counted as smokers, exact numbers not provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 13:55:30 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Miller-1997">
<DESCRIPTION>
<P>Deaths excluded from MA denominator; all others lost to follow-up considered smokers; similar loss to follow-up across all groups (10%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 10:00:58 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Mohiuddin-2007">
<DESCRIPTION>
<P>Similar number lost to follow-up in both groups (5/109 intervention, 4/100 control). Participants lost to follow-up counted as smokers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 17:04:52 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Molyneux-2003">
<DESCRIPTION>
<P>Large number lost to follow-up but similar across all groups. Losses to follow-up counted as continuing smokers. All losses fully detailed in flow chart.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:37:37 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Nagle-2005">
<DESCRIPTION>
<P>"At 12 months no difference for completed surveys or for loss to follow-up existed between the intervention group and the control group." 28 deaths at 12m excluded from denominator, all other participants missing data counted as smokers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 10:14:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ortega-2011">
<DESCRIPTION>
<P>Number not specified. Participants lost to follow-up included as smokers in outcome data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 10:21:53 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Ortigosa-2000">
<DESCRIPTION>
<P>No participants lost to follow-up. 3 deaths excluded from the analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:38:18 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Pedersen-2005">
<DESCRIPTION>
<P>10 participants lost to follow-up (7 intervention, 3 control) counted as smokers in final analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 10:29:18 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Pederson-1991">
<DESCRIPTION>
<P>8 deaths excluded, 8 lost to follow-up included and counted as smokers. Similar number lost to follow-up in both groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 10:40:15 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Pelletier-1998">
<DESCRIPTION>
<P>Number lost to follow-up not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:39:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Planer-2011">
<DESCRIPTION>
<P>1 lost to follow-up in each group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 11:13:29 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Quist_x002d_Paulsen-2003">
<DESCRIPTION>
<P>Meta-analysis does not include 5 deaths; all other losses to follow-up considered to be smoking but differential loss to follow-up (15 in intervention group, 2 in control group).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 11:28:17 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Reid-2003">
<DESCRIPTION>
<P>19.5% in usual care and 9.5% in treatment group lost to follow-up at 12m. Participants lost to follow-up counted as smokers in analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 13:55:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reid-2007">
<DESCRIPTION>
<P>~15% lost to follow-up, similar between groups. 1 Control death excluded, others included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 11:34:46 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Rigotti-1994">
<DESCRIPTION>
<P>7 deaths not counted in final meta-analysis. No other patients lost to follow-up at 12m.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 13:55:42 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Rigotti-1997">
<DESCRIPTION>
<P>73 (22.4%) lost to follow-up included in ITT analysis, no evidence of differential loss. 35 (5.4%) deaths excluded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:41:49 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Rigotti-2006">
<DESCRIPTION>
<P>"Subjects were considered smokers if they were lost to follow-up..."; same percentage lost to follow-up in both groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 17:15:14 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Simon-1997">
<DESCRIPTION>
<P>28 lost to follow-up included in ITT analysis, 25 deaths excluded from denominator.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 13:55:46 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Simon-2003">
<DESCRIPTION>
<P>7 (3%) lost to follow-up included in ITT analysis, 14 (6%) died &amp; excluded from denominator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 11:47:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Simon-2009">
<DESCRIPTION>
<P>Similar number lost to follow-up in both groups. All except deaths included in MA.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:43:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smith-2009">
<DESCRIPTION>
<P>Participants lost to follow-up counted as smokers. Similar percentage lost to follow-up in both groups (9.4% control, 8.8% intervention).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-10 09:18:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smith-BJ-2011">
<DESCRIPTION>
<P>low risk (&gt;80% follow-up in both groups)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 12:15:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smith-PM-2011">
<DESCRIPTION>
<P>Participants lost to follow-up counted as smokers but not specified, deaths excluded from final denominators</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 13:56:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Steinberg-2011">
<DESCRIPTION>
<P>ITT analysis conducted; unvalidated smoking status included where ascertained for non-attenders; lost to follow-up the same in 2 groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 13:55:48 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="YES" STUDY_ID="STD-Stevens-1993">
<DESCRIPTION>
<P>6% loss to follow-up, no difference by group, included in ITT analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:04:27 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Stevens-2000">
<DESCRIPTION>
<P>Number lost to follow-up not specified. All not contacted at 1 year were counted as smokers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 13:55:50 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="NO" STUDY_ID="STD-Taylor-1990">
<DESCRIPTION>
<P>14/86 patients in intervention group and 29/87 patients in control group missing data at 12m follow-up. Higher loss to follow-up in control group increases apparent effect of intervention when using ITT approach, so denominators in MA based on numbers followed-up.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-30 13:12:52 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" RESULT="UNKNOWN" STUDY_ID="STD-Vial-2002">
<DESCRIPTION>
<P>Follow-up incomplete due to time constraints; analysis therefore does not include all participants randomized. 64 out of 102 participants included in 12m data, 19 of whom lost to follow-up.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-05 13:56:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-de-Azevedo-2010">
<DESCRIPTION>
<P>32% lost to follow-up in intervention and 22% in control but if analysis are done ITT low risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-08-01 11:11:36 +0100" MODIFIED_BY="Kate Cahill"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2012-04-04 14:52:37 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2012-03-29 12:56:07 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Intervention v Control, by intensity of counselling intervention</NAME>
<DICH_OUTCOME CHI2="70.95250945706937" CI_END="1.3164670704982884" CI_START="1.169742810779598" CI_STUDY="95" CI_TOTAL="95" DF="40" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2409383108533039" ESTIMABLE="YES" EVENTS_1="1774" EVENTS_2="1517" I2="43.62426317817207" I2_Q="78.81924041603547" ID="CMP-001.01" LOG_CI_END="0.11941000033555883" LOG_CI_START="0.06809038470555626" LOG_EFFECT_SIZE="0.09375019252055755" METHOD="MH" MODIFIED="2012-03-29 12:56:07 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0018424809502055606" P_Q="0.002690469681335239" P_Z="8.015632354011232E-13" Q="14.163797988959903" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="38" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="8264" TOTAL_2="8941" WEIGHT="400.0" Z="7.160887650006737">
<NAME>Quit at longest follow-up (6+ months)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5945217500652176" CI_START="0.8208316526770797" DF="0" EFFECT_SIZE="1.144042797860107" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="59" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.20263044761088841" LOG_CI_START="-0.08574590476887706" LOG_EFFECT_SIZE="0.058442271421005665" NO="1" P_CHI2="1.0" P_Z="0.4269559111867268" STUDIES="1" TAU2="0.0" TOTAL_1="678" TOTAL_2="673" WEIGHT="100.0" Z="0.7944115126960242">
<NAME>Intensity 1</NAME>
<DICH_DATA CI_END="1.5945217500652173" CI_START="0.8208316526770797" EFFECT_SIZE="1.144042797860107" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="59" LOG_CI_END="0.20263044761088833" LOG_CI_START="-0.08574590476887706" LOG_EFFECT_SIZE="0.058442271421005665" ORDER="1" O_E="0.0" SE="0.16939369687384068" STUDY_ID="STD-Hennrikus-2005" TOTAL_1="678" TOTAL_2="673" VAR="0.02869422454058662" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="14.20793282395733" CI_END="1.25172369092089" CI_START="0.9613646063097763" DF="8" EFFECT_SIZE="1.0969789666765637" ESTIMABLE="YES" EVENTS_1="384" EVENTS_2="315" I2="43.693427473766995" ID="CMP-001.01.02" LOG_CI_END="0.09750847204381925" LOG_CI_START="-0.01711187093975201" LOG_EFFECT_SIZE="0.04019830055203362" MODIFIED="2012-03-05 13:35:27 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.07650417927832465" P_Z="0.16920862289929742" STUDIES="9" TAU2="0.0" TOTAL_1="2165" TOTAL_2="1810" WEIGHT="100.0" Z="1.3747511003870438">
<NAME>Intensity 2</NAME>
<DICH_DATA CI_END="1.4094562166406508" CI_START="0.8966713656984366" EFFECT_SIZE="1.1241970604246054" ESTIMABLE="YES" EVENTS_1="103" EVENTS_2="110" LOG_CI_END="0.14905158948984848" LOG_CI_START="-0.04736669877871843" LOG_EFFECT_SIZE="0.05084244535556503" MODIFIED="2012-03-05 13:35:27 +0000" MODIFIED_BY="[Empty name]" ORDER="2" O_E="0.0" SE="0.11537707481516396" STUDY_ID="STD-Bolman-2002" TOTAL_1="334" TOTAL_2="401" VAR="0.013311869392903942" WEIGHT="31.775118407060226"/>
<DICH_DATA CI_END="4.538826505183261" CI_START="0.8483427585699576" EFFECT_SIZE="1.9622641509433962" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="7" LOG_CI_END="0.6569435823283083" LOG_CI_START="-0.07142864293232576" LOG_EFFECT_SIZE="0.2927574696979913" ORDER="3" O_E="0.0" SE="0.42784945061876034" STUDY_ID="STD-Chouinard-2005" TOTAL_1="53" TOTAL_2="56" VAR="0.18305515239477504" WEIGHT="2.1636289130236315"/>
<DICH_DATA CI_END="1.3487353440452154" CI_START="0.46984739818794496" EFFECT_SIZE="0.7960526315789473" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="8" LOG_CI_END="0.12992673848068179" LOG_CI_START="-0.3280431737373267" LOG_EFFECT_SIZE="-0.09905821762832248" ORDER="4" O_E="0.0" SE="0.26901379342448517" STUDY_ID="STD-Croghan-2005" TOTAL_1="19" TOTAL_2="11" VAR="0.07236842105263158" WEIGHT="3.220755061183785"/>
<DICH_DATA CI_END="1.1340060760204747" CI_START="0.731341118914741" EFFECT_SIZE="0.9106839586228193" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="102" LOG_CI_END="0.05461538151905246" LOG_CI_START="-0.13588000812129006" LOG_EFFECT_SIZE="-0.04063231330111879" ORDER="5" O_E="0.0" SE="0.11189793484212392" STUDY_ID="STD-Hajek-2002" TOTAL_1="254" TOTAL_2="251" VAR="0.01252114782193221" WEIGHT="32.61203313906312"/>
<DICH_DATA CI_END="3.711722590031634" CI_START="1.1020200265447841" EFFECT_SIZE="2.0224719101123596" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="14" LOG_CI_END="0.5695755100790025" LOG_CI_START="0.042189486837784035" LOG_EFFECT_SIZE="0.30588249845839327" MODIFIED="2012-03-05 13:35:26 +0000" MODIFIED_BY="[Empty name]" ORDER="84" O_E="0.0" SE="0.30978916065481005" STUDY_ID="STD-Meysman-2010" TOTAL_1="178" TOTAL_2="180" VAR="0.0959693240592117" WEIGHT="4.424868574943027"/>
<DICH_DATA CI_END="2.4178661662811507" CI_START="0.4227276077536578" EFFECT_SIZE="1.010989010989011" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="7" LOG_CI_END="0.3834322581235215" LOG_CI_START="-0.37393938807459814" LOG_EFFECT_SIZE="0.0047464350244616526" ORDER="6" O_E="0.0" SE="0.44488385402688807" STUDY_ID="STD-Molyneux-2003" TOTAL_1="182" TOTAL_2="92" VAR="0.19792164357381747" WEIGHT="2.955658337457844"/>
<DICH_DATA CI_END="1.2887952330925918" CI_START="0.6095630985450564" EFFECT_SIZE="0.8863419293218721" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="54" LOG_CI_END="0.11018392107549142" LOG_CI_START="-0.2149813319954519" LOG_EFFECT_SIZE="-0.052398705459980245" MODIFIED="2012-03-05 13:28:47 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.191003679247834" STUDY_ID="STD-Nagle-2005" TOTAL_1="698" TOTAL_2="696" VAR="0.03648240548620946" WEIGHT="17.187858646946392"/>
<DICH_DATA CI_END="3.5919181057431198" CI_START="0.6066781752376925" EFFECT_SIZE="1.4761904761904763" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.5553264263724084" LOG_CI_START="-0.21704162817170153" LOG_EFFECT_SIZE="0.16914239910035345" MODIFIED="2012-03-02 09:09:49 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="0.4536928185227413" STUDY_ID="STD-Pederson-1991" TOTAL_1="35" TOTAL_2="31" VAR="0.20583717357910905" WEIGHT="2.022603357800822"/>
<DICH_DATA CI_END="4.24370380372491" CI_START="0.9517462570083366" EFFECT_SIZE="2.0097087378640777" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="7" LOG_CI_END="0.6277450639906315" LOG_CI_START="-0.02147882248714043" LOG_EFFECT_SIZE="0.30313312075174553" MODIFIED="2012-03-05 13:35:26 +0000" MODIFIED_BY="[Empty name]" ORDER="9" O_E="0.0" SE="0.38135732462711136" STUDY_ID="STD-Pelletier-1998" TOTAL_1="412" TOTAL_2="92" VAR="0.145433409046748" WEIGHT="3.637475562521161"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.618893173551498" CI_END="1.2360191155661102" CI_START="0.9316041749699869" DF="5" EFFECT_SIZE="1.0730706260093503" ESTIMABLE="YES" EVENTS_1="274" EVENTS_2="354" I2="11.014503291585424" ID="CMP-001.01.03" LOG_CI_END="0.09202518735529255" LOG_CI_START="-0.03076857384885907" LOG_EFFECT_SIZE="0.030628306753216733" MODIFIED="2012-03-05 13:35:24 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.3450849770760428" P_Z="0.3282013976105358" STUDIES="6" TAU2="0.0" TOTAL_1="1844" TOTAL_2="2632" WEIGHT="100.00000000000001" Z="0.9777431288865859">
<NAME>Intensity 3</NAME>
<DICH_DATA CI_END="1.4231241916742745" CI_START="0.8109304860574476" EFFECT_SIZE="1.0742694226657163" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="122" LOG_CI_END="0.15324280128271253" LOG_CI_START="-0.09101637244182802" LOG_EFFECT_SIZE="0.031113214420442244" ORDER="10" O_E="0.0" SE="0.14347904774820525" STUDY_ID="STD-Miller-1997" TOTAL_1="460" TOTAL_2="942" VAR="0.020586237142731757" WEIGHT="27.358889097490472"/>
<DICH_DATA CI_END="1.22269690535196" CI_START="0.6604363096668469" EFFECT_SIZE="0.8986175115207373" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="31" LOG_CI_END="0.0873188130076865" LOG_CI_START="-0.1801690579797095" LOG_EFFECT_SIZE="-0.0464251224860115" ORDER="11" O_E="0.0" SE="0.1571236995043124" STUDY_ID="STD-Ortigosa-2000" TOTAL_1="42" TOTAL_2="45" VAR="0.024687856945921464" WEIGHT="10.228702368921173"/>
<DICH_DATA CI_END="1.5316391466485235" CI_START="0.6513038433384127" EFFECT_SIZE="0.998780487804878" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="20" LOG_CI_END="0.18515645780373388" LOG_CI_START="-0.18621635905033032" LOG_EFFECT_SIZE="-5.299506232982156E-4" MODIFIED="2012-03-05 13:28:49 +0000" MODIFIED_BY="[Empty name]" ORDER="12" O_E="0.0" SE="0.21814623094516886" STUDY_ID="STD-Rigotti-1994" TOTAL_1="41" TOTAL_2="39" VAR="0.04758777807558295" WEIGHT="7.005718385165481"/>
<DICH_DATA CI_END="1.5633313656656305" CI_START="0.5519835429462017" EFFECT_SIZE="0.9289419712872482" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="27" LOG_CI_END="0.19405104137638243" LOG_CI_START="-0.2580738703037663" LOG_EFFECT_SIZE="-0.032011414463691906" ORDER="13" O_E="0.0" SE="0.26558041117532705" STUDY_ID="STD-Rigotti-1997" TOTAL_1="307" TOTAL_2="308" VAR="0.07053295480005578" WEIGHT="9.212040403670303"/>
<DICH_DATA CI_END="2.0536429118267367" CI_START="1.052512164108197" EFFECT_SIZE="1.4701986754966887" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="61" LOG_CI_END="0.3125249305440117" LOG_CI_START="0.022227123770926654" LOG_EFFECT_SIZE="0.16737602715746916" MODIFIED="2012-03-05 13:35:24 +0000" MODIFIED_BY="[Empty name]" ORDER="14" O_E="0.0" SE="0.1705223686958293" STUDY_ID="STD-Stevens-1993" TOTAL_1="453" TOTAL_2="666" VAR="0.02907787822563634" WEIGHT="16.878224559147124"/>
<DICH_DATA CI_END="1.2788865042119917" CI_START="0.7315148977162422" EFFECT_SIZE="0.9672251704330889" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="93" LOG_CI_END="0.10683200438361651" LOG_CI_START="-0.1357768247948919" LOG_EFFECT_SIZE="-0.014472410205637668" MODIFIED="2012-03-05 13:35:24 +0000" MODIFIED_BY="[Empty name]" ORDER="15" O_E="0.0" SE="0.14250962719252866" STUDY_ID="STD-Stevens-2000" TOTAL_1="541" TOTAL_2="632" VAR="0.020308993842553507" WEIGHT="29.31642518560546"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="35.461488434549594" CI_END="1.4808320828054886" CI_START="1.27055167024213" DF="24" EFFECT_SIZE="1.3716682092097365" ESTIMABLE="YES" EVENTS_1="1048" EVENTS_2="789" I2="32.320945737243335" ID="CMP-001.01.04" LOG_CI_END="0.17050581500636205" LOG_CI_START="0.10399233144442621" LOG_EFFECT_SIZE="0.13724907322539412" MODIFIED="2012-03-29 12:56:07 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.06184504321389228" P_Z="6.031333860582479E-16" STUDIES="25" TAU2="0.0" TOTAL_1="3577" TOTAL_2="3826" WEIGHT="100.00000000000003" Z="8.088682956525146">
<NAME>Intensity 4</NAME>
<DICH_DATA CI_END="4.1563437329501225" CI_START="1.3111018884894887" EFFECT_SIZE="2.3343928798474254" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="13" LOG_CI_END="0.6187114568712981" LOG_CI_START="0.1176364429405379" LOG_EFFECT_SIZE="0.368173949905918" MODIFIED="2012-03-28 19:22:25 +0100" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.29433394354425024" STUDY_ID="STD-Borglykke-2008" TOTAL_1="121" TOTAL_2="102" VAR="0.08663247032230989" WEIGHT="1.8414804407101746"/>
<DICH_DATA CI_END="6.245599076604995" CI_START="1.1992932330861175" EFFECT_SIZE="2.736842105263158" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="6" LOG_CI_END="0.7955741021473663" LOG_CI_START="0.07892538321657405" LOG_EFFECT_SIZE="0.4372497426819702" MODIFIED="2012-03-28 19:22:25 +0100" MODIFIED_BY="[Empty name]" ORDER="80" O_E="0.0" SE="0.42096300496831884" STUDY_ID="STD-Caruthers-2006" TOTAL_1="38" TOTAL_2="39" VAR="0.17720985155195682" WEIGHT="0.7730140233936982"/>
<DICH_DATA CI_END="2.179872040097343" CI_START="0.9688693788871531" EFFECT_SIZE="1.4532760472610096" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="28" LOG_CI_END="0.33843100098503537" LOG_CI_START="-0.013734769752474806" LOG_EFFECT_SIZE="0.16234811561628032" MODIFIED="2012-03-29 12:56:05 +0100" MODIFIED_BY="[Empty name]" ORDER="16" O_E="0.0" SE="0.2068639169798934" STUDY_ID="STD-CASIS-1992" TOTAL_1="133" TOTAL_2="123" VAR="0.04279268014826423" WEIGHT="3.797632695656801"/>
<DICH_DATA CI_END="4.380650692204946" CI_START="0.8162114355397149" EFFECT_SIZE="1.8909090909090909" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="7" LOG_CI_END="0.6415386244413569" LOG_CI_START="-0.08819732483228385" LOG_EFFECT_SIZE="0.2766706498045365" MODIFIED="2012-03-28 19:22:25 +0100" MODIFIED_BY="[Empty name]" ORDER="17" O_E="0.0" SE="0.4286505088545431" STUDY_ID="STD-Chouinard-2005" TOTAL_1="55" TOTAL_2="56" VAR="0.18374125874125874" WEIGHT="0.9054844603882639"/>
<DICH_DATA CI_END="2.2928589592378805" CI_START="0.3028727264913275" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.36037734077066724" LOG_CI_START="-0.5187398328659169" LOG_EFFECT_SIZE="-0.07918124604762482" MODIFIED="2012-03-28 19:22:26 +0100" MODIFIED_BY="[Empty name]" ORDER="79" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Cossette-2011" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="0.7831852605436153"/>
<DICH_DATA CI_END="1.3893102988456938" CI_START="0.7177411218840728" EFFECT_SIZE="0.9985815602836879" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="45" LOG_CI_END="0.142799255115612" LOG_CI_START="-0.14403217081418504" LOG_EFFECT_SIZE="-6.164578492864953E-4" MODIFIED="2012-03-05 13:35:21 +0000" MODIFIED_BY="[Empty name]" ORDER="77" O_E="0.0" SE="0.16848619942962004" STUDY_ID="STD-de-Azevedo-2010" TOTAL_1="141" TOTAL_2="132" VAR="0.0283875993982377" WEIGHT="6.067534161354382"/>
<DICH_DATA CI_END="1.6245911445659944" CI_START="1.0851749859801167" EFFECT_SIZE="1.327767175572519" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="64" LOG_CI_END="0.21074408162231625" LOG_CI_START="0.035499774422391606" LOG_EFFECT_SIZE="0.12312192802235393" MODIFIED="2012-03-29 12:56:06 +0100" MODIFIED_BY="[Empty name]" ORDER="18" O_E="0.0" SE="0.1029393735225468" STUDY_ID="STD-DeBusk-1994" TOTAL_1="131" TOTAL_2="121" VAR="0.010596514621214408" WEIGHT="8.68548310105512"/>
<DICH_DATA CI_END="2.3895820758653845" CI_START="0.9299985878490681" EFFECT_SIZE="1.4907407407407407" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="16" LOG_CI_END="0.3783219519872874" LOG_CI_START="-0.03151771089748743" LOG_EFFECT_SIZE="0.17340212054489998" ORDER="19" O_E="0.0" SE="0.24074184671756713" STUDY_ID="STD-Dornelas-2000" TOTAL_1="54" TOTAL_2="46" VAR="0.05795663676098459" WEIGHT="2.2555735503656122"/>
<DICH_DATA CI_END="1.499336398187621" CI_START="0.8763422504507496" EFFECT_SIZE="1.146268656716418" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="55" LOG_CI_END="0.17589908413980726" LOG_CI_START="-0.057326249478436134" LOG_EFFECT_SIZE="0.059286417330685584" MODIFIED="2012-03-28 19:22:27 +0100" MODIFIED_BY="[Empty name]" ORDER="20" O_E="0.0" SE="0.13699771545137687" STUDY_ID="STD-Froelicher-2004" TOTAL_1="134" TOTAL_2="132" VAR="0.018768374038896425" WEIGHT="7.233177155647174"/>
<DICH_DATA CI_END="1.6714829007597893" CI_START="0.7939680384386532" EFFECT_SIZE="1.152" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="25" LOG_CI_END="0.2231019381265218" LOG_CI_START="-0.10019697995213533" LOG_EFFECT_SIZE="0.06145247908719321" MODIFIED="2012-03-05 13:25:29 +0000" MODIFIED_BY="[Empty name]" ORDER="21" O_E="0.0" SE="0.18990738483485792" STUDY_ID="STD-Hasuo-2004" TOTAL_1="60" TOTAL_2="54" VAR="0.03606481481481483" WEIGHT="3.4350230725597157"/>
<DICH_DATA CI_END="1.5793195037908654" CI_START="0.8090875514110221" EFFECT_SIZE="1.1304015880287066" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="59" LOG_CI_END="0.19846999872051715" LOG_CI_START="-0.09200448081371672" LOG_EFFECT_SIZE="0.05323275895340023" MODIFIED="2012-03-28 19:22:30 +0100" MODIFIED_BY="Lindsay Stead" ORDER="22" O_E="0.0" SE="0.17062614715027238" STUDY_ID="STD-Hennrikus-2005" TOTAL_1="666" TOTAL_2="673" VAR="0.029113282091346407" WEIGHT="7.6610608981331385"/>
<DICH_DATA CI_END="1.7035906471622617" CI_START="0.7099717219159818" EFFECT_SIZE="1.0997732426303855" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="27" LOG_CI_END="0.2313652470996627" LOG_CI_START="-0.14875894883081248" LOG_EFFECT_SIZE="0.04130314913442511" MODIFIED="2012-03-28 19:22:31 +0100" MODIFIED_BY="[Empty name]" ORDER="82" O_E="0.0" SE="0.22328683433467778" STUDY_ID="STD-Lacasse-2008" TOTAL_1="98" TOTAL_2="97" VAR="0.04985701038720184" WEIGHT="3.5424071784588134"/>
<DICH_DATA CI_END="5.74214020900589" CI_START="0.4682739487424587" EFFECT_SIZE="1.6397849462365592" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="3" LOG_CI_END="0.7590737926979564" LOG_CI_START="-0.3295000024402174" LOG_EFFECT_SIZE="0.21478689512886953" MODIFIED="2012-03-28 19:22:36 +0100" MODIFIED_BY="[Empty name]" ORDER="23" O_E="0.0" SE="0.6394336357913543" STUDY_ID="STD-Lewis-1998" TOTAL_1="124" TOTAL_2="61" VAR="0.40887537458135026" WEIGHT="0.524945796256261"/>
<DICH_DATA CI_END="1.8219130474732323" CI_START="1.1221915096712487" EFFECT_SIZE="1.429872495446266" ESTIMABLE="YES" EVENTS_1="100" EVENTS_2="122" LOG_CI_END="0.26052764601585654" LOG_CI_START="0.05006697857446477" LOG_EFFECT_SIZE="0.15529731229516067" MODIFIED="2012-03-28 19:22:36 +0100" MODIFIED_BY="[Empty name]" ORDER="24" O_E="0.0" SE="0.12362563785217921" STUDY_ID="STD-Miller-1997" TOTAL_1="540" TOTAL_2="942" VAR="0.015283298334358167" WEIGHT="11.605093334370979"/>
<DICH_DATA CI_END="6.561365310550588" CI_START="1.960217791926911" EFFECT_SIZE="3.586321934945788" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="11" LOG_CI_END="0.8169942182083978" LOG_CI_START="0.2923043267530781" LOG_EFFECT_SIZE="0.5546492724807379" MODIFIED="2012-03-28 19:22:37 +0100" MODIFIED_BY="[Empty name]" ORDER="25" O_E="0.0" SE="0.30820543949770546" STUDY_ID="STD-Mohiuddin-2007" TOTAL_1="109" TOTAL_2="100" VAR="0.09499059293597378" WEIGHT="1.4976700596360362"/>
<DICH_DATA CI_END="2.0276413776188322" CI_START="0.86221933732254" EFFECT_SIZE="1.3222222222222222" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="20" LOG_CI_END="0.306991145191025" LOG_CI_START="-0.06438224128461323" LOG_EFFECT_SIZE="0.12130445195320586" MODIFIED="2012-03-28 19:22:37 +0100" MODIFIED_BY="[Empty name]" ORDER="26" O_E="0.0" SE="0.21814656554370113" STUDY_ID="STD-Pedersen-2005" TOTAL_1="54" TOTAL_2="51" VAR="0.047587924058512296" WEIGHT="2.6852066075781096"/>
<DICH_DATA CI_END="1.8225290309112434" CI_START="1.0026208110635617" EFFECT_SIZE="1.3517786561264822" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="44" LOG_CI_END="0.2606744548852888" LOG_CI_START="0.0011367148753453878" LOG_EFFECT_SIZE="0.1309055848803171" MODIFIED="2012-03-28 19:22:38 +0100" MODIFIED_BY="[Empty name]" ORDER="27" O_E="0.0" SE="0.1524537532143737" STUDY_ID="STD-Quist_x002d_Paulsen-2003" TOTAL_1="115" TOTAL_2="120" VAR="0.02324214686914916" WEIGHT="5.621159458653465"/>
<DICH_DATA CI_END="1.4869744382572234" CI_START="0.7876992096547699" EFFECT_SIZE="1.0822608695652174" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="46" LOG_CI_END="0.1723035028734986" LOG_CI_START="-0.1036395902838186" LOG_EFFECT_SIZE="0.03433195629484004" MODIFIED="2012-03-28 19:22:38 +0100" MODIFIED_BY="[Empty name]" ORDER="28" O_E="0.0" SE="0.16209033886094887" STUDY_ID="STD-Reid-2003" TOTAL_1="125" TOTAL_2="127" VAR="0.02627327795205723" WEIGHT="5.956766201224586"/>
<DICH_DATA CI_END="2.1590891196495003" CI_START="0.814215586490572" EFFECT_SIZE="1.3258823529411765" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" LOG_CI_END="0.334270568861887" LOG_CI_START="-0.0892605881982593" LOG_EFFECT_SIZE="0.1225049903318138" MODIFIED="2012-03-28 19:22:39 +0100" MODIFIED_BY="[Empty name]" ORDER="107" O_E="0.0" SE="0.2487842981701695" STUDY_ID="STD-Reid-2007" TOTAL_1="50" TOTAL_2="49" VAR="0.0618936270160238" WEIGHT="2.241439297852098"/>
<DICH_DATA CI_END="4.268814298017756" CI_START="0.9463354165957388" EFFECT_SIZE="2.009907997169144" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="9" LOG_CI_END="0.6303072625340134" LOG_CI_START="-0.023954906137055098" LOG_EFFECT_SIZE="0.3031761781984791" MODIFIED="2012-03-28 19:22:39 +0100" MODIFIED_BY="[Empty name]" ORDER="29" O_E="0.0" SE="0.38431683652735277" STUDY_ID="STD-Simon-1997" TOTAL_1="157" TOTAL_2="142" VAR="0.147699430838392" WEIGHT="1.2337132365085042"/>
<DICH_DATA CI_END="2.439469971083997" CI_START="0.9206099306476536" EFFECT_SIZE="1.4985994397759104" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="21" LOG_CI_END="0.3872954764869059" LOG_CI_START="-0.03592434466883544" LOG_EFFECT_SIZE="0.17568556590903525" MODIFIED="2012-03-28 19:22:40 +0100" MODIFIED_BY="[Empty name]" ORDER="30" O_E="0.0" SE="0.24860141791878448" STUDY_ID="STD-Simon-2003" TOTAL_1="102" TOTAL_2="107" VAR="0.06180266499123013" WEIGHT="2.6755706986992407"/>
<DICH_DATA CI_END="2.033852957579136" CI_START="1.171162859804435" EFFECT_SIZE="1.5433641975308643" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="48" LOG_CI_END="0.30831955132990224" LOG_CI_START="0.06861729148263655" LOG_EFFECT_SIZE="0.18846842140626938" MODIFIED="2012-02-21 18:12:12 +0000" MODIFIED_BY="[Empty name]" ORDER="89" O_E="0.0" SE="0.14080229397960645" STUDY_ID="STD-Smith-2009" TOTAL_1="135" TOTAL_2="137" VAR="0.01982528598991952" WEIGHT="6.219412363140474"/>
<DICH_DATA CI_END="1.5271887428018558" CI_START="0.8970281440121441" EFFECT_SIZE="1.1704406364749083" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="76" LOG_CI_END="0.18389271413033645" LOG_CI_START="-0.0471939308718193" LOG_EFFECT_SIZE="0.06834939162925856" MODIFIED="2012-03-05 13:25:44 +0000" MODIFIED_BY="[Empty name]" ORDER="112" O_E="0.0" SE="0.1357414391716076" STUDY_ID="STD-Smith-PM-2011" TOTAL_1="301" TOTAL_2="315" VAR="0.018425738308379246" WEIGHT="9.69488421006263"/>
<DICH_DATA CI_END="2.8035917244068473" CI_START="1.2782386626490498" EFFECT_SIZE="1.8930555555555555" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="20" LOG_CI_END="0.4477147693705219" LOG_CI_START="0.10661194943628817" LOG_EFFECT_SIZE="0.2771633594034051" MODIFIED="2012-03-29 12:56:07 +0100" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.2003654849155591" STUDY_ID="STD-Taylor-1990" TOTAL_1="72" TOTAL_2="58" VAR="0.04014632754544714" WEIGHT="2.891760962007195"/>
<DICH_DATA CI_END="34.85339197329303" CI_START="0.6376564385167515" EFFECT_SIZE="4.714285714285714" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="1" LOG_CI_END="1.5422450505430365" LOG_CI_START="-0.1954132508157753" LOG_EFFECT_SIZE="0.6734158998636307" MODIFIED="2012-03-28 19:22:41 +0100" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="1.0207090877654819" STUDY_ID="STD-Vial-2002" TOTAL_1="42" TOTAL_2="22" VAR="1.041847041847042" WEIGHT="0.17132177574391583"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2012-03-29 09:24:14 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Intervention v Control, trials with post discharge intervention</NAME>
<DICH_OUTCOME CHI2="3.5959323431053667" CI_END="2.219947916141418" CI_START="1.0291470239462965" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5115067949608176" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="29" I2="44.381600954348194" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.34634278526247403" LOG_CI_START="0.012477422505329747" LOG_EFFECT_SIZE="0.17941010388390186" METHOD="MH" MODIFIED="2012-03-01 08:06:02 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.16563548244567594" P_Q="1.0" P_Z="0.03516424466843661" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="108" TOTAL_2="108" WEIGHT="100.0" Z="2.106461953232451">
<NAME>Quit at longest follow-up (6+ months)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<DICH_DATA CI_END="6.245599076604995" CI_START="1.1992932330861175" EFFECT_SIZE="2.736842105263158" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="6" LOG_CI_END="0.7955741021473663" LOG_CI_START="0.07892538321657405" LOG_EFFECT_SIZE="0.4372497426819702" MODIFIED="2012-02-28 10:24:16 +0000" MODIFIED_BY="[Empty name]" ORDER="99" O_E="0.0" SE="0.42096300496831884" STUDY_ID="STD-Caruthers-2006" TOTAL_1="38" TOTAL_2="39" VAR="0.17720985155195682" WEIGHT="20.355123499652812"/>
<DICH_DATA CI_END="2.2928589592378805" CI_START="0.3028727264913275" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.36037734077066724" LOG_CI_START="-0.5187398328659169" LOG_EFFECT_SIZE="-0.07918124604762482" MODIFIED="2012-02-28 08:25:38 +0000" MODIFIED_BY="[Empty name]" ORDER="100" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Cossette-2011" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="20.622954072016665"/>
<DICH_DATA CI_END="2.1590891196495003" CI_START="0.814215586490572" EFFECT_SIZE="1.3258823529411765" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" LOG_CI_END="0.334270568861887" LOG_CI_START="-0.0892605881982593" LOG_EFFECT_SIZE="0.1225049903318138" MODIFIED="2012-02-28 08:26:05 +0000" MODIFIED_BY="[Empty name]" ORDER="101" O_E="0.0" SE="0.2487842981701695" STUDY_ID="STD-Reid-2007" TOTAL_1="50" TOTAL_2="49" VAR="0.0618936270160238" WEIGHT="59.02192242833053"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2012-03-29 09:24:21 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Intervention v Control, trials in rehabilitation centers</NAME>
<DICH_OUTCOME CHI2="1.442888494826179" CI_END="2.136227608958444" CI_START="1.368930430805127" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.7100722151503687" ESTIMABLE="YES" EVENTS_1="182" EVENTS_2="99" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.3296475236600959" LOG_CI_START="0.13638137780151527" LOG_EFFECT_SIZE="0.23301445073080557" METHOD="MH" MODIFIED="2012-03-29 09:02:54 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.48604984906425086" P_Q="1.0" P_Z="2.2884539743927034E-6" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="674" TOTAL_2="636" WEIGHT="100.0" Z="4.726124477526911">
<NAME>Quit at longest follow-up (6+ months)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.174800164287492" CI_START="1.1321581904816256" EFFECT_SIZE="1.5691455696202532" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="40" LOG_CI_END="0.33741935713689614" LOG_CI_START="0.05390711276515413" LOG_EFFECT_SIZE="0.1956632349510251" MODIFIED="2012-02-28 08:16:12 +0000" MODIFIED_BY="[Empty name]" ORDER="96" O_E="0.0" SE="0.16653649575220475" STUDY_ID="STD-Floter-2009" TOTAL_1="316" TOTAL_2="211" VAR="0.027734404417424113" WEIGHT="48.286045851884026"/>
<DICH_DATA CI_END="3.2509597485480577" CI_START="1.3822684832936583" EFFECT_SIZE="2.1198347107438016" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="26" LOG_CI_END="0.5120115923531903" LOG_CI_START="0.14059240590957964" LOG_EFFECT_SIZE="0.32630199913138497" MODIFIED="2012-03-29 09:02:54 +0100" MODIFIED_BY="[Empty name]" ORDER="97" O_E="0.0" SE="0.2181734686716016" STUDY_ID="STD-Haug-2011" TOTAL_1="242" TOTAL_2="234" VAR="0.04759966243219832" WEIGHT="26.611352326801768"/>
<DICH_DATA CI_END="2.3838350582423544" CI_START="1.0036217428050374" EFFECT_SIZE="1.546760710553814" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="33" LOG_CI_END="0.3772762025055558" LOG_CI_START="0.0015700614488326553" LOG_EFFECT_SIZE="0.18942313197719424" MODIFIED="2012-02-28 08:17:58 +0000" MODIFIED_BY="[Empty name]" ORDER="98" O_E="0.0" SE="0.22069164703211147" STUDY_ID="STD-Metz-2007" TOTAL_1="116" TOTAL_2="191" VAR="0.04870480306974608" WEIGHT="25.102601821314206"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2012-03-29 11:36:46 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Intervention v Control, trials of pharmacotherapy (pharmacotherapy systematically varied by group)</NAME>
<DICH_OUTCOME CHI2="17.75538385440825" CI_END="1.6103750844015146" CI_START="1.261878665995424" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4255167355232459" ESTIMABLE="YES" EVENTS_1="480" EVENTS_2="333" I2="43.67905486021227" I2_Q="59.643323328048766" ID="CMP-004.01" LOG_CI_END="0.20692704256201658" LOG_CI_START="0.10101759799689379" LOG_EFFECT_SIZE="0.15397232027945518" METHOD="MH" MODIFIED="2012-03-29 11:36:46 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.05923291990563084" P_Q="0.08391893602294143" P_Z="1.2062920305797482E-8" Q="4.955809459380096" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1726" TOTAL_2="1699" WEIGHT="300.0" Z="5.698834577085074">
<NAME>Quit at longest follow-up (6+ months)</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.426937645918013" CI_END="1.7850103838005054" CI_START="1.3350816821509541" DF="5" EFFECT_SIZE="1.5437404787921118" ESTIMABLE="YES" EVENTS_1="357" EVENTS_2="228" I2="32.67750130165566" ID="CMP-004.01.01" LOG_CI_END="0.25164074684269033" LOG_CI_START="0.125507837252826" LOG_EFFECT_SIZE="0.18857429204775814" MODIFIED="2012-02-28 08:32:12 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.19077493303291382" P_Z="4.615697420022151E-9" STUDIES="6" TAU2="0.0" TOTAL_1="1256" TOTAL_2="1231" WEIGHT="100.00000000000001" Z="5.860466107148986">
<NAME>NRT v Placebo or no NRT</NAME>
<DICH_DATA CI_END="1.6866842429902695" CI_START="0.5709226264033885" EFFECT_SIZE="0.9813084112149533" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.22703378776870237" LOG_CI_START="-0.24342274499924546" LOG_EFFECT_SIZE="-0.00819447861527157" ORDER="70" O_E="0.0" SE="0.27634849614528817" STUDY_ID="STD-Campbell-1991" TOTAL_1="107" TOTAL_2="105" VAR="0.07636849132176235" WEIGHT="9.259347460857947"/>
<DICH_DATA CI_END="9.730209366892334" CI_START="0.8315200518768441" EFFECT_SIZE="2.8444444444444446" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.9881221851715154" LOG_CI_START="-0.08012727342646583" LOG_EFFECT_SIZE="0.4539974558725247" ORDER="71" O_E="0.0" SE="0.6274950199005567" STUDY_ID="STD-Campbell-1996" TOTAL_1="30" TOTAL_2="32" VAR="0.39375" WEIGHT="1.2681306225732494"/>
<DICH_DATA CI_END="2.247292501420914" CI_START="0.1977688459172235" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.35165960267531093" LOG_CI_START="-0.7038421207866734" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="72" O_E="0.0" SE="0.6200069371793655" STUDY_ID="STD-Lewis-1998" TOTAL_1="62" TOTAL_2="62" VAR="0.3844086021505376" WEIGHT="2.6208032866513817"/>
<DICH_DATA CI_END="7.6815771425743335" CI_START="0.8136349976048579" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="4" LOG_CI_END="0.8854503963333015" LOG_CI_START="-0.08957037898922633" LOG_EFFECT_SIZE="0.3979400086720376" ORDER="73" O_E="0.0" SE="0.5727320298551304" STUDY_ID="STD-Molyneux-2003" TOTAL_1="91" TOTAL_2="91" VAR="0.32802197802197797" WEIGHT="1.7472021911009212"/>
<DICH_DATA CI_END="1.8360840296926577" CI_START="1.3454872537228346" EFFECT_SIZE="1.5717594150236638" ESTIMABLE="YES" EVENTS_1="305" EVENTS_2="193" LOG_CI_END="0.2638925531161746" LOG_CI_START="0.12887958789385867" LOG_EFFECT_SIZE="0.19638607050501666" MODIFIED="2012-02-28 08:32:12 +0000" MODIFIED_BY="[Empty name]" ORDER="102" O_E="0.0" SE="0.07930728409654485" STUDY_ID="STD-Ortega-2011" TOTAL_1="924" TOTAL_2="919" VAR="0.006289645310770075" WEIGHT="84.5312157198615"/>
<DICH_DATA CI_END="34.85339197329303" CI_START="0.6376564385167515" EFFECT_SIZE="4.714285714285714" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="1" LOG_CI_END="1.5422450505430365" LOG_CI_START="-0.1954132508157753" LOG_EFFECT_SIZE="0.6734158998636307" ORDER="74" O_E="0.0" SE="1.0207090877654819" STUDY_ID="STD-Vial-2002" TOTAL_1="42" TOTAL_2="22" VAR="1.041847041847042" WEIGHT="0.5733007189549898"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.79776418342352" CI_END="1.453812942962365" CI_START="0.7466010582002123" DF="2" EFFECT_SIZE="1.0418340950654603" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="52" I2="28.514346854184314" ID="CMP-004.01.02" LOG_CI_END="0.16250853096227863" LOG_CI_START="-0.12691139885896788" LOG_EFFECT_SIZE="0.017798566051655387" MODIFIED="2012-03-29 09:32:30 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.24687307153693205" P_Z="0.8095045208569454" STUDIES="3" TAU2="0.0" TOTAL_1="240" TOTAL_2="240" WEIGHT="100.0" Z="0.24106528157371515">
<NAME>Bupropion v Placebo</NAME>
<DICH_DATA CI_END="1.4884649830088992" CI_START="0.5839043227075914" EFFECT_SIZE="0.9322666666666667" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="25" LOG_CI_END="0.1727386220765351" LOG_CI_START="-0.2336583096072419" LOG_EFFECT_SIZE="-0.030459843765353416" MODIFIED="2012-03-29 09:32:30 +0100" MODIFIED_BY="[Empty name]" ORDER="103" O_E="0.0" SE="0.23871956936830668" STUDY_ID="STD-Planer-2011" TOTAL_1="75" TOTAL_2="76" VAR="0.056987032799389783" WEIGHT="47.89469513621466"/>
<DICH_DATA CI_END="2.5410344095703565" CI_START="0.8238495702545927" EFFECT_SIZE="1.4468690702087286" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="17" LOG_CI_END="0.40501054611504794" LOG_CI_START="-0.08415208050249424" LOG_EFFECT_SIZE="0.1604292328062768" ORDER="75" O_E="0.0" SE="0.2873365482691978" STUDY_ID="STD-Rigotti-2006" TOTAL_1="124" TOTAL_2="122" VAR="0.08256229197125704" WEIGHT="33.052064215540845"/>
<DICH_DATA CI_END="1.5362859337012964" CI_START="0.24590157701876814" EFFECT_SIZE="0.6146341463414634" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.1864720541536976" LOG_CI_START="-0.6092386860300804" LOG_EFFECT_SIZE="-0.2113833159381914" MODIFIED="2012-02-28 09:15:41 +0000" MODIFIED_BY="[Empty name]" ORDER="104" O_E="0.0" SE="0.4674044276156398" STUDY_ID="STD-Simon-2009" TOTAL_1="41" TOTAL_2="42" VAR="0.21846689895470384" WEIGHT="19.053240648244493"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.5993809102586853" CI_END="1.7567911943815155" CI_START="0.94848558399072" DF="1" EFFECT_SIZE="1.2908489926992648" ESTIMABLE="YES" EVENTS_1="69" EVENTS_2="53" I2="61.52930122501816" ID="CMP-004.01.03" LOG_CI_END="0.24472014594787714" LOG_CI_START="-0.022969265556404495" LOG_EFFECT_SIZE="0.11087544019573635" MODIFIED="2012-03-29 11:36:46 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.1069055132147747" P_Z="0.10445864409070926" STUDIES="2" TAU2="0.0" TOTAL_1="230" TOTAL_2="228" WEIGHT="100.0" Z="1.6236119937092997">
<NAME>Varenicline v Placebo or no Varenicline</NAME>
<DICH_DATA CI_END="2.024676658864946" CI_START="1.030912533019682" EFFECT_SIZE="1.444736842105263" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="42" LOG_CI_END="0.30635567620100995" LOG_CI_START="0.013221819465553548" LOG_EFFECT_SIZE="0.15978874783328173" MODIFIED="2012-03-05 09:24:52 +0000" MODIFIED_BY="[Empty name]" ORDER="105" O_E="0.0" SE="0.1721882784823999" STUDY_ID="STD-Smith-BJ-2011" TOTAL_1="190" TOTAL_2="189" VAR="0.029648803246732497" WEIGHT="79.08126144659926"/>
<DICH_DATA CI_END="1.5730494386459286" CI_START="0.3196402509689636" EFFECT_SIZE="0.7090909090909091" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="11" LOG_CI_END="0.1967423720789232" LOG_CI_START="-0.4953385370144125" LOG_EFFECT_SIZE="-0.14929808246774462" MODIFIED="2012-03-29 11:36:46 +0100" MODIFIED_BY="[Empty name]" ORDER="106" O_E="0.0" SE="0.40653175185717694" STUDY_ID="STD-Steinberg-2011" TOTAL_1="40" TOTAL_2="39" VAR="0.16526806526806528" WEIGHT="20.91873855340074"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2012-04-04 14:52:37 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Intervention v Control, by intervention intensity within diagnostic subgroups</NAME>
<DICH_OUTCOME CHI2="22.63210498456427" CI_END="1.278209196369128" CI_START="1.0723868146662965" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1707837924106466" ESTIMABLE="YES" EVENTS_1="829" EVENTS_2="845" I2="20.46696490548932" I2_Q="30.259748874077587" ID="CMP-005.01" LOG_CI_END="0.10660193785500151" LOG_CI_START="0.0303514655562049" LOG_EFFECT_SIZE="0.06847670170560322" METHOD="MH" MODIFIED="2012-03-29 12:13:53 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2051258088859076" P_Q="0.2306774290372916" P_Z="4.3107598324733403E-4" Q="4.301676508997975" RANDOM="NO" SCALE="100.0" SORT_BY="EFFECT_SIZE" STUDIES="17" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="5604" TOTAL_2="6624" WEIGHT="400.0" Z="3.520289516297013">
<NAME>All hospital patients, unselected by diagnosis</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5945217500652176" CI_START="0.8208316526770797" DF="0" EFFECT_SIZE="1.144042797860107" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="59" I2="0.0" ID="CMP-005.01.01" LOG_CI_END="0.20263044761088841" LOG_CI_START="-0.08574590476887706" LOG_EFFECT_SIZE="0.058442271421005665" NO="1" P_CHI2="1.0" P_Z="0.4269559111867268" STUDIES="1" TAU2="0.0" TOTAL_1="678" TOTAL_2="673" WEIGHT="100.0" Z="0.7944115126960242">
<NAME>intensity 1</NAME>
<DICH_DATA CI_END="1.5945217500652173" CI_START="0.8208316526770797" EFFECT_SIZE="1.144042797860107" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="59" LOG_CI_END="0.20263044761088833" LOG_CI_START="-0.08574590476887706" LOG_EFFECT_SIZE="0.058442271421005665" ORDER="33" O_E="0.0" SE="0.16939369687384068" STUDY_ID="STD-Hennrikus-2005" TOTAL_1="678" TOTAL_2="673" VAR="0.02869422454058662" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.07386274499035442" CI_END="1.2759250098716697" CI_START="0.6413840598875211" DF="1" EFFECT_SIZE="0.9046313961738874" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="61" I2="0.0" ID="CMP-005.01.02" LOG_CI_END="0.10582515028172006" LOG_CI_START="-0.19288183765502712" LOG_EFFECT_SIZE="-0.04352834368665356" NO="2" P_CHI2="0.7857934874851132" P_Z="0.5678492405975946" STUDIES="2" TAU2="0.0" TOTAL_1="880" TOTAL_2="788" WEIGHT="100.0" Z="0.5712218955559762">
<NAME>Intensity 2</NAME>
<DICH_DATA CI_END="1.2887952330925918" CI_START="0.6095630985450564" EFFECT_SIZE="0.8863419293218721" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="54" LOG_CI_END="0.11018392107549142" LOG_CI_START="-0.2149813319954519" LOG_EFFECT_SIZE="-0.052398705459980245" ORDER="35" O_E="0.0" SE="0.191003679247834" STUDY_ID="STD-Nagle-2005" TOTAL_1="698" TOTAL_2="696" VAR="0.03648240548620946" WEIGHT="85.32699955153706"/>
<DICH_DATA CI_END="2.4178661662811507" CI_START="0.4227276077536578" EFFECT_SIZE="1.010989010989011" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="7" LOG_CI_END="0.3834322581235215" LOG_CI_START="-0.37393938807459814" LOG_EFFECT_SIZE="0.0047464350244616526" ORDER="34" O_E="0.0" SE="0.44488385402688807" STUDY_ID="STD-Molyneux-2003" TOTAL_1="182" TOTAL_2="92" VAR="0.19792164357381747" WEIGHT="14.67300044846295"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.140904052684434" CI_END="1.293819841472081" CI_START="0.9367784846510595" DF="3" EFFECT_SIZE="1.1009189754499147" ESTIMABLE="YES" EVENTS_1="227" EVENTS_2="303" I2="27.552052357861736" ID="CMP-005.01.03" LOG_CI_END="0.11187380701142856" LOG_CI_START="-0.02836309242824648" LOG_EFFECT_SIZE="0.04175535729159101" NO="3" P_CHI2="0.2466456295186047" P_Z="0.24314839180691472" STUDIES="4" TAU2="0.0" TOTAL_1="1761" TOTAL_2="2548" WEIGHT="100.0" Z="1.1671535349128934">
<NAME>Intensity 3</NAME>
<DICH_DATA CI_END="1.5633313656656305" CI_START="0.5519835429462017" EFFECT_SIZE="0.9289419712872482" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="27" LOG_CI_END="0.19405104137638243" LOG_CI_START="-0.2580738703037663" LOG_EFFECT_SIZE="-0.032011414463691906" ORDER="37" O_E="0.0" SE="0.26558041117532705" STUDY_ID="STD-Rigotti-1997" TOTAL_1="307" TOTAL_2="308" VAR="0.07053295480005578" WEIGHT="11.13027962542189"/>
<DICH_DATA CI_END="1.2788865042119917" CI_START="0.7315148977162422" EFFECT_SIZE="0.9672251704330889" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="93" LOG_CI_END="0.10683200438361651" LOG_CI_START="-0.1357768247948919" LOG_EFFECT_SIZE="-0.014472410205637668" ORDER="39" O_E="0.0" SE="0.14250962719252866" STUDY_ID="STD-Stevens-2000" TOTAL_1="541" TOTAL_2="632" VAR="0.020308993842553507" WEIGHT="35.42103547478403"/>
<DICH_DATA CI_END="1.4231241916742745" CI_START="0.8109304860574476" EFFECT_SIZE="1.0742694226657163" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="122" LOG_CI_END="0.15324280128271253" LOG_CI_START="-0.09101637244182802" LOG_EFFECT_SIZE="0.031113214420442244" ORDER="36" O_E="0.0" SE="0.14347904774820525" STUDY_ID="STD-Miller-1997" TOTAL_1="460" TOTAL_2="942" VAR="0.020586237142731757" WEIGHT="33.055878236774795"/>
<DICH_DATA CI_END="2.0536429118267367" CI_START="1.052512164108197" EFFECT_SIZE="1.4701986754966887" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="61" LOG_CI_END="0.3125249305440117" LOG_CI_START="0.022227123770926654" LOG_EFFECT_SIZE="0.16737602715746916" ORDER="38" O_E="0.0" SE="0.1705223686958293" STUDY_ID="STD-Stevens-1993" TOTAL_1="453" TOTAL_2="666" VAR="0.02907787822563634" WEIGHT="20.392806663019282"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="14.65316540530539" CI_END="1.4166039946286912" CI_START="1.1231096426250309" DF="11" EFFECT_SIZE="1.261349121436496" ESTIMABLE="YES" EVENTS_1="472" EVENTS_2="422" I2="24.93089584577206" ID="CMP-005.01.04" LOG_CI_END="0.151248462114885" LOG_CI_START="0.05042215596106859" LOG_EFFECT_SIZE="0.10083530903797677" MODIFIED="2012-03-29 12:13:53 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.19893219958916541" P_Z="8.844688618360363E-5" STUDIES="12" TAU2="0.0" TOTAL_1="2285" TOTAL_2="2615" WEIGHT="100.00000000000003" Z="3.9202779834639427">
<NAME>Intensity 4</NAME>
<DICH_DATA CI_END="1.5362859337012964" CI_START="0.24590157701876814" EFFECT_SIZE="0.6146341463414634" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.1864720541536976" LOG_CI_START="-0.6092386860300804" LOG_EFFECT_SIZE="-0.2113833159381914" MODIFIED="2012-03-06 10:05:32 +0000" MODIFIED_BY="[Empty name]" ORDER="213" O_E="0.0" SE="0.4674044276156398" STUDY_ID="STD-Simon-2009" TOTAL_1="41" TOTAL_2="42" VAR="0.21846689895470384" WEIGHT="2.5295353290441605"/>
<DICH_DATA CI_END="1.5376362245082456" CI_START="0.34775882226045496" EFFECT_SIZE="0.73125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.18685360180126925" LOG_CI_START="-0.45872184362079554" LOG_EFFECT_SIZE="-0.13593412090976315" MODIFIED="2012-03-06 10:08:05 +0000" MODIFIED_BY="[Empty name]" ORDER="217" O_E="0.0" SE="0.3792142122909145" STUDY_ID="STD-Steinberg-2011" TOTAL_1="40" TOTAL_2="39" VAR="0.1438034188034188" WEIGHT="3.1113518835788625"/>
<DICH_DATA CI_END="1.3893102988456938" CI_START="0.7177411218840728" EFFECT_SIZE="0.9985815602836879" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="45" LOG_CI_END="0.142799255115612" LOG_CI_START="-0.14403217081418504" LOG_EFFECT_SIZE="-6.164578492864953E-4" MODIFIED="2012-03-06 10:07:15 +0000" MODIFIED_BY="[Empty name]" ORDER="211" O_E="0.0" SE="0.16848619942962004" STUDY_ID="STD-de-Azevedo-2010" TOTAL_1="141" TOTAL_2="132" VAR="0.0283875993982377" WEIGHT="11.901562029939885"/>
<DICH_DATA CI_END="1.5793195037908654" CI_START="0.8090875514110221" EFFECT_SIZE="1.1304015880287066" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="59" LOG_CI_END="0.19846999872051715" LOG_CI_START="-0.09200448081371672" LOG_EFFECT_SIZE="0.05323275895340023" MODIFIED="2012-03-06 09:47:35 +0000" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="0.17062614715027238" STUDY_ID="STD-Hennrikus-2005" TOTAL_1="666" TOTAL_2="673" VAR="0.029113282091346407" WEIGHT="15.027289351746449"/>
<DICH_DATA CI_END="1.6714829007597893" CI_START="0.7939680384386532" EFFECT_SIZE="1.152" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="25" LOG_CI_END="0.2231019381265218" LOG_CI_START="-0.10019697995213533" LOG_EFFECT_SIZE="0.06145247908719321" MODIFIED="2012-03-06 09:47:33 +0000" MODIFIED_BY="[Empty name]" ORDER="40" O_E="0.0" SE="0.18990738483485792" STUDY_ID="STD-Hasuo-2004" TOTAL_1="60" TOTAL_2="54" VAR="0.03606481481481483" WEIGHT="6.737850844373084"/>
<DICH_DATA CI_END="1.5271887428018558" CI_START="0.8970281440121441" EFFECT_SIZE="1.1704406364749083" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="76" LOG_CI_END="0.18389271413033645" LOG_CI_START="-0.0471939308718193" LOG_EFFECT_SIZE="0.06834939162925856" MODIFIED="2012-03-06 10:09:16 +0000" MODIFIED_BY="[Empty name]" ORDER="214" O_E="0.0" SE="0.1357414391716076" STUDY_ID="STD-Smith-PM-2011" TOTAL_1="301" TOTAL_2="315" VAR="0.018425738308379246" WEIGHT="19.016665210400614"/>
<DICH_DATA CI_END="1.8219130474732323" CI_START="1.1221915096712487" EFFECT_SIZE="1.429872495446266" ESTIMABLE="YES" EVENTS_1="100" EVENTS_2="122" LOG_CI_END="0.26052764601585654" LOG_CI_START="0.05006697857446477" LOG_EFFECT_SIZE="0.15529731229516067" MODIFIED="2012-03-06 09:48:08 +0000" MODIFIED_BY="[Empty name]" ORDER="43" O_E="0.0" SE="0.12362563785217921" STUDY_ID="STD-Miller-1997" TOTAL_1="540" TOTAL_2="942" VAR="0.015283298334358167" WEIGHT="22.76356992960507"/>
<DICH_DATA CI_END="2.024676658864946" CI_START="1.030912533019682" EFFECT_SIZE="1.444736842105263" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="42" LOG_CI_END="0.30635567620100995" LOG_CI_START="0.013221819465553548" LOG_EFFECT_SIZE="0.15978874783328173" MODIFIED="2012-03-06 10:08:48 +0000" MODIFIED_BY="[Empty name]" ORDER="215" O_E="0.0" SE="0.1721882784823999" STUDY_ID="STD-Smith-BJ-2011" TOTAL_1="190" TOTAL_2="189" VAR="0.029648803246732497" WEIGHT="10.781983588642184"/>
<DICH_DATA CI_END="2.439469971083997" CI_START="0.9206099306476536" EFFECT_SIZE="1.4985994397759104" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="21" LOG_CI_END="0.3872954764869059" LOG_CI_START="-0.03592434466883544" LOG_EFFECT_SIZE="0.17568556590903525" MODIFIED="2012-03-06 09:48:10 +0000" MODIFIED_BY="[Empty name]" ORDER="44" O_E="0.0" SE="0.24860141791878448" STUDY_ID="STD-Simon-2003" TOTAL_1="102" TOTAL_2="107" VAR="0.06180266499123013" WEIGHT="5.2481732758716895"/>
<DICH_DATA CI_END="5.74214020900589" CI_START="0.4682739487424587" EFFECT_SIZE="1.6397849462365592" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="3" LOG_CI_END="0.7590737926979564" LOG_CI_START="-0.3295000024402174" LOG_EFFECT_SIZE="0.21478689512886953" MODIFIED="2012-03-29 12:13:53 +0100" MODIFIED_BY="[Empty name]" ORDER="42" O_E="0.0" SE="0.6394336357913543" STUDY_ID="STD-Lewis-1998" TOTAL_1="124" TOTAL_2="61" VAR="0.40887537458135026" WEIGHT="1.0296892922817071"/>
<DICH_DATA CI_END="6.245599076604995" CI_START="1.1992932330861175" EFFECT_SIZE="2.736842105263158" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="6" LOG_CI_END="0.7955741021473663" LOG_CI_START="0.07892538321657405" LOG_EFFECT_SIZE="0.4372497426819702" MODIFIED="2012-03-06 10:02:18 +0000" MODIFIED_BY="[Empty name]" ORDER="216" O_E="0.0" SE="0.42096300496831884" STUDY_ID="STD-Caruthers-2006" TOTAL_1="38" TOTAL_2="39" VAR="0.17720985155195682" WEIGHT="1.5162789536532053"/>
<DICH_DATA CI_END="34.85339197329303" CI_START="0.6376564385167515" EFFECT_SIZE="4.714285714285714" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="1" LOG_CI_END="1.5422450505430365" LOG_CI_START="-0.1954132508157753" LOG_EFFECT_SIZE="0.6734158998636307" MODIFIED="2012-03-29 12:13:49 +0100" MODIFIED_BY="[Empty name]" ORDER="45" O_E="0.0" SE="1.0207090877654819" STUDY_ID="STD-Vial-2002" TOTAL_1="42" TOTAL_2="22" VAR="1.041847041847042" WEIGHT="0.3360503108631076"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="42.98932792811756" CI_END="1.3657043704332241" CI_START="1.1807732042234431" CI_STUDY="95" CI_TOTAL="95" DF="23" EFFECT_MEASURE="RR" EFFECT_SIZE="1.26987681508814" ESTIMABLE="YES" EVENTS_1="1049" EVENTS_2="861" I2="46.4983494544081" I2_Q="68.88433315456793" ID="CMP-005.02" LOG_CI_END="0.13535669921033874" LOG_CI_START="0.07216648896580533" LOG_EFFECT_SIZE="0.10376159408807206" METHOD="MH" MODIFIED="2012-04-04 14:52:37 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.006945867181232357" P_Q="0.012005126416405054" P_Z="1.220792173191282E-10" Q="12.85526040585956" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="22" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2886" TOTAL_2="2883" WEIGHT="100.0" Z="6.436724505396906">
<NAME>Patients with cardiovascular disease</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.176796132565347" CI_END="1.2776212188764347" CI_START="0.9414272098435514" DF="3" EFFECT_SIZE="1.096716635837972" ESTIMABLE="YES" EVENTS_1="273" EVENTS_2="226" I2="58.19861753649048" ID="CMP-005.02.01" LOG_CI_END="0.1064021160017661" LOG_CI_START="-0.026213253539369746" LOG_EFFECT_SIZE="0.04009443123119815" NO="1" P_CHI2="0.06647126891135124" P_Z="0.2359635997348143" STUDIES="4" TAU2="0.0" TOTAL_1="1053" TOTAL_2="800" WEIGHT="27.09658749479743" Z="1.1851362548047726">
<NAME>Intensity 2</NAME>
<DICH_DATA CI_END="1.4094562166406508" CI_START="0.8966713656984366" EFFECT_SIZE="1.1241970604246054" ESTIMABLE="YES" EVENTS_1="103" EVENTS_2="110" LOG_CI_END="0.14905158948984848" LOG_CI_START="-0.04736669877871843" LOG_EFFECT_SIZE="0.05084244535556503" ORDER="46" O_E="0.0" SE="0.11537707481516396" STUDY_ID="STD-Bolman-2002" TOTAL_1="334" TOTAL_2="401" VAR="0.013311869392903942" WEIGHT="12.266970642619375"/>
<DICH_DATA CI_END="4.538826505183261" CI_START="0.8483427585699576" EFFECT_SIZE="1.9622641509433962" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="7" LOG_CI_END="0.6569435823283083" LOG_CI_START="-0.07142864293232576" LOG_EFFECT_SIZE="0.2927574696979913" ORDER="47" O_E="0.0" SE="0.42784945061876034" STUDY_ID="STD-Chouinard-2005" TOTAL_1="53" TOTAL_2="56" VAR="0.18305515239477504" WEIGHT="0.8352816193341417"/>
<DICH_DATA CI_END="1.1340060760204747" CI_START="0.731341118914741" EFFECT_SIZE="0.9106839586228193" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="102" LOG_CI_END="0.05461538151905246" LOG_CI_START="-0.13588000812129006" LOG_EFFECT_SIZE="-0.04063231330111879" ORDER="48" O_E="0.0" SE="0.11189793484212392" STUDY_ID="STD-Hajek-2002" TOTAL_1="254" TOTAL_2="251" VAR="0.01252114782193221" WEIGHT="12.590066478686317"/>
<DICH_DATA CI_END="4.24370380372491" CI_START="0.9517462570083366" EFFECT_SIZE="2.0097087378640777" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="7" LOG_CI_END="0.6277450639906315" LOG_CI_START="-0.02147882248714043" LOG_EFFECT_SIZE="0.30313312075174553" ORDER="49" O_E="0.0" SE="0.38135732462711136" STUDY_ID="STD-Pelletier-1998" TOTAL_1="412" TOTAL_2="92" VAR="0.145433409046748" WEIGHT="1.4042687541575936"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.2714834278231701" CI_END="1.2843609758769405" CI_START="0.8438133080388517" DF="2" EFFECT_SIZE="1.0410383680588957" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="125" I2="0.0" ID="CMP-005.02.02" LOG_CI_END="0.10868710145785845" LOG_CI_START="-0.07375362950846108" LOG_EFFECT_SIZE="0.01746673597469865" NO="2" P_CHI2="0.5295425999517159" P_Z="0.7074441308918489" STUDIES="3" TAU2="0.0" TOTAL_1="221" TOTAL_2="394" WEIGHT="11.781990473322814" Z="0.37529090413696553">
<NAME>Intensity 3</NAME>
<DICH_DATA CI_END="1.6139076176493876" CI_START="0.8244993112103038" EFFECT_SIZE="1.153544849197023" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="74" LOG_CI_END="0.20787867146822647" LOG_CI_START="-0.08380970283048629" LOG_EFFECT_SIZE="0.06203448431887011" ORDER="50" O_E="0.0" SE="0.17133919494380326" STUDY_ID="STD-Miller-1997" TOTAL_1="138" TOTAL_2="310" VAR="0.02935711972399062" WEIGHT="5.593946457052536"/>
<DICH_DATA CI_END="1.22269690535196" CI_START="0.6604363096668469" EFFECT_SIZE="0.8986175115207373" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="31" LOG_CI_END="0.0873188130076865" LOG_CI_START="-0.1801690579797095" LOG_EFFECT_SIZE="-0.0464251224860115" ORDER="51" O_E="0.0" SE="0.1571236995043124" STUDY_ID="STD-Ortigosa-2000" TOTAL_1="42" TOTAL_2="45" VAR="0.024687856945921464" WEIGHT="3.672630568288959"/>
<DICH_DATA CI_END="1.5316391466485235" CI_START="0.6513038433384127" EFFECT_SIZE="0.998780487804878" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="20" LOG_CI_END="0.18515645780373388" LOG_CI_START="-0.18621635905033032" LOG_EFFECT_SIZE="-5.299506232982156E-4" ORDER="52" O_E="0.0" SE="0.21814623094516886" STUDY_ID="STD-Rigotti-1994" TOTAL_1="41" TOTAL_2="39" VAR="0.04758777807558295" WEIGHT="2.5154134479813206"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="18.984331550478448" CI_END="1.5603077495508688" CI_START="1.2933556561858217" DF="13" EFFECT_SIZE="1.4205748319860474" ESTIMABLE="YES" EVENTS_1="628" EVENTS_2="456" I2="31.522477020412285" ID="CMP-005.02.03" LOG_CI_END="0.19321026550200698" LOG_CI_START="0.11171796670546656" LOG_EFFECT_SIZE="0.15246411610373675" MODIFIED="2012-02-28 09:20:10 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.12359031157624256" P_Z="2.237141759316257E-13" STUDIES="14" TAU2="0.0" TOTAL_1="1369" TOTAL_2="1450" WEIGHT="54.446842648559574" Z="7.333801620791762">
<NAME>Intensity 4</NAME>
<DICH_DATA CI_END="2.179872040097343" CI_START="0.9688693788871531" EFFECT_SIZE="1.4532760472610096" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="28" LOG_CI_END="0.33843100098503537" LOG_CI_START="-0.013734769752474806" LOG_EFFECT_SIZE="0.16234811561628032" ORDER="53" O_E="0.0" SE="0.2068639169798934" STUDY_ID="STD-CASIS-1992" TOTAL_1="133" TOTAL_2="123" VAR="0.04279268014826423" WEIGHT="3.5698931708393435"/>
<DICH_DATA CI_END="4.380650692204946" CI_START="0.8162114355397149" EFFECT_SIZE="1.8909090909090909" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="7" LOG_CI_END="0.6415386244413569" LOG_CI_START="-0.08819732483228385" LOG_EFFECT_SIZE="0.2766706498045365" ORDER="54" O_E="0.0" SE="0.4286505088545431" STUDY_ID="STD-Chouinard-2005" TOTAL_1="55" TOTAL_2="56" VAR="0.18374125874125874" WEIGHT="0.8511836321448547"/>
<DICH_DATA CI_END="2.2928589592378805" CI_START="0.3028727264913275" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.36037734077066724" LOG_CI_START="-0.5187398328659169" LOG_EFFECT_SIZE="-0.07918124604762482" MODIFIED="2012-02-28 09:19:53 +0000" MODIFIED_BY="[Empty name]" ORDER="108" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Cossette-2011" TOTAL_1="20" TOTAL_2="20" VAR="0.2666666666666667" WEIGHT="0.7362185701408743"/>
<DICH_DATA CI_END="1.6245911445659944" CI_START="1.0851749859801167" EFFECT_SIZE="1.327767175572519" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="64" LOG_CI_END="0.21074408162231625" LOG_CI_START="0.035499774422391606" LOG_EFFECT_SIZE="0.12312192802235393" ORDER="55" O_E="0.0" SE="0.1029393735225468" STUDY_ID="STD-DeBusk-1994" TOTAL_1="131" TOTAL_2="121" VAR="0.010596514621214408" WEIGHT="8.164624989498797"/>
<DICH_DATA CI_END="2.3895820758653845" CI_START="0.9299985878490681" EFFECT_SIZE="1.4907407407407407" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="16" LOG_CI_END="0.3783219519872874" LOG_CI_START="-0.03151771089748743" LOG_EFFECT_SIZE="0.17340212054489998" ORDER="56" O_E="0.0" SE="0.24074184671756713" STUDY_ID="STD-Dornelas-2000" TOTAL_1="54" TOTAL_2="46" VAR="0.05795663676098459" WEIGHT="2.1203094820057182"/>
<DICH_DATA CI_END="1.499336398187621" CI_START="0.8763422504507496" EFFECT_SIZE="1.146268656716418" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="55" LOG_CI_END="0.17589908413980726" LOG_CI_START="-0.057326249478436134" LOG_EFFECT_SIZE="0.059286417330685584" ORDER="57" O_E="0.0" SE="0.13699771545137687" STUDY_ID="STD-Froelicher-2004" TOTAL_1="134" TOTAL_2="132" VAR="0.018768374038896425" WEIGHT="6.799412107692035"/>
<DICH_DATA CI_END="1.894839776669872" CI_START="1.07480099132895" EFFECT_SIZE="1.4270864270864272" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="74" LOG_CI_END="0.27757249290567393" LOG_CI_START="0.031328058327277294" LOG_EFFECT_SIZE="0.1544502756164756" ORDER="58" O_E="0.0" SE="0.14464519980095997" STUDY_ID="STD-Miller-1997" TOTAL_1="182" TOTAL_2="310" VAR="0.02092223382545963" WEIGHT="6.717745056000878"/>
<DICH_DATA CI_END="6.561365310550588" CI_START="1.960217791926911" EFFECT_SIZE="3.586321934945788" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="11" LOG_CI_END="0.8169942182083978" LOG_CI_START="0.2923043267530781" LOG_EFFECT_SIZE="0.5546492724807379" ORDER="59" O_E="0.0" SE="0.30820543949770546" STUDY_ID="STD-Mohiuddin-2007" TOTAL_1="109" TOTAL_2="100" VAR="0.09499059293597378" WEIGHT="1.4078565639536016"/>
<DICH_DATA CI_END="2.0276413776188322" CI_START="0.86221933732254" EFFECT_SIZE="1.3222222222222222" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="20" LOG_CI_END="0.306991145191025" LOG_CI_START="-0.06438224128461323" LOG_EFFECT_SIZE="0.12130445195320586" ORDER="60" O_E="0.0" SE="0.21814656554370113" STUDY_ID="STD-Pedersen-2005" TOTAL_1="54" TOTAL_2="51" VAR="0.047587924058512296" WEIGHT="2.524177954768712"/>
<DICH_DATA CI_END="1.8225290309112434" CI_START="1.0026208110635617" EFFECT_SIZE="1.3517786561264822" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="44" LOG_CI_END="0.2606744548852888" LOG_CI_START="0.0011367148753453878" LOG_EFFECT_SIZE="0.1309055848803171" ORDER="61" O_E="0.0" SE="0.1524537532143737" STUDY_ID="STD-Quist_x002d_Paulsen-2003" TOTAL_1="115" TOTAL_2="120" VAR="0.02324214686914916" WEIGHT="5.284065198457906"/>
<DICH_DATA CI_END="1.4869744382572234" CI_START="0.7876992096547699" EFFECT_SIZE="1.0822608695652174" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="46" LOG_CI_END="0.1723035028734986" LOG_CI_START="-0.1036395902838186" LOG_EFFECT_SIZE="0.03433195629484004" ORDER="62" O_E="0.0" SE="0.16209033886094887" STUDY_ID="STD-Reid-2003" TOTAL_1="125" TOTAL_2="127" VAR="0.02627327795205723" WEIGHT="5.5995460030555915"/>
<DICH_DATA CI_END="2.1590891196495003" CI_START="0.814215586490572" EFFECT_SIZE="1.3258823529411765" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" LOG_CI_END="0.334270568861887" LOG_CI_START="-0.0892605881982593" LOG_EFFECT_SIZE="0.1225049903318138" MODIFIED="2012-02-28 09:20:10 +0000" MODIFIED_BY="[Empty name]" ORDER="109" O_E="0.0" SE="0.2487842981701695" STUDY_ID="STD-Reid-2007" TOTAL_1="50" TOTAL_2="49" VAR="0.0618936270160238" WEIGHT="2.107022843837519"/>
<DICH_DATA CI_END="2.033852957579136" CI_START="1.171162859804435" EFFECT_SIZE="1.5433641975308643" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="48" LOG_CI_END="0.30831955132990224" LOG_CI_START="0.06861729148263655" LOG_EFFECT_SIZE="0.18846842140626938" MODIFIED="2012-02-28 07:55:00 +0000" MODIFIED_BY="[Empty name]" ORDER="94" O_E="0.0" SE="0.14080229397960645" STUDY_ID="STD-Smith-2009" TOTAL_1="135" TOTAL_2="137" VAR="0.01982528598991952" WEIGHT="5.846441586412825"/>
<DICH_DATA CI_END="2.8035917244068473" CI_START="1.2782386626490498" EFFECT_SIZE="1.8930555555555555" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="20" LOG_CI_END="0.4477147693705219" LOG_CI_START="0.10661194943628817" LOG_EFFECT_SIZE="0.2771633594034051" ORDER="63" O_E="0.0" SE="0.2003654849155591" STUDY_ID="STD-Taylor-1990" TOTAL_1="72" TOTAL_2="58" VAR="0.04014632754544714" WEIGHT="2.7183454897509205"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.184070419920617" CI_START="0.6211775471267351" DF="0" EFFECT_SIZE="1.1647727272727273" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="12" I2="0.0" ID="CMP-005.02.04" LOG_CI_END="0.33926663700426496" LOG_CI_START="-0.20678425052105592" LOG_EFFECT_SIZE="0.06624119324160449" NO="4" P_CHI2="1.0" P_Z="0.634413005635142" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="41" WEIGHT="1.5244055099387515" Z="0.47552473958933905">
<NAME>Nicotine replacement therapy</NAME>
<DICH_DATA CI_END="2.184070419920617" CI_START="0.6211775471267351" EFFECT_SIZE="1.1647727272727273" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="12" LOG_CI_END="0.33926663700426496" LOG_CI_START="-0.20678425052105592" LOG_EFFECT_SIZE="0.06624119324160449" ORDER="64" O_E="0.0" SE="0.3207529943278601" STUDY_ID="STD-Campbell-1991" TOTAL_1="44" TOTAL_2="41" VAR="0.10288248337028824" WEIGHT="1.5244055099387515"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.401165331558862" CI_END="1.6372235829248134" CI_START="0.797112393330169" DF="1" EFFECT_SIZE="1.1423883790558238" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="42" I2="28.630834814657216" ID="CMP-005.02.05" LOG_CI_END="0.2141079916905235" LOG_CI_START="-0.09848043850139519" LOG_EFFECT_SIZE="0.05781377659456416" MODIFIED="2012-03-05 14:00:26 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.23652877164232944" P_Z="0.46845355103361563" STUDIES="2" TAU2="0.0" TOTAL_1="199" TOTAL_2="198" WEIGHT="5.150173873381429" Z="0.7249975302414118">
<NAME>Bupropion</NAME>
<DICH_DATA CI_END="1.4884649830088992" CI_START="0.5839043227075914" EFFECT_SIZE="0.9322666666666667" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="25" LOG_CI_END="0.1727386220765351" LOG_CI_START="-0.2336583096072419" LOG_EFFECT_SIZE="-0.030459843765353416" MODIFIED="2012-02-28 07:46:50 +0000" MODIFIED_BY="[Empty name]" ORDER="93" O_E="0.0" SE="0.23871956936830668" STUDY_ID="STD-Planer-2011" TOTAL_1="75" TOTAL_2="76" VAR="0.056987032799389783" WEIGHT="3.047262293629447"/>
<DICH_DATA CI_END="2.5410344095703565" CI_START="0.8238495702545927" EFFECT_SIZE="1.4468690702087286" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="17" LOG_CI_END="0.40501054611504794" LOG_CI_START="-0.08415208050249424" LOG_EFFECT_SIZE="0.1604292328062768" ORDER="65" O_E="0.0" SE="0.2873365482691978" STUDY_ID="STD-Rigotti-2006" TOTAL_1="124" TOTAL_2="122" VAR="0.08256229197125704" WEIGHT="2.102911579751982"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.315144190044641" CI_END="1.5879380374812464" CI_START="0.9528063824027154" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2300396322770148" ESTIMABLE="YES" EVENTS_1="94" EVENTS_2="121" I2="64.64914690597311" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="0.20083355192924093" LOG_CI_START="-0.02099534238065576" LOG_EFFECT_SIZE="0.08991910477429259" METHOD="MH" MODIFIED="2012-03-29 12:55:56 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.023241502935614555" P_Q="0.8819050790054545" P_Z="0.11207026453676465" Q="0.02206848136683262" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="355" TOTAL_2="533" WEIGHT="200.0" Z="1.588956275763526">
<NAME>Patients with respiratory disease</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="8.44901649071837" CI_END="1.6012189440708255" CI_START="0.9293181743809444" DF="2" EFFECT_SIZE="1.2198532148943508" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="110" I2="76.32860579456684" ID="CMP-005.03.01" LOG_CI_END="0.20445071961490324" LOG_CI_START="-0.03183556940746531" LOG_EFFECT_SIZE="0.08630757510371898" MODIFIED="2012-03-06 10:33:04 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.014632553162042039" P_Z="0.15219528956024347" STUDIES="3" TAU2="0.0" TOTAL_1="269" TOTAL_2="446" WEIGHT="100.0" Z="1.4318201830175696">
<NAME>Counselling</NAME>
<DICH_DATA CI_END="4.1563437329501225" CI_START="1.3111018884894887" EFFECT_SIZE="2.3343928798474254" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="13" LOG_CI_END="0.6187114568712981" LOG_CI_START="0.1176364429405379" LOG_EFFECT_SIZE="0.368173949905918" MODIFIED="2012-03-06 10:33:04 +0000" MODIFIED_BY="[Empty name]" ORDER="107" O_E="0.0" SE="0.29433394354425024" STUDY_ID="STD-Borglykke-2008" TOTAL_1="121" TOTAL_2="102" VAR="0.08663247032230989" WEIGHT="20.41399000713776"/>
<DICH_DATA CI_END="1.2374104606839011" CI_START="0.5838806305231032" EFFECT_SIZE="0.85" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="40" LOG_CI_END="0.09251378309023106" LOG_CI_START="-0.23367593166164569" LOG_EFFECT_SIZE="-0.07058107428570727" ORDER="68" O_E="0.0" SE="0.1916054531103814" STUDY_ID="STD-Miller-1997" TOTAL_1="113" TOTAL_2="113" VAR="0.03671264966163457" WEIGHT="57.880734540263454"/>
<DICH_DATA CI_END="2.0479236918233052" CI_START="0.6546729387231122" EFFECT_SIZE="1.1578947368421053" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="57" LOG_CI_END="0.31131377025424345" LOG_CI_START="-0.18397561051548883" LOG_EFFECT_SIZE="0.0636690798693773" ORDER="69" O_E="0.0" SE="0.29093543398611643" STUDY_ID="STD-Pederson-1991" TOTAL_1="35" TOTAL_2="231" VAR="0.08464342674868991" WEIGHT="21.705275452598794"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.8174720490950245" CI_END="2.6893009600318667" CI_START="0.6228018985019109" DF="1" EFFECT_SIZE="1.2941799502197746" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="11" I2="64.50719004217979" ID="CMP-005.03.02" LOG_CI_END="0.4296394068968671" LOG_CI_START="-0.20565007223165158" LOG_EFFECT_SIZE="0.11199466733260775" MODIFIED="2012-03-29 12:55:56 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0932432544285432" P_Z="0.489539828128316" STUDIES="2" TAU2="0.0" TOTAL_1="86" TOTAL_2="87" WEIGHT="100.0" Z="0.6910409243155432">
<NAME>Nicotine replacement therapy</NAME>
<DICH_DATA CI_END="1.9842680974496323" CI_START="0.2734459540046787" EFFECT_SIZE="0.7366071428571429" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.29760034996377377" LOG_CI_START="-0.5631284982042867" LOG_EFFECT_SIZE="-0.13276407412025648" MODIFIED="2012-03-05 14:08:51 +0000" MODIFIED_BY="[Empty name]" ORDER="212" O_E="0.0" SE="0.5055963860904324" STUDY_ID="STD-Campbell-1991" TOTAL_1="56" TOTAL_2="55" VAR="0.2556277056277056" WEIGHT="73.54763543928401"/>
<DICH_DATA CI_END="9.730209366892334" CI_START="0.8315200518768441" EFFECT_SIZE="2.8444444444444446" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.9881221851715154" LOG_CI_START="-0.08012727342646583" LOG_EFFECT_SIZE="0.4539974558725247" MODIFIED="2012-03-05 14:08:51 +0000" MODIFIED_BY="[Empty name]" ORDER="213" O_E="0.0" SE="0.6274950199005567" STUDY_ID="STD-Campbell-1996" TOTAL_1="30" TOTAL_2="32" VAR="0.39375" WEIGHT="26.452364560715992"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2012-03-30 13:55:42 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2012-03-30 09:17:04 +0100" MODIFIED_BY="[Empty name]" NO="1" REF_ID="CMP-001.01" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Intervention v Control, by intensity of counselling intervention, outcome: 1.1 Quit at longest follow-up (6+ months).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsAAAARgCAMAAADQPRAJAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2012-04-05 14:10:37 +0100" MODIFIED_BY="Kate Cahill">
<APPENDIX ID="APP-01" MODIFIED="2012-04-05 14:10:37 +0100" MODIFIED_BY="Jamie Hartmann-Boyce" NO="1">
<TITLE MODIFIED="2012-04-05 14:10:24 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">Details of search strategies for Tobacco Addiction register and CINAHL</TITLE>
<APPENDIX_BODY MODIFIED="2012-04-05 14:10:28 +0100" MODIFIED_BY="Jamie Hartmann-Boyce">
<P>Search strategy for the Tobacco Addiction specialised register:<BR/>(hospital and patient*) or hospitali* or inpatient* or admission* or admitted</P>
<P>Search strategy for CINAHL (EBSCO):<BR/>S14      S4 and S5 and S13      <BR/>S13      S6 or S7 or S8 or S9 or S10 or S11 or S12           <BR/>S12      MH Placebos  <BR/>S11      TX RCT     <BR/>S10      MH (Random assignment OR Clinical Trials+ OR Quantitative Studies)<BR/>S9      TX "control group*"    <BR/>S8      TX "treatment arm"   <BR/>S7      TX (trial and (control* OR comparative))<BR/>S6       TX (random* OR factorial* OR placebo* OR assign* OR allocat*  <BR/>S5        MJ (smok* OR tobacco OR nicotine)<BR/>S4        S1 or S2 or S3<BR/>S3        MJ (hospitali* OR inpatient*)<BR/>S2        TI (hospitali* OR inpatient* OR admission* OR admitted) or AB (hospitali* OR inpatient* OR admission* OR admitted)     <BR/>S1        TI (hospital with patient*) or AB (hospital with patient*)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2012-04-05 14:10:37 +0100" MODIFIED_BY="Kate Cahill" NO="2">
<TITLE MODIFIED="2008-08-01 11:11:22 +0100" MODIFIED_BY="Kate Cahill">Glossary of tobacco-specific terms</TITLE>
<APPENDIX_BODY MODIFIED="2008-08-01 11:11:27 +0100" MODIFIED_BY="Kate Cahill">
<TABLE COLS="2" ROWS="27">
<TR>
<TH>
<P>Term</P>
</TH>
<TH>
<P>Definition</P>
</TH>
</TR>
<TR>
<TD>
<P>Abstinence</P>
</TD>
<TD>
<P>A period of being quit, i.e. stopping the use of cigarettes or other tobacco products, May be defined in various ways; see also:<BR/>point prevalence abstinence; prolonged abstinence; continuous/sustained abstinence<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Biochemical verification</P>
</TD>
<TD>
<P>Also called 'biochemical validation' or 'biochemical confirmation':<BR/>A procedure for checking a tobacco user's report that he or she has not smoked or used tobacco. It can be measured by testing levels of nicotine or cotinine or other chemicals in blood, urine, or saliva, or by measuring levels of carbon monoxide in exhaled breath or in blood.<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Bupropion</P>
</TD>
<TD>
<P>A pharmaceutical drug originally developed as an antidepressant, but now also licensed for smoking cessation; trade names Zyban, Wellbutrin (when prescribed as an antidepressant)</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbon monoxide (CO)</P>
</TD>
<TD>
<P>A colourless, odourless highly poisonous gas found in tobacco smoke and in the lungs of people who have recently smoked, or (in smaller amounts) in people who have been exposed to tobacco smoke. May be used for biochemical verification of abstinence.</P>
</TD>
</TR>
<TR>
<TD>
<P>Cessation</P>
</TD>
<TD>
<P>Also called 'quitting'<BR/>The goal of treatment to help people achieve abstinence from smoking or other tobacco use, also used to describe the process of changing the behaviour<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Continuous abstinence</P>
</TD>
<TD>
<P>Also called 'sustained abstinence'<BR/>A measure of cessation often used in clinical trials involving avoidance of all tobacco use since the quit day until the time the assessment is made. The definition occasionally allows for lapses. This is the most rigorous measure of abstinence<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>'Cold Turkey'</P>
</TD>
<TD>
<P>Quitting abruptly, and/or quitting without behavioural or pharmaceutical support.</P>
</TD>
</TR>
<TR>
<TD>
<P>Craving</P>
</TD>
<TD>
<P>A very intense urge or desire [to smoke].<BR/>See: Shiffman et al 'Recommendations for the assessment of tobacco craving and withdrawal in smoking cessation trials'<BR/>Nicotine &amp; Tobacco Research 2004: 6(4): 599-614<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Dopamine</P>
</TD>
<TD>
<P>A neurotransmitter in the brain which regulates mood, attention, pleasure, reward, motivation and movement</P>
</TD>
</TR>
<TR>
<TD>
<P>Efficacy</P>
</TD>
<TD>
<P>Also called 'treatment effect' or 'effect size':<BR/>The difference in outcome between the experimental and control groups<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Harm reduction</P>
</TD>
<TD>
<P>Strategies to reduce harm caused by continued tobacco/nicotine use, such as reducing the number of cigarettes smoked, or switching to different brands or products, e.g. potentially reduced exposure products (PREPs), smokeless tobacco.</P>
</TD>
</TR>
<TR>
<TD>
<P>Lapse/slip</P>
</TD>
<TD>
<P>Terms sometimes used for a return to tobacco use after a period of abstinence. A lapse or slip might be defined as a puff or two on a cigarette. This may proceed to relapse, or abstinence may be regained. Some definitions of continuous, sustained or prolonged abstinence require complete abstinence, but some allow for a limited number or duration of slips. People who lapse are very likely to relapse, but some treatments may have their effect by helping people recover from a lapse.</P>
</TD>
</TR>
<TR>
<TD>
<P>nAChR</P>
</TD>
<TD>
<P>[neural nicotinic acetylcholine receptors]: Areas in the brain which are thought to respond to nicotine, forming the basis of nicotine addiction by stimulating the overflow of dopamine</P>
</TD>
</TR>
<TR>
<TD>
<P>Nicotine</P>
</TD>
<TD>
<P>An alkaloid derived from tobacco, responsible for the psychoactive and addictive effects of smoking.</P>
</TD>
</TR>
<TR>
<TD>
<P>Nicotine Replacement Therapy (NRT)</P>
</TD>
<TD>
<P>A smoking cessation treatment in which nicotine from tobacco is replaced for a limited period by pharmaceutical nicotine. This reduces the craving and withdrawal experienced during the initial period of abstinence while users are learning to be tobacco-free The nicotine dose can be taken through the skin, using patches, by inhaling a spray, or by mouth using gum or lozenges.</P>
</TD>
</TR>
<TR>
<TD>
<P>Outcome</P>
</TD>
<TD>
<P>Often used to describe the result being measured in trials that is of relevance to the review. For example smoking cessation is the outcome used in reviews of ways to help smokers quit. The exact outcome in terms of the definition of abstinence and the length of time that has elapsed since the quit attempt was made may vary from trial to trial.</P>
</TD>
</TR>
<TR>
<TD>
<P>Pharmacotherapy</P>
</TD>
<TD>
<P>A treatment using pharmaceutical drugs, e.g. NRT, bupropion</P>
</TD>
</TR>
<TR>
<TD>
<P>Point prevalence abstinence (PPA)</P>
</TD>
<TD>
<P>A measure of cessation based on behaviour at a particular point in time, or during a relatively brief specified period, e.g. 24 hours, 7 days. It may include a mixture of recent and long-term quitters. cf. prolonged abstinence, continuous abstinence</P>
</TD>
</TR>
<TR>
<TD>
<P>Prolonged abstinence</P>
</TD>
<TD>
<P>A measure of cessation which typically allows a 'grace period' following the quit date (usually of about two weeks), to allow for slips/lapses during the first few days when the effect of treatment may still be emerging.<BR/>See: Hughes et al 'Measures of abstinence in clinical trials: issues and recommendations'; Nicotine &amp; Tobacco Research, 2003: 5 (1); 13-25<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Relapse</P>
</TD>
<TD>
<P>A return to regular smoking after a period of abstinence</P>
</TD>
</TR>
<TR>
<TD>
<P>Secondhand smoke</P>
</TD>
<TD>
<P>Also called passive smoking or environmental tobacco smoke [ETS]<BR/>A mixture of smoke exhaled by smokers and smoke released from smouldering cigarettes, cigars, pipes, bidis, etc. The smoke mixture contains gases and particulates, including nicotine, carcinogens and toxins.<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Self-efficacy</P>
</TD>
<TD>
<P>The belief that one will be able to change one's behaviour, e.g. to quit smoking</P>
</TD>
</TR>
<TR>
<TD>
<P>SPC [Summary of Product Characteristics]</P>
</TD>
<TD>
<P>Advice from the manufacturers of a drug, agreed with the relevant licensing authority, to enable health professionals to prescribe and use the treatment safely and effectively.</P>
</TD>
</TR>
<TR>
<TD>
<P>Tapering</P>
</TD>
<TD>
<P>A gradual decrease in dose at the end of treatment, as an alternative to abruptly stopping treatment</P>
</TD>
</TR>
<TR>
<TD>
<P>Titration</P>
</TD>
<TD>
<P>A technique of dosing at low levels at the beginning of treatment, and gradually increasing to full dose over a few days, to allow the body to get used to the drug. It is designed to limit side effects.</P>
</TD>
</TR>
<TR>
<TD>
<P>Withdrawal</P>
</TD>
<TD>
<P>A variety of behavioural, affective, cognitive and physiological symptoms, usually transient, which occur after use of an addictive drug is reduced or stopped.<BR/>See: Shiffman et al 'Recommendations for the assessment of tobacco craving and withdrawal in smoking cessation trials'<BR/>Nicotine &amp; Tobacco Research 2004: 6(4): 599-614<BR/>
</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>

<EXTENSION ID="AFF_00175645592969318203110707120830_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="00175645592969318203110707120830"><ADDRESS><DEPARTMENT>Tobacco Research and Treatment Center</DEPARTMENT><ORGANISATION>Massachusetts General Hospital and Harvard Medical School</ORGANISATION><ADDRESS_1>9th Floor</ADDRESS_1><ADDRESS_2>50 Staniford Street</ADDRESS_2><CITY>Boston</CITY><ZIP>02114</ZIP><REGION>Massachusetts</REGION><COUNTRY CODE="US">USA</COUNTRY></ADDRESS></ALIAS></EXTENSION></EXTENSIONS>
</COCHRANE_REVIEW>